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PREFACE 
“The food you eat can either be the safest and most powerful form of medicine…or the 
slowest form of poison.” ~Ann Wigmore 
My interest in nutrition started at an early age when I was encouraged to pursue a career in a 
field that was constantly growing and from which I could always learn.  While gaining a BSc 
in nutrition at the University of Nottingham I was struck by the extent to which nutritional 
status underpinned health across the life course and how it could be a vehicle for optimising 
the health of nations; particularly in vulnerable settings.  I was determined to understand how 
my learning in the field of nutrition could have relevance across populations and enrolled for 
an MSc in Public Health Nutrition at the London School of Hygiene and Tropical Medicine.  
Here I was exposed to some of the leading academics in the field and was inspired by their 
expertise, as well as the opportunities that academia provided to learn and grow across one’s 
career while potentially influencing policy and population health.  With every intention of 
returning to South Africa after my MSc I seized the opportunity to conduct my research 
project at the Developmental Pathways for Health Research Unit (DPHRU) in Johannesburg.  
This, as well as the subsequent year spent as a research assistant with the unit in Cape Town, 
exposed me to the amazing research being done on home soil and the vast opportunities for 
nutrition research in this setting. 
I took a brief break from academia in 2013/2014 in order to gain exposure to the South 
African health system through an Analyst position at Broadreach Healthcare.  My main role 
was to assess key health indicators (predominantly human immunodeficiency virus 
(HIV)/tuberculosis (TB) and maternal and child health focused) across specified health 
districts and to analyse the potential root causes of poor performance in these indicators at 
primary healthcare facilities.  This provided me with unique insight into the South African 
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health system and the various challenges being faced at facility level in improving health 
outcomes.  I was amazed by the lack of focus on nutrition, particularly in optimising health of 
pregnant women who were exposed to multiple morbidities such as obesity and HIV that 
greatly increased the risk of adverse outcomes for themselves and their infants.  However, I 
was pleasantly surprised by the motivation that these pregnant women had to improving their 
health behaviours during pregnancy – for example via adherence to antiretroviral treatment - 
and the window of opportunity for optimising maternal and child health during this time; 
thereby establishing improved health trajectories in the long term.  This is really where my 
interest in maternal and child nutrition was established and I decided that a PhD in this area 
was the perfect next step.  Through discussions with A/Prof Lisa Micklesfied and Prof Shane 
Norris at DPHRU, I discovered that my research aspirations were perfectly aligned with those 
of the unit and that the opportunity to explore maternal dietary intake and its association with 
infant outcomes were available within their wider Soweto First 1000-Day Study (S1000).  I 
was lucky enough to be awarded a PhD Scholarship by the Centre of Excellence (CoE) in 
Human Development at the beginning of 2015; following which I relocated to Johannesburg 
to begin this PhD journey. 
This is a PhD with publications; with each paper filling a key research gap in the field of 
maternal and child nutrition and providing the formative work for my academic career in 
nutritional epidemiology.  Three of the four articles have been published in peer reviewed 
journals; with the fourth currently under review with the British Journal of Nutrition 
(submitted: 20/12/2017).  Section 1 provides the background to my PhD study as well as its 
participants and methods (Chapters 1-3).  Chapter 1 outlines the background and motivation 
for the study and includes the problem statement, conceptual frameworks and global context, 
as well as the overall aim and specific objectives of the PhD.  As a result of the research gaps 
identified in Chapter 1 - particularly with regard to the African setting - Chapter 2 presents 
18 
 
the results of objective one of my study; using a systematic approach to report on the 
available data from Africa.  An outline of the overall study methods – including the study 
context, participants and ethical clearance are presented in Chapter 3.  Section 2 contains the 
empirical chapters, with Chapters 4-6 presenting the results for study objectives 2-4.  Lastly, 
Section 3 provides an integrated discussion of the thesis as a whole, as well as its final 
conclusion.   
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ABSTRACT 
Background: Maternal pre-pregnancy overweight and obesity and excessive gestational 
weight gain (GWG) are established predictors of fetal growth, which substantially increase 
the risk of adverse birth outcomes, such as high birth weight and large-for-gestational age 
deliveries.  While sub-optimal growth in utero has serious implications for infant health in the 
short term, nutritional insults during this critical period of plasticity may additionally impair 
growth and development of body tissues and thereby, increase long-term risk of obesity and 
non-communicable diseases in later life.  This double burden of malnutrition (maternal 
overweight coupled with micronutrient deficiencies) is of particular relevance to low-or 
middle-income countries, such as South Africa, where rapid urbanisation and a transition 
towards diets high in saturated fat, sugar, salt and processed foods and decreased levels of 
physical activity has resulted in substantial increases in obesity.  Although the implications of 
anthropometrically defined maternal nutritional status (MNS) on birth size have been well 
established, the role of dietary patterns within these relationships has not been thoroughly 
examined.  In addition, the use of birth weight as a proxy for fetal growth does not 
distinguish between the components of body composition (i.e. fat mass and fat-free mass), 
which may be more indicative of metabolic risk.  Lastly, the influence of other maternal 
factors such as human immunodeficiency virus (HIV) on the associations between maternal 
nutrition and infant outcomes and metabolic risk is yet to be explored.     
Aim: The overall aim of this thesis was to examine maternal nutrition (nutritional status; 
dietary patterns) of urban, black South African women and explore the relationship between 
maternal dietary patterns during pregnancy and birth outcomes (including neonatal body 
composition). Furthermore, the extent to which other maternal factors – i.e. 
HIV/antiretroviral treatment (ART) status, body mass index (BMI) at recruitment, GWG, 
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demographics, socioeconomic status etc. - act as confounders or effect modifiers to these 
associations was explored.  The following four specific study components addressed this aim:  
1) To review and report on MNS in African women and its associations with fetal, birth, 
neonatal and infant outcomes in the first 1000 days; 2) to compare body composition 
measurements using two methods, namely (i) dual-energy x-ray absorptiometry (DXA) and 
(ii) air displacement plethysmography (ADP; Peapod), in black South African neonates; 3) to 
characterise, depict and report on maternal dietary patterns during pregnancy using 
multivariate dimension-reduction techniques in urban black South African women and to 
examine the association between dietary patterns and GWG in the context of other maternal 
lifestyle and socioeconomic factors; and 4) to examine the associations between maternal 
dietary patterns and birth size and neonatal body composition and explore how specific 
maternal factors – i.e. HIV/ART status, maternal BMI and GWG – may influence these 
associations. 
Methods: Comprehensive literature searches were independently performed by two 
researchers in May 2015 in order to identify all relevant studies conducted in Africa.  The 
review used a systematic approach to search the following databases: Medline, EMBASE, 
Web of Science, Google Scholar, ScienceDirect, SciSearch and Cochrane Library.  Full-text 
articles were obtained and reviewed and data were extracted from relevant publications into 
tables appropriately.   
Within a wider longitudinal cohort study taking place in Soweto, Johannesburg (the Soweto 
First 1000-Day Study; S1000), habitual dietary intake of 538 pregnant women was assessed 
using a quantitative food-frequency questionnaire and dietary patterns were depicted via 
principal component analysis. Associations between dietary patterns and BMI-specific GWG 
were analysed using linear and multinomial logistic regression.  ―Traditional‖ diet pattern 
adherence (pattern score) was used to classify maternal diet for the final study objective 
21 
 
(objective 4)  and multiple linear regression models were used to examine associations 
between maternal ―traditional‖ diet pattern score, HIV/treatment status [three groups: HIV 
negative, HIV positive (antenatal ART initiation), HIV positive (pre-pregnancy ART 
initiation)], BMI and GWG (kg/week) and: newborn (1) weight-to-length ratio (WLR, kg/m) 
in 393 mother-neonate pairs; (2) Peapod estimated fat mass index (FMI, kg/m
3
) in a 171-pair 
subsample. 
Results:  Twenty-six studies met the inclusion criteria for the literature review (objective 1).  
Overall, MNS in Africa showed features typical of the epidemiological transition; including 
higher overweight and obesity and lower underweight prevalences, alongside high anaemia 
prevalences’ and poor-quality diets. Maternal BMI and GWG were positively associated with 
birth weight; however, maternal overweight and obesity were associated with both increased 
macrosomia (birth weight >4kgs) and intrauterine growth restriction risk. In addition, 
maternal anaemia was associated with lower birth weight and both macro- and micronutrient 
supplementation during pregnancy was associated with improvements in GWG, birth weight 
and mortality risk. 
During the comparison of body composition assessment techniques (objective 2), significant 
correlations were observed between ADP and DXA measurements of fat mass (r = 0.766; 
p<0.001), fat-free mass (r = 0.942; p<0.001) and %fat (r = 0.630; p<0.001).  However, fat mass 
(408 ± 172 g vs. 337 ± 165 g; p<0.001) and body fat percentage (12.9 ± 4.4% vs. 9.9 ± 4%; 
p<0.001) were significantly higher and fat-free mass (2681 ± 348 g vs. 2969 ± 375 g; 
p<0.001) significantly lower when estimated by ADP than by DXA. There was greater 
consistency in the estimation of fat-free mass between the methods when compared to 
estimates of fat mass and body fat percentage.  
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Longitudinal assessment (objectives 3 and 4) identified three dietary patterns in urban black 
South African women during pregnancy: namely ―western‖, ―traditional‖ and ―mixed‖. 
―Western‖ and ―mixed‖ diet patterns were associated with 35 g/week (p=0.021) and 24 
g/week (p=0.041) higher GWG in normal weight and obese women respectively.  High 
intakes of the ―traditional‖ diet pattern were associated with a reduced odds of excessive 
weight gain in the total sample (OR: 0.81; p=0.006) and in normal weight women (OR: 0.68; 
p=0.003).  In the final, fully adjusted study models, maternal obesity and GWG were 
associated with 0.25 kg/m (P=0.008) and 0.48 kg/m (P=0.002) higher newborn WLR, while 
―traditional‖ diet pattern score was associated with lower newborn WLR (-0.04 per +1 SD; 
P=0.033).  Additionally, ―traditional‖ pattern score was associated with 0.13 kg/m3 (P=0.027) 
and 0.32 kg/m
3
 (P=0.005) lower FMI in the total sample and in newborns of normal weight 
women, respectively.  HIV positive (pre-pregnancy ART) vs. HIV negative (ref) status was 
associated with 1.11 kg/m
3
 (P=0.002) higher newborn FMI in a fully adjusted model.   
Conclusion: This thesis confirms the rapid transition in MNS across urban African 
populations and demonstrates the implications that the rise in maternal overweight and 
obesity alongside poor dietary patterns and micronutrient deficiencies may have on birth 
outcomes, as well as potentially on longer term health trajectories.  However, it also 
highlights a lack of data on infant outcomes beyond birth, and therefore, a need for 
longitudinal data that examines longer-term implications in the African setting.   
In South Africa in particular, the thesis indicates that promotion of a traditional-style diet 
pattern - high in whole grains, legumes, vegetables and traditional meats and low in 
processed foods - alongside a healthy preconception weight in urban, black women would 
significantly improve both maternal and infant adiposity profiles.  This may have substantial 
benefits in reducing long-term risk of non-communicable diseases in both current and future 
generations.  However, the need for a holistic approach which incorporates other health and 
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lifestyle determinants of growth and adiposity in the infant is critical in optimising metabolic 
health trajectories.  In HIV-positive women for example, development of targeted monitoring 
and management strategies is necessary in order to limit the treatment-specific effects on 
adiposity in the newborn. 
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CHAPTER 1: Introduction 
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1.1 Problem statement 
In low-or middle-income countries (LMICs), rapid economic development and continued 
inequality in education, employment and food security have shifted the focus of the  maternal 
and child nutrition agenda from undernutrition to a double burden of disease, where both 
stunting and obesity occur in parallel (1).  In South Africa, although chronic undernutrition 
persists in childhood, the substantial increase in overweight and obesity – particularly 
prevalent in adult women – is coupled with increasing burdens of non-communicable 
diseases (NCDs) such as type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) 
(2–4).  These dual burdens not only increase the risk of poor educational attainment and 
productivity, morbidity and mortality at individual levels, but have serious implications for 
economic growth and development at a national level, while placing enormous pressure on 
the health system (1,5,6).      
Maternal obesity, adiposity and excessive weight gain, as well as, poor dietary diversity and 
micronutrient deficiencies, prior to and during pregnancy, are associated with increased risk 
of developing gestational diabetes mellitus (GDM) and pre-eclampsia during pregnancy, 
adverse birth outcomes such as preterm birth, neonatal death, low birth weight (LBW) and 
macrosomia (birth weight >4kgs), sub-optimal infant growth and development, and an 
increased risk of future NCDs for both mother and infant (1,7–11).  However, the influence 
of maternal diet on adiposity (i.e. fat vs. fat-free mass) in the newborn within the obesogenic 
context of urbanising African settings is not known.  An understanding of nutritional status 
and dietary patterns in pregnant South African women and the associations with gestational 
weight gain (GWG), fetal growth and neonatal adiposity are therefore critical in order to 
develop interventions designed to improve health outcomes and metabolic profiles – both 
during pregnancy and infancy, as well as in the longer term.   
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In addition, the associations between maternal nutritional status (MNS) and infant growth and 
development may be further complicated by other maternal factors, such as demographics, 
lifestyle factors and socioeconomic status (SES) (12–14).  In particular, the high burden of 
human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) in this 
setting must be considered; with both HIV infection and antiretroviral treatment (ART) 
exposure being associated with changes in weight, fat distribution and glucose and fat 
metabolism, as well as with pre-term birth and LBW (15–19).  Without a holistic approach 
which examines the relationships between MNS, dietary patterns and infant growth and body 
composition in this broader context, substantial and sustained improvements in maternal and 
child nutrition and health will not be possible.        
1.2 Conceptual frameworks 
In 2008, The Lancet recognised maternal and child undernutrition as a key global issue, due 
to a high prevalence in LMICs and evidence that they make a significant contribution to 
morbidity and mortality in these settings.  The Maternal and Child Undernutrition Series (20–
24) was based on a conceptual framework developed by UNICEF  in 1990 (Figure 1), which 
described maternal and child undernutrition as a consequence of multisectoral development 
inadequacies and elucidated the immediate (individual), underlying (household and 
community level) and basic (societal structures and processes) causes of undernutrition. 
Additionally, the series outlined the consequences of maternal and child undernutrition – 
namely, morbidity, mortality and disability in the short term, and reduced adult size, 
intellectual ability and economic productivity, plus an increased risk of metabolic and 
cardiovascular disease, in the long term. 
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Figure 1: United Nations Children’s Fund (UNICEF) conceptual framework of the relations 
between poverty, food insecurity, and other underlying and immediate causes to maternal and 
child undernutrition and its short-term and long-term consequences (20) 
 
Although this series and framework confronted a critical component of the challenges facing 
maternal and child health, while emphasising the need to focus on multifaceted influences of 
nutrition and subsequent health outcomes across sectors, the rapid effects of urbanisation on 
maternal and child nutrition in LMICs in recent years encouraged a re-evaluation of global 
priorities and strategies in this area.  While undernutrition remains a prominent issue, with 
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stunting affecting approximately 165 million children under five in 2011 worldwide, 
overweight affected approximately 43 million under-fives in 2011 (the majority in LMICs) 
and the number continues to rise (1).   
As a result, The Lancet Series on Maternal and Child Nutrition (second series) was published 
in 2013, identifying the need to focus on both under- and overnutrition, due to the increasing 
double burden of malnutrition being experienced in LMICs. This series introduced a new 
conceptual framework (Figure 2) that illustrates the means to optimum fetal and child growth 
and development by tackling malnutrition from both sides of the disease spectrum.  This 
framework outlines the dietary, behavioural, and health determinants of optimum nutrition, 
growth and development, and how they are affected by various underlying conditions (food 
security, care-giving resources, health services, etc.), which are in turn shaped by economic 
and social conditions, national and global contexts, capacity, resources and governance. In 
addition, the framework outlines the different levels at which determinants can be changed to 
enhance maternal and childhood outcomes, including nutrition-specific interventions that 
address both the immediate and underlying causes of malnutrition. 
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Figure 2: The Lancet conceptual framework for actions to achieve optimum fetal and child nutrition and development (1) 
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The framework provides a more comprehensive and goal-oriented approach to addressing 
maternal and child health, with the focus on achieving optimal nutrition and development 
through multi-level platforms (from individually focused nutrition and lifestyle interventions 
to building enabling environments) rather than simply avoiding adverse health outcomes.  For 
this reason it has become the key framework for research – and potential intervention – in the 
area of maternal and child nutrition, and will therefore, form the foundation upon which this 
thesis is built.  The key aspects of the framework to which this research relates are 
highlighted in Figure 3.  Firstly, it contextualises the research in relation to the 
Developmental Origins of Health and Disease (DOHaD) paradigm by highlighting the 
benefits of optimal fetal and childhood growth and development in reducing long-term risk of 
obesity and NCDs.  Secondly, it depicts the potential relationship between the main exposure 
of interest (maternal nutrition during pregnancy) and the key outcomes to be explored, i.e. 
optimal fetal nutrition and growth, assessed using birth size (weight and length) and neonatal 
body composition (adiposity).  Lastly, it introduces the influence that other maternal 
demographic, health and socioeconomic variables may have on the complex associations 
between MNS, dietary patterns and infant outcomes.  Specifically the extent to whether 
maternal HIV/ART exposure acts as a potential modifier or confounder must be explored in 
order to gain a comprehensive understanding of these complex associations, as well as the 
possible means of intervention to optimise both short and long term health outcomes. 
Due to the focus on maternal and neonatal adiposity, this framework is therefore 
complemented by the conceptual model modified and presented by the Institute of Medicine 
(IoM) in their 2009 updated GWG guidelines.  This framework provides a more focused 
picture, placing MNS and diet (and other influential maternal factors) as determinants of 
GWG (including fat and fat-free mass in both the mother and fetus) and, subsequently, 
overall neonatal size and body composition, as well as long-term obesity and disease risk.  
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The specific factors included in this thesis – as they fit within the IoM framework - are 
presented in figure 4; therefore providing a final schematic for the thesis itself. 
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Figure 3: Link between The Lancet conceptual framework and PhD thesis (1) 
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Figure 4: Conceptual model for PhD thesis within the Institute of Medicine (IoM) 
framework for gestational weight gain (GWG) (25) 
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1.3 Literature review 
1.3.1 The nutrition transition 
As LMICs become increasingly urbanised, significant demographic and lifestyle changes – 
characterised by a transition to typically westernised diets and decreased levels of physical 
activity – occur (26).  Such shifts in consumption to energy-dense diets high in saturated fat, 
added sugar and salt and processed/convenience foods low in fibre and essential 
micronutrients have been implicated in the rapidly rising overweight and obesity prevalence 
in these populations, as well as the emerging burdens of T2DM and CVD (26–28). 
Although urbanisation has progressed across Sub-Saharan Africa, the extent to which this has 
occurred – as well as the magnitude of the resulting metabolic and health consequences – 
differs between settings.  In countries such as South Africa, where the transition has been 
most profound, the implications for maternal and child nutrition are extensive.  Although 
undernutrition persists, and one in four children are stunted by the age of two, approximately 
39% of adult women are obese and 25% of young children (2-4 years) are either overweight 
or obese (2). These co-existing burdens of childhood stunting and maternal obesity are not 
only present at a population and community level, but are evident in mother-child pairs 
within single households (1,29–31).    
1.3.2 The DOHaD paradigm 
The DOHaD paradigm describes a transgenerational effect between maternal environment 
and fetal development, leading to altered susceptibility of the infant to NCDs in later life 
(32).  Early environmental factors, such as those experienced in utero and in early infancy, 
have been shown to programme the growth and development of body tissues via changes in 
gene expression during these critical periods of developmental plasticity. These changes may 
lead to permanently altered body function and metabolism, thereby influencing the ability of 
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individuals to cope with the adult environment later in life and increasing the risk of obesity, 
T2DM, metabolic syndrome and CVD (32–34). 
1.3.2.1 The first 1 000 days 
The first 1000 days – constituting the period of pregnancy plus the first two years of infancy 
– has been proposed as a critical window of developmental plasticity during which growth 
and development can be targeted for long-term health benefits (35,36).  Evidence shows that 
improving environmental influences during this period to facilitate optimal nutrition and 
growth has lasting effects throughout life.  These include reductions in childhood morbidity 
and mortality, increased cognitive and motor development, increased school performance and 
later work capacity, higher adult stature and reduced obesity and NCD risk (Figure 5) (1,37). 
 
 
Figure 5: The Developmental Origins of Health and Disease (DOHaD) paradigm: short- and 
long-term effects on health outcomes (37)  
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1.3.3 MNS, fetal growth and birth outcomes 
1.3.3.1 Anthropometry 
Maternal underweight 
Traditionally, the risks associated with pregnancy in LMICs have been focused on maternal 
underweight and short adult stature, which may result in a high risk of adverse birth 
outcomes, such as maternal death, intrauterine growth restriction (IUGR), LBW and small-
for-gestational-age (SGA) infants (20).  Although maternal underweight and stunting rates 
have declined in the developing world, they continue to persist in Africa, with over 10% of 
adult women underweight in 2008 (1).  However, due to the low burden of underweight in 
South African adult females, approximately 3% of women 15 years and older in the 2016 
South African Demographic and Health Survey (SADHS) (3), this thesis focuses on over- 
rather than underweight. 
Maternal overweight and obesity 
With the rise in obesity prevalence worldwide – predicted to reach approximately 21% in 
adult women by 2025 – maternal obesity has been recognised as a pertinent global issue that 
affects not only the health of the mother and her immediate offspring, but may have 
longstanding consequences across generations (5).  In 2016, the need to address obesity early 
in the lifespan – i.e. in the mother prior to, and during, pregnancy – was highlighted in the 
Lancet Diabetes and Endocrinology series on Maternal Obesity (5,38–41).  By prioritising 
early intervention, this series proposed that we may be able to reduce the immediate and 
longer-term risks to maternal and infant health while curbing the propagation of obesity 
through the life course and potentially in future generations.   
Although overweight and obesity have traditionally been viewed as an epidemic of high-
income countries (HICs), thanks to a prevalence ranging between 61.9%, 56.8% and 47.6% 
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for adult women in the USA, Eastern and Western Europe respectively in 2013, the growing 
burden of overweight and obesity in LMICs has resulted in prevalence estimates of 28.3% in 
Southeast Asia and 34.5% and 63.7% respectively in Western and Southern Sub-Saharan 
Africa in recent years (42).  Such rapid changes in the nutritional profile in LMICs – 
attributed to the transitioning lifestyles in these settings and exhibited predominantly in 
women – pose a serious threat to maternal and child health, as well as to the long-term risk of 
NCDs in the most vulnerable settings where health systems are least equipped to respond 
(5,43).  In South Africa in particular, substantial effects have already been seen in recent 
years, with the International Diabetes Federation estimating the number of diagnosed diabetes 
cases in adults (20-79 years) at 2.3 million in 2015 (4) and 44% of black women aged 15 
years and older being identified as hypertensive in the 2016 SADHS (3). 
Maternal obesity prior to pregnancy is associated with a wide range of pregnancy and 
delivery complications, as well as with morbidity and mortality in the offspring.  Specifically, 
obesity is associated with an increased risk of GDM and pre-eclampsia during pregnancy, 
maternal death, haemorrhage and infection during delivery and weight retention post-partum, 
as well as poor infant outcomes, such as neonatal death, birth trauma and macrosomia 
(1,10,11,44).  Focusing specifically on birth size – used commonly as a proxy for growth and 
development in utero, as well as for long-term NCD risk – a Canadian study found that a 10% 
higher pre-pregnancy body mass index (BMI) was associated with an approximately 10% 
increased risk of macrosomia (45), while researchers in Italy showed maternal obesity to be 
an independent predictor of macrosomia (46).  Even within a group of obese women in the 
US, a dose-dependent effect of increased adiposity has been shown, with a 30% higher risk of 
large-for-gestational age (LGA) shown for class III vs. class I obesity sub-groups compared 
to normal-weight women (47). Similar results have been shown in Asian settings, where 
higher pre-pregnancy BMI was associated with higher macrosomia risk in China (48).  Due 
39 
 
to the differences in under- and overweight/obesity prevalence across the African continent, 
higher pre-pregnancy BMI has been beneficially associated with increased birth weight in 
countries such as Sudan (49).  However, in regions such as Zambia and Ghana, where the 
nutrition transition has progressed further, results have shown similar effects of maternal 
overweight and obesity increasing macrosomia risk, as seen in more developed settings 
(50,51).  In South Africa, maternal overweight and obesity have been associated with dual 
burdens of risk for the new born, with elevated risk of both macrosomia and IUGR evident 
from previous studies (52,53). 
Gestational weight gain 
In addition to maternal BMI at conception, weight gain during pregnancy has been shown to 
have significant effects on pregnancy outcomes, with both insufficient and excessive weight 
gain increasing risk for both mother and infant (25).  The most commonly utilised guidelines 
for assessing pregnancy-associated weight gain in both clinical and research contexts were 
published by the IoM in 2009 (Table 1) (25). These prescribe recommended ranges of 
maternal weight gain according to a woman’s BMI status (underweight, normal weight, 
overweight or obese) prior to conception, with the capacity for gain decreasing with increased 
BMI.   
Table 1: Institute of Medicine (IoM) guidelines for total and rate of gestational weight gain 
(GWG) according to pre-pregnancy body mass index (BMI) (25) 
Pre-pregnancy BMI 
Total weight gain 
Rates of weight gain 
(2
nd
 and 3
rd
 trimester) 
Range (kg) Total range (kg/week) 
   
Underweight (<18.5 kg/m
2
) 12.5-18 0.51 (0.44-0.58) 
Normal weight (18.5-24.9 kg/m
2
) 11.5-16 0.42 (0.35-0.50) 
Overweight (25.0-29.9 kg/m
2
) 7-11 0.28 (0.23-0.33) 
Obese (≥30.0 kg/m2) 5-9 0.22 (0.17-0.27) 
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In a recent systematic review and meta-analysis across the US, Europe and Asia, pooled 
estimates showed that, compared to weight gain within IoM-recommended ranges, 
inadequate gain was associated with a 5% higher risk of SGA and a 2% lower risk of both 
LGA and macrosomia (54). The increase in SGA risk associated with inadequate weight gain 
was greatest for underweight women. Conversely, GWG that exceeded recommendations was 
associated with a 2% reduction in SGA risk and 4% and 6% increases in the risk of LGA and 
macrosomia respectively.  These findings demonstrate the complexity of the association 
between baseline MNS and GWG and fetal growth and birth outcomes.  While reductions in 
weight gain may improve birth outcomes at one end of the risk spectrum, they may 
simultaneously increase risk at the other, with the resulting effects on birth size being 
strongly influenced by pre-pregnancy BMI.  
Although this systematic review and meta-analysis included data on 1,309,136 pregnancies 
from 23 studies across 10 countries, no data was available from the African context.   While 
not using the IoM guideline ranges, Mochhoury et al demonstrated an increased risk of 
macrosomia in women who gained >8kg weight compared to those who gained <8kg during 
pregnancy in Morocco (55).  However, limited evidence of an association between GWG and 
high birth weight, as well as a lack of comparability in the weight-gain cut-offs used in this 
and other studies, makes it impossible to draw conclusions around the applicability of these 
associations to African settings.        
Although excessive weight gain during pregnancy is associated with increased risk regardless 
of pre-pregnancy weight, and women in high BMI categories have reduced capacity for 
healthy weight gain, studies show that women who are overweight or obese are more likely to 
experience high GWG than their normal weight counterparts.  In a study across Australia, 
New Zealand and Ireland, overweight and obese women were 3 and 2.5 times more likely to 
exceed the IoM recommended weight-gain ranges respectively than those within normal 
41 
 
weight categories at the start of pregnancy (56).  In addition to the risks associated with high 
GWG during pregnancy and delivery, weight gain above IoM-recommended ranges has been 
linked to higher risk of postpartum weight retention over 2kg (57).  This may have 
implications for the development of overweight or obesity after pregnancy, as well as 
increase the risk profile of women during subsequent pregnancies.  This was demonstrated in 
the USA, where one third of women who had a normal pre-pregnancy BMI were found to be 
overweight or obese at one year postpartum (58). 
1.3.3.2 Diet 
Dietary intake and quality 
Energy and nutrient requirements increase during pregnancy in order to meet the needs of 
both the mother and the growing fetus.  It is recommended that the requirements are met 
through increased consumption of a healthy, balanced diet rich in essential micronutrients.  
Specific recommendations relate only to certain nutrients that are likely to be insufficient in 
supply from the diet, such as iron and folate.  However, these recommendations are based on 
the assumption that the pre-pregnancy diet adequately meets the mother’s baseline nutritional 
needs while providing an appropriate supply of energy, and that an increase in quantity will 
result in an increase in overall diet quality during pregnancy. 
Although pregnancy-associated risk has been largely linked to overnutrition in recent years, 
high energy intakes have not been coupled with improvements in diet quality.  In Australia, 
pregnant women have been shown to consume diets containing less than the recommended 
levels of fruit, vegetables, breads and cereals and above recommended levels of energy-dense 
―non-core‖ convenience foods, as well as low intakes of fibre and key micronutrients such as 
iron, folate and calcium (59–61).  Studies in the USA have found similarly low-quality diets 
in pregnant populations, with lower than recommended servings of vegetables, fruit and 
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grains consumed and higher than recommended total fat and saturated fat servings, as well as 
moderate folate and low iron levels (62,63).  In Israel, pregnant women were shown to have 
adequate total energy intakes, with 42% being overweight and obese, but at least 50% of 
women had insufficient protein and fibre intakes and 95% consumed less than the 
recommended levels of calcium, iron and folate (64). 
Studies from LMICs, while demonstrating lower energy intakes in some cases than those 
seen in developed countries due to limited food availability, also show this dual burden of 
high overweight and obesity prevalence coupled with poor dietary diversity and low 
micronutrient intakes (5).    In Swaziland, only 6%, 12%, 43% and 41% of participants 
reported eating grains, dairy products, vegetables and fruits respectively at least four times 
during the previous week and only 30% reported consuming at least four different food 
groups the previous day, suggesting low-quality diets in this African population (65).  
Although literature depicting dietary intake in South African pregnant women is limited, May 
et al (2014) showed that urban pregnant women, while consuming diets sufficient in 
carbohydrate and protein, have low fibre and essential fatty acid intakes, as well as 
inadequate intakes of vitamins A, C, D and E and minerals such as iron, folate, calcium and 
zinc (66). 
Evidence for the association between maternal dietary intake and fetal growth and birth 
outcomes is more limited and inconsistent than that for anthropometric measures of 
nutritional status.  In the USA, while energy and macronutrient intakes were significantly 
associated with GWG by the second trimester, and this weight gain was positively associated 
with birth size, no relationship was found between dietary intake variables and infant size at 
delivery (67).  However, when using a healthy-eating index to depict maternal diet quality in 
Spain, higher scores were associated with beneficial increases in birth weight and length, as 
well as reduced risk of fetal growth restriction (68).  While limiting growth restriction is 
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beneficial, excessive increases in birth weight are associated with risk of both maternal and 
infant morbidity and mortality and should also be prevented.  In France, high carbohydrate 
intake (and low fat intake) was negatively associated with birth weight in women with 
gestational diabetes and reduced the incidence of macrosomia (69).  However, potential 
benefits of this macronutrient profile to non-diabetic pregnancies have not been adequately 
shown.  Data from India showed that, although energy and protein intakes during pregnancy 
were not associated with birth size, higher fat intake in the second trimester was associated 
with neonatal length, birth weight and triceps skinfold thickness, while in Jordan, energy and 
carbohydrate intakes were associated negatively with gestational age (70,71). 
Although evidence characterising maternal food and nutrient intakes during pregnancy exists, 
few studies – particularly in the African context – have looked at the associations between 
these factors and any fetal, birth or neonatal outcomes. In a review of dietary interventions – 
largely using nutrition education and counselling – in overweight/obese pregnant women, 
Flynn et al showed that, while improvements in dietary behaviour and quality, as well as 
reductions in GWG were observed, only one study showed a significant reduction in the 
likelihood of macrosomia in the intervention group (72).  However, the methodological 
differences between studies highlighted in this review makes comparability of intervention 
strategies and assessment of outcomes difficult to ascertain, ultimately limiting the 
conclusions that can be drawn from any beneficial effects of dietary change on offspring 
health.   
Dietary patterns 
The aforementioned studies represent traditional approaches to the assessment of dietary 
intake; namely, through analysis of individual macro- and/or micronutrient consumption.  
Although these methods have provided some useful exploration into dietary component 
effects, they have come under scrutiny in recent years, as diets consist of a range foods and 
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nutrients eaten in combination and while there is a high level of correlation between some 
nutrients, individual nutrients may have only small effects, so the risk of confounding in the 
analysis of single nutrients by the overall pattern of intake is high (67,68).   This not only 
makes associations with outcomes of interest difficult to ascertain, but may limit the 
applicability of findings to the development of dietary recommendations and public health 
messaging  (73,74).  As a result, recent studies have focused on the analysis of overall 
patterns of intake by applying various statistical methods to dietary assessment data, e.g. from 
food frequency questionnaires (FFQs).  Although a number of dietary pattern analysis 
methods such as principal component analysis (PCA) and cluster analysis have been used in 
epidemiology – each with its own strengths and weaknesses – PCA has been identified as the 
beneficial method in a number of studies, as it allows for better interpretation of dietary 
patterns and provides factor scores per pattern that are continuous in nature and may provide 
for more robust and informative analyses (75,76).   
Although studies exploring the associations between dietary patterns in pregnant women and 
fetal growth exist, they have been largely limited to HICs and show inconsistent results.  In 
the UK, New Zealand and the Netherlands, higher adherence to ―traditional‖ or 
―Mediterranean‖ dietary patterns – characterised by high vegetable, fruit and whole grain 
intakes – was associated with higher birth weight and reduced odds of SGA births (77–79).  
Conversely a ―western‖ dietary pattern – high in red and processed meat, refined grains and 
full-fat dairy products – was associated with an increase in the odds of SGA in Denmark (80).  
However, in Brazil and Australia, energy-dense and highly processed ―snack‖ and ―junk 
food‖ patterns were associated with higher birth weight and increased odds of macrosomia 
respectively (81,82).     
These differences in dietary-outcome relationships reflect the complex nature of the 
associations between patterns of intake and fetal growth, which may be strongly influenced 
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by other factors, such as demographics, BMI, GWG and any pre-existing conditions such as 
HIV status, as well as socioeconomic and lifestyle factors (73).  It is therefore critical to 
explore such relationships in Africa, due to the continent’s unique nutrition and health 
context.                   
1.3.3.3 Neonatal body composition 
Methods for measuring body composition 
In addition to birth weight – which has traditionally been the focus for assessing neonatal 
outcomes – recent studies have explored, not only total size, but body composition, i.e. fat 
mass and fat-free mass. The ability to differentiate between the components of body weight 
using objective measures has been shown to provide more sensitive markers of in-utero 
nutrition and growth and may better reflect long term metabolic risk (83,84).  The most 
common methods of assessing neonatal body composition are dual-energy x-ray 
absorptiometry (DXA) and air displacement plethysmography (ADP) using the Peapod, due 
to their non-invasive nature, ease and efficiency of use and low cost relative to other 
objective techniques (85–87).  DXA has been shown to provide reliable measurements of fat 
mass and fat-free mass in neonates (88), but concerns around the risks of radiation exposure 
to the infant for repeated measures and the need to prevent movement of the subject during 
testing restrict its use in paediatric populations.  Although the Peapod can only be used to 
measure infants up to approximately six months of age who weigh less than 8 kgs, it may be 
a more practical method of body composition assessment in early life (89).  However, due to 
low access to these objective methods, use of the techniques has been limited in LMICs and 
the accuracy and reliability of ADP in comparison to DXA has not been examined in African 
infants. In the USA, a strong correlation was demonstrated between DXA and ADP at six 
months of age; however, percentage fat and fat mass were significantly lower and fat-free 
mass significantly higher, when using the Peapod (89).  Due to the lack of evidence to 
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support the use of one method above the other, as well as the lack of neonatal body 
composition data in Africa, comparison of the two methods in African neonates is needed. 
MNS and neonatal body composition 
The associations between MNS during pregnancy, as measured by BMI and GWG, and 
neonatal body composition within the first three days of life have been studied in the US.  
Pre-pregnancy BMI was associated with neonate size and body composition, with a 1kg/m
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increase in BMI associated with 5.2g and 7.7g increases in fat and fat-free mass respectively, 
as well as a 0.12% increase in body fat percentage.  In addition, each 0.1kg/week increase in 
GWG was associated with a 24g increase in fat mass, a 34g increase in fat-free mass and a 
0.6% increase in percentage fat (90).  Data from Australia showed similar results, with pre-
pregnancy BMI and GWG both being associated with neonate body fat percentage within 48 
hours of birth (91).  One study from Ethiopia demonstrated a positive association between 
birth weight and Peapod-estimated fat mass in neonates within 48 hours of birth; however the 
association between body composition variables and MNS was not explored in this setting 
(92). 
Only one study in the US has explored the associations between maternal diet and neonatal 
adiposity assessed objectively via ADP (93).  This showed that a diet high in starchy 
vegetables, solid fats and refined grains and low in dairy and green vegetables was associated 
with higher birth weight, as well as greater fat mass and body fat percentage (%fat). 
Literature therefore suggests a relationship between maternal pre-pregnancy BMI and GWG 
and neonatal adiposity, with higher maternal BMI and weight-gain increasing both fat mass 
and body fat percentages in early life.  In addition, there is data to suggest that refined and 
high-fat maternal dietary patterns have a role in greater fat mass accrual in utero.  However, 
47 
 
data is scarce, with only one study exploring the role of dietary patterns in these relationships, 
and none examining these associations in the African context. 
1.3.4 The role of HIV and ART 
In addition to the relationship between MNS and fetal, birth and neonatal outcomes, these 
outcomes may be influenced by maternal HIV, as well as ART, in countries such as South 
Africa, where the HIV prevalence was estimated at 22.3% in women aged 15-49 in 2016 
(94).  HIV infection has been associated with both MNS and birth outcomes, but the 
influence of infection, particularly with treatment, on the relationship between these factors is 
yet to be thoroughly explored. 
The current literature on HIV infection and MNS has largely concentrated on maternal 
anthropometry prior to, and during, pregnancy, with a particular focus on low pre-pregnancy 
weight and/or poor GWG in predominantly ART naïve, HIV-positive women (95). However, 
data from HIV-positive pregnant women in three African countries (Malawi, Nigeria and 
Zambia) suggests more of a spread across anthropometric risk categories than is traditionally 
associated with HIV during pregnancy, with approximately equal numbers of pregnant 
women being underweight, normal weight and overweight at enrolment and GWG ranging 
between weight loss/insufficient weight gain and excessive weight gain in these settings (96).  
Although the proportions of underweight women at baseline, as well as the high number 
experiencing weight loss/low weight gain during pregnancy, is still of concern, it is coupled 
with an increasing number of overweight women who may be experiencing a different 
spectrum of pregnancy-associated risk. 
The limited number of studies that have assessed the relationship between maternal 
anthropometry and birth outcomes in HIV-positive and HIV-negative women indicate an 
association between infection and increased risk of preterm birth and LBW (15,16).  In 
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Rwanda, HIV-positive women were at increased risk of giving birth to premature, LBW or 
growth-restricted infants than HIV-negative women (97). 
The aforementioned studies focused on the associations between HIV infection and MNS 
during pregnancy prior to the increase in ART treatment availability in Africa.  In high-risk 
populations such as South Africa, health policy now prescribes mandatory ART initiation 
with fixed-dose combination antiretrovirals for all pregnant women, regardless of their CD4 
count. This makes exploration into the effects of infection and treatment on pregnancy critical 
for the South African setting.  In Botswana, HIV was associated with increased risk of 
stillbirth, preterm birth, SGA infants and neonatal death, with women who had been receiving 
highly active ART prior to conception being at greatest risk of adverse outcomes. However, 
low CD4 counts during pregnancy were also independently associated with risk of stillbirth 
and SGA infants (98).  Although the effectiveness of ART use in reducing HIV transmission 
rates is undeniable, the effects of maternal HIV and ART use on MNS or neonatal outcomes 
is limited, with the available literature focusing on these in isolation, rather than on the 
interplay between maternal pre-pregnancy nutritional status, diet and HIV/treatment and the 
subsequent effect on fetal growth and development, as well as on metabolic risk, in the longer 
term. Both HIV and antiretroviral use have been associated with changes in weight and fat 
distribution, as well as with altered glucose and lipid metabolism, in adults during recent 
years (17–19).  ART exposure in particular has been associated with central fat deposition 
and dyslipidaemia, as well as with disordered glucose metabolism and insulin resistance, with 
obese individuals being at greatest risk of adverse metabolic outcomes (17–19).  This makes 
the inclusion of HIV and treatment in the exploration of the diet-outcome associations in 
increasingly overweight/obese populations such as South Africa all the more critical, as the 
resulting impact on fetal growth and metabolic risk is yet to be explored.   
1.4 Research gaps 
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It is clear that in LMICs, maternal and child health are influenced by a number of complex 
and often conflicting factors, such as the dual burdens of under- and overnutrition, as well as 
communicable and non-communicable diseases. Although evidence exists for the 
relationships between isolated maternal factors, such as obesity, specific micronutrient 
deficiencies and HIV infection, and the associated fetal, neonatal and infant outcomes, very 
little is known about the interplay between these factors, particularly maternal nutritional 
intake and dietary patterns, and their associations with birth outcomes and neonatal body 
composition within an African context. 
1.5 Aim and objectives 
1.5.1 Aim 
The overall aim of this study is to examine maternal nutrition (nutritional status; dietary 
patterns) of urban, black South African women and to explore the relationship between 
maternal dietary patterns during pregnancy and birth outcomes and neonatal body 
composition. Furthermore, the extent to which other maternal factors – i.e. HIV/ART status, 
BMI at recruitment, GWG, demographics, SES etc. - act as confounders or effect modifiers to 
these associations will be explored. 
1.5.2 Objectives 
1. To review and report on MNS in African women and its associations with fetal, birth, 
neonatal and infant outcomes in the first 1000 days.  
2. To compare body composition measurements using two methods, namely (i) DXA and (ii) 
ADP (Peapod), in black South African neonates. 
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3. To characterise, depict and report on maternal dietary intakes and patterns during 
pregnancy using multivariate dimension reduction techniques in urban black South African 
women 
4.  To examine the associations between maternal dietary intakes and patterns with neonatal 
body composition and to explore how specific maternal factors i.e. HIV, maternal BMI and 
GWG may influence these associations 
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CHAPTER 2: Review of the importance of 
nutrition during the first 1000 days: Maternal 
nutritional status and its associations with fetal 
growth and birth, neonatal and infant outcomes 
among African woman1 
 
 
 
 
 
 
 
___________________________________________________________________________ 
1
Wrottesley SV, Lamper C, Pisa PT. Review of the importance of nutrition during the first 
1000 days: maternal nutritional status and its associations with fetal growth and birth, 
neonatal and infant outcomes among African women. J Dev Orig Health Dis. 2016 
Apr;7(2):144–62. (99)
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2.1  Introduction 
Nutrition, among other factors, seems to be one of the pivotal drivers and determinants of 
maternal and child health.  Maternal nutritional status (MNS) has been shown to be an 
important predictor of maternal health (7–9,11,100), fetal growth (11,101,102), birth 
outcomes (10,101,103,104) and infant growth (10) in both high-income countries (HICs) and 
low-or middle-income countries (LMICs). However, the association between maternal 
nutrition and these multifaceted outcomes is complex and is influenced by many other 
factors, including genetic, socioeconomic, and demographic variables which differ greatly 
between populations (100,105). Increased prevalence of non-communicable diseases (NCDs) 
in LMICs, including Africa, is attributed mainly to the epidemiological health transition.  
Poor maternal and child health has been associated with increased risk of NCDs, including 
obesity, type 2 diabetes mellitus (T2DM), metabolic syndrome and cardiovascular disease 
(CVD) in various studies (106–109).  
Additionally, restricted fetal growth, adverse birth outcomes and poor growth in infancy have 
been associated with increased risk of developing NCDs in adulthood (109). Malnutrition 
and/or other adverse exposures during critical periods of plasticity (fetal and infant 
development) may alter gene expression and permanently restructure the body’s tissues, 
thereby resetting metabolism and function, with long-term consequences (110). Maternal 
undernutrition has long been thought to play a role in phenotypic programming of the 
growing fetus, which results in intrauterine growth restriction (IUGR) and low birth weight 
(LBW) babies with increased risk of developing adult NCDs.  Maternal obesity, adiposity 
and weight gain are associated with negative outcomes for: (i) women, including increased 
risk of gestational diabetes mellitus (GDM), pre-eclampsia, pre-term births, stillbirths and 
low breast-feeding rates, (ii) fetal growth and (iii) birth and infant outcomes.  Although the 
importance of maternal nutrition in fetal development and birth outcomes has been clearly 
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demonstrated in experimental animal studies, the findings of studies in humans are less 
consistent. 
The first 1000 days of life – defined as the period from conception to 2 years of age – seems 
to be an optimistic window for intervention to prevent/reverse programming and improve 
both maternal, fetal, birth and infant outcomes; ultimately reducing the risk of infants 
developing NCDs in later life.  Evidence seems to suggest that, where mother and child are 
concerned, chronic conditions have a transgenerational effect (110).  However, the extent to 
which maternal biological factors independently and interactively relate to patterns and 
proportionality of fetal growth, birth outcomes, and infant growth, remains unclear.  
To date, most of the studies and literature reviews dealing with maternal nutrition and its 
various outcomes have investigated single nutrients in isolation. Though important, nutrient 
deficiencies are generally found in low socioeconomic status (SES) populations, where they 
present as multiple, rather than single deficiencies. Studies addressing and pulling together 
the broader picture of multiple nutrient intakes or deficiencies are lacking. In addition, studies 
reporting on associations between MNS and maternal, fetal, birth and infant outcomes in 
Africa are few.  
In this review, our aim was  to provide and report on the available data from Africa, using a 
systematic approach, to illustrate whether maternal nutrition during the first 1000 days of life 
is important to this unique continent, undergoing rapid urbanization and characterized by a 
triple burden of disease, including infection-related undernutrition illnesses, human 
immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) and the 
emergence of NCDs (111). The specific objectives were to: 
i) Report on MNS of pregnant African women 
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ii) Examine the associations between MNS (using anthropometric indicators) and 
fetal growth and birth, neonatal and infant outcomes 
iii) Examine the associations between MNS (using nutritional biomarkers) and fetal 
growth and birth, neonatal and infant outcomes 
iv) Examine the associations between MNS (using reported dietary intakes) and fetal 
growth and birth, neonatal and infant outcomes 
v) Explore the evidence from randomised/quasi-randomised clinical trials on the 
associations between maternal nutritional interventions and fetal growth and birth, 
neonatal and infant outcomes 
vi) Explore the evidence from randomised/quasi-randomised clinical trials on the 
associations between nutritional interventions in the first two years of life and any 
later adolescent or adult health outcomes 
2.2 Methods 
2.2.1 Search strategy 
Comprehensive literature searches were independently performed in May 2015 by a team of 
researchers.  Although this is not a generic systematic review, this paper followed a 
systematic approach to select all available studies describing MNS and how it associates with 
fetal, birth, neonatal and/or infant outcomes in Africa.  Databases used to conduct the 
searches included: Medline, EMBASE, Web of Science, Google Scholar, Science Direct, 
SciSearch and Cochrane Library.  Search terms and phrases included the following, as well as 
variations of the following where applicable: prenatal/anthropometry/[specific 
anthropometric measure of interest, e.g. body mass index]/maternal nutrition/[specific 
nutrient of interest, e.g. protein or iron]/[specific micronutrient deficiency of interest, e.g. 
anaemia]/[specific nutritional biomarker of interest, e.g. ferritin]/[specific dietary intake 
assessment method of interest, e.g. food frequency questionnaire] and birth 
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outcome/pregnancy outcome/[specific adverse outcome of interest, e.g. low birth 
weight]/[specific growth or body composition variable of interest, e.g. head circumference or 
fat mass] and Africa.  These terms and phrases were used in different combinations to be 
identified in titles and abstracts.  Full text articles were obtained and reviewed to identify 
those which met selection criteria below and data was extracted from relevant publications 
into tables appropriately.                
2.2.2 Selection criteria 
Studies which met the following criteria were considered relevant for inclusion: 
 Studies conducted in African countries  
 Any study design 
 For observational studies: 
- Studies that described MNS (defined by reported dietary intakes, anthropometric 
data and biochemical indicators) in pregnant women of any age 
- Studies that associated MNS in pregnant women of any age with any fetal, birth, 
neonatal or infant outcome 
 For intervention studies:   
- Nutritional interventions done in pregnancy with dietary values and/or where 
biochemical indicators and fetal, birth, neonatal and/or infant outcome data from 
both the intervention and control group could be extracted 
- Nutritional interventions done in infancy with later adolescent or adult outcomes 
reported 
 Studies reporting data in a format that enabled daily mean or median nutrient intake 
for the population to be extracted 
Studies were excluded from the review according to the following criteria: 
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 Studies conducted in animals 
 Studies in subjects with health conditions that may have influenced dietary intake (i.e. 
GDM, celiac disease) 
 Interventions (including any supplements) in which MNS and fetal, birth, neonatal 
and/or infancy outcomes were reported for the intervention group only 
2.3  Results 
The results of the scientific papers included in this review are presented and structured 
according to the specific aims:  
2.3.1 MNS of pregnant African women (Table 2) 
Nineteen studies met the inclusion criteria (49,50,52,112–127).  The publication year ranged 
from 2002 to 2014.  The number of pregnant women examined in the studies ranged from 30 
to 191 834 and the gestational age at MNS assessment varied between 18 and 39 weeks.  Six 
studies used anthropometric measurements to describe MNS in pregnant women 
(49,50,52,113,117,118), one used a biomarker of anaemia (haemoglobin (Hb)) (127), two 
used reported dietary intakes (114,119) and the remaining ten used a combination of 
anthropometry, biomarkers and reported dietary intakes (112,115,116,120–126) (Table 2).   
Of the studies including anthropometric measures of MNS, five provided data for the 
mean/median body mass index (BMI).  BMI varied from being within the normal range 
(18.5-24.9) in Tanzania (115), Ethiopia (112) and Zambia (50), to being within the 
overweight category (25.0-29.9) in South Africa (124), Sudan (49,117) and Zambia (50). No 
studies reported mean/median BMI in either the underweight or obese categories.  BMI was 
described according to World Health Organisation (WHO) classification in two studies, with 
one describing a prevalence of 79.1% overweight and obesity in South African women and 
the other showing prevalence’s of 34.1% and 60.2% overweight and obesity in women who 
57 
 
gave birth to normal weight and macrosomic babies respectively in Zambia (50,122).  Weight 
gain was 228g/week from approximately 23 week’s gestational age in Malawi (118) and 
1.06kg/week during the third trimester in Liberia (120).  In Sudan, the mean mid-upper arm 
circumference (MUAC) of pregnant women at delivery was 26.9 cm (49,117), while in 
Ethiopia 52.7% of women had a MUAC of <23 cm (113) (Table 2). 
Hb was used as a biomarker of iron status in pregnant women in five studies.(115)  All 
studies described mean Hb values above the threshold for diagnosis of anaemia in pregnant 
women (<11g/dL), with the exception of one study in Tanzania (115).  Based on this cut-off 
point 66.7% of rural and 26.7% of urban women were classified as anaemic in one study in 
Ghana and 32% were anaemic in another study in the same setting (125,127).  Kenyan 
pregnant women had a 32% anaemia prevalence in one study (121), while 42.2% and 21.8% 
of women from  pastoral and farming communities respectively were diagnosed with anaemia 
in a another study (123).  In addition to anaemia diagnosed via Hb concentrations, 
Keverenge-Ettyang (2006) also assessed iron stores in pregnant women using serum ferritin 
concentrations.  Pregnant women from pastoral communities had significantly higher serum 
ferritin concentrations than those from farming communities, although the difference was 
relatively small (25.8µg/L v. 24.4µg/L, P<0.05).  The prevalence of low maternal iron stores 
(serum ferritin <32µg/L) was high in both groups (77% in pastoral and 85.9% in farming 
communities) (123).  27.9% and 24.2% of women from pastoral and farming communities 
respectively had low vitamin A status (serum retinol).  Iron deficiency and iron deficiency 
anaemia (IDA) prevalence’s were 41.6% and 50% respectively in pregnant South African 
women based on a combination of biochemical markers (serum iron, ferritin, transferrin, Hb, 
haematocrit, mean corpuscular volume and red blood cell count) (122).   
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Red cell folate concentrations were between 166 and 183nmol/L in rural and between 158 
and 177nmol/L in urban Nigerian women (126).  Mean calcium concentrations were 
8.9mg/dL in Egyptian pregnant women (116).     
Of the ten studies reporting dietary intake in pregnant women, most used 24 hour recall 
and/or food frequency questionnaires (FFQs) as the assessment method 
(114,115,119,121,122,124,125), while two used weighed food records (112,126) and one 
used a food survey questionnaire  for calcium intake specifically (116).     Mean energy 
intake ranged between 952 and 3981 kcal/day across study sites.  Mean macronutrient intakes 
ranged as follows: carbohydrate 231-350 g/d, protein 15-104 g/d and fat 7-62 g/d; with the 
lowest intakes of all macronutrients found in the same Ethiopia population (112).  Mean 
intake of the key pregnancy micronutrients analysed ranged between 7-41 mg/d of iron, 194-
424 µg/d of folate, 355-974 mg/d of calcium and 5-13 mg/d of zinc.   
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Table 2: Results from observational studies describing maternal nutritional status (MNS) of pregnant African women 
 
First Author, 
Year Country Main Objective(s) 
Sample 
Size 
Gestational 
Age 
MNS Measures [mean(SD)/ median(range)] 
Anthropometry Biomarkers Dietary Intake 
Measurement(s) Value(s) Type(s) Value(s) 
Energy, 
kcal/day 
Macronutrient(s)/ 
Fibre, g/day 
Micronutrient(s), 
mg/day 
Changamire, 
2014 
Tanzania To examine the effect of 
maternal macronutrient 
intake on GWG 
8428 12-27 weeks Weight, kg 59.5 (10.7) Hb, g/dL 10.2 (1.6) 2108 
(804) 
CHO: 344 (132)  
BMI, kg/m
2
 24.6 (3.9) Protein: 53 (35) 
Fat: 59 (37) 
Kesa, 2005 South 
Africa 
Explore anthropometry 
and nutritional intake of
 pregnant and lactating 
women (table includes 
only pregnant women)  
315 1st, 2nd and 
3rd 
trimesters 
Overweight/ 
obese (BMI >25 
kg/m
2
) ( %) 
79.12% Fe deficient 
(%)
b
 
41.6% 8425.71 
(2279)
a
 
CHO: 292.45 
(72.2) 
Fe: 9.74 (3.8) 
Fe deficiency 
anaemia (%)
b
 
50% Protein: 73.18 
(23) 
Fat: 62.29 (23.7) 
Darwish, 
2009 
Egypt To assess the prevalence 
and predictors of low 
calcium intake in 
pregnant women 
503 34 (2) weeks Weight, kg 67.5 (42-
107) 
Ca, mg/dL 8.9 (1.6)   Ca: 879.1 (504.9) 
Height, m 160.6 (143-
173) 
Abebe, 2007 Ethiopia To assess the prevalence 
of zinc inadequacy based 
on dietary intakes and 
plasma zinc 
concentrations 
99 >28 weeks Weight, kg 52.1 (6.1)    3981 
(3156, 
5211)
a
 
CHO: 231.2 (178.2, 
299.7) 
Fe: 27.1 (20.7, 
33.2) 
Height, m 154.8 (6.5) Protein: 15.5 (10.4, 
20.1) 
Ca: 479 (220, 680) 
BMI, kg/m
2
 21.7 (2.0) Fat: 7.7 (4.7, 11.7) Zn: 5.0 (3.3, 7.2) 
Fibre: 24.4 (15.3, 
32.8) 
Vit C: 2.2 (0.8, 4.7) 
Keverenge-
Ettyang, 
2006 
Kenya To assess differences in 
maternal body 
composition, iron and 
vitamin A status during 
pregnancy and 
postpartum in pastoral 
122 P,                    
128 F  
3rd trimester 
(28-36 
weeks) 
Weight, kg P: 51.9 
(5.5)                 
F: 51.6 
(7.1) 
Hb, g/L P: 119 (11.3)           
F: 124 (15.0) 
   
Height, m P: 160 
(5.6)                   
Hematocrit P: 33 (3.95)            
F: 32 (5.42) 
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First Author, 
Year Country Main Objective(s) 
Sample 
Size 
Gestational 
Age 
MNS Measures [mean(SD)/ median(range)] 
Anthropometry Biomarkers Dietary Intake 
Measurement(s) Value(s) Type(s) Value(s) 
Energy, 
kcal/day 
Macronutrient(s)/ 
Fibre, g/day 
Micronutrient(s), 
mg/day 
(P) and farming (F) 
communities 
F: 160 
(6.8) 
Serum ferritin 
(SF), μg/L 
P: 25.8 (4.82)                
F: 24.4 (4.87) 
Serum retinol 
(SR), μmol/L 
P: 0.92 (0.43)               
F: 0.92 (0.35) 
Anaemia (Hb 
<110g/L), n (%) 
P: 49 (42.2%)               
F: 27 (21.8%) 
Low Fe stores 
(SF <32 μg/L),    
n (%) 
P: 95 (77%)                
F: 110 
(85.9%) 
Low vit A status 
(SR <0.70 
μmol/L), n (%) 
P: 34 (27.9%)                  
F: 31 (24.2%) 
Kamau-
Mbuthia, 
2007 
Kenya To determine diet quality 
and common food 
sources of nutrients in 
pregnant women 
716 1st antenatal 
visit 
   Hb, g/dLd 11.7 (1.98) 2055 
(537) 
CHO: 350 (96.8) Fe: 16.1 (5.4) 
Anaemia (Hb 
<11g/dL), n (%) 
18 (32%) Protein: 59.3 
(22.4) 
Folate (µg/d): 317 
(161) 
Fat:  51 (24.5) Ca: 441 (386) 
PUFA: 13.8 (8.3) Zn: 9.4 (3.4) 
Fibre: 38.8 (15.1) Vit A (µg/d): 1187 
(878) 
Vit C: 110 (71.9) 
Belgnaoui, 
2006 
Morocco To assess dietary intake 
and nutrient adequacy in 
an agricultural 
population of pregnant 
women 
172 First 
(19.4%), 
second 
(49%), 3rd 
(31.6%) 
trimesters 
      2947.0 
(827.9) 
Protein: 104.1 
(38.7) 
Fe: 17.2 (5.1) 
Folate (µg/d): 
423.8 (140.4) 
Ca: 832.3 (397.4) 
Zn: 10.4 (4.3) 
Vit C: 127.6 
(112.5) 
Vit B1: 1.55 (0.50) 
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First Author, 
Year Country Main Objective(s) 
Sample 
Size 
Gestational 
Age 
MNS Measures [mean(SD)/ median(range)] 
Anthropometry Biomarkers Dietary Intake 
Measurement(s) Value(s) Type(s) Value(s) 
Energy, 
kcal/day 
Macronutrient(s)/ 
Fibre, g/day 
Micronutrient(s), 
mg/day 
Ph: 1867.0 (519.8) 
Mg: 528.2 (192.9) 
Vit E: 22.7 (24.1) 
Oguntona, 
2002 
Nigeria To assess the food intake 
and nutrition status of 
rural and urban pregnant 
adolescents in the south-
western region of 
Nigeria 
54 rural 
(R), 47 
urban (U) 
>28 weeks    Red Cell Folate 
(nmol/L) 
R <17y: 166 
(18.4)      R 
>17y: 183 
(41.4) 
R <17y: 
5571 
(307)
a
                                 
R >17y: 
5693 
(481)
a
 
Protein:                                    
R <17y: 33.6 (2.4)                                           
R >17y: 37.0 (3.0) 
Fe:                                                                                       
R <17y: 9.7 (2.1)                                                                          
R >17y: 10.9 (1.5) 
U <17y: 158 
(28.5)                                
U >17y: 177 
(24.7) 
U <17y: 
5209
(214)
a
                                                       
U >17y: 
5864 
(416)
a
 
U <17y: 33.1 (2.2)                                   
U >17y: 42.2 (3.9) 
U <17y: 9.9 (1.0)                                                             
U >17y: 11.8 (3.3) 
Fat:                                                             
R <17y: 11.2 (1.1)                                                  
R >17y: 24.4 (2.1) 
Zn:                                                                           
R <17y: 10.6 (2.6)                                                              
R >17y: 12.0 (2.1) 
U <17y: 9.0 (1.0)                                              
U >17y: 26.5 (5.8) 
U <17y: 10.8 (2.0)                                                                 
U >17y: 13.6 (2.1) 
Ca:                                                         
R <17y: 662.6 
(200.3)                                                                                      
R >17y: 609.4 
(210.5) 
U <17y: 623.8 
(176.8)                                                                                   
U >17y: 739.5 
(119.0) 
Nti, 2002 Ghana To determine the food 
consumption, diet quality 
and awareness of 
15 rural 
(R),  15 
suburba
6 months    Anaemia (Hb 
<11g/dL), n (%) 
R: 10 (66.7%)                                     
S: 4 (26.7%) 
R: 2640
(2189–
3205)                                                      
Protein:                                                                                                          
R: 41.6 (35.0–
57.3)                                     
Fe:                    
R: 7.3 4.9–9.3                                                                                  
S: 10.6 7.6–13.7 
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First Author, 
Year Country Main Objective(s) 
Sample 
Size 
Gestational 
Age 
MNS Measures [mean(SD)/ median(range)] 
Anthropometry Biomarkers Dietary Intake 
Measurement(s) Value(s) Type(s) Value(s) 
Energy, 
kcal/day 
Macronutrient(s)/ 
Fibre, g/day 
Micronutrient(s), 
mg/day 
nutritional requirements 
in rural and suburban 
pregnant women  
n (S) S:  3018 
(2314–
3783) 
S: 59.6 (46.2–
83.7) 
Ca:                                                                                          
R:  860.0 419.1–1 
744.5                                                                   
S:  974.4 453.2–
1700.0 
Vit A (IU/d):                                                                                
R: 13 825 1 396–37 
310                                            
S: 21 893 3 118–7 
1643 
Thiamin:                                                                   
R: 1.6 0.7–2.4                                                                                              
S: 2.2 1.3–4.6 
Riboflavin:                                                                                   
R: 1.5 0.5–2.1                                                                                                 
S: 1.4 0.8–1.9 
Niacin:                                                                                                                
R: 16.6 5.7–25.6                                                                                        
S: 20.2 14.9–31.7 
Vit C:                                                                                                       
R: 42 18.0–85.0                                                                                    
S:  36 22.3–51.2 
Huybregts, 
2009 
Burkina 
Faso 
To assess potential 
changes in dietary habits 
in during pregnancy in a 
sample of rural women 
218 126 in 1/2nd 
trimester 
(T1/2), 92 in 
3rd trimester 
(T3) 
      T1/2: 
8600 
(6800; 
11100)
a
                                                                            
T3: 9000 
(7000; 
11300)
a
 
Protein:                                                              
T1/2: 60.5 (44.8; 
76.8)                                            
T3: 61.2 (46.5;
77.8) 
 
Fat:                                                                                                                
T1/2: 31.2 (17.1; 
47.5)                                   
T3: 27.0 (15.4; 
Fe:                                                   
T1/2: 40.6 (28.9; 
57.7)                                                                                               
T3: 40.1 (25.4; 
54.6) 
Folate (µg/d):                                                                                                        
T1/2: 234.7 (152.1;
367.5)                                                                 
T3:  217.2 (150.3; 
316.9) 
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First Author, 
Year Country Main Objective(s) 
Sample 
Size 
Gestational 
Age 
MNS Measures [mean(SD)/ median(range)] 
Anthropometry Biomarkers Dietary Intake 
Measurement(s) Value(s) Type(s) Value(s) 
Energy, 
kcal/day 
Macronutrient(s)/ 
Fibre, g/day 
Micronutrient(s), 
mg/day 
46.5) Ca                                                                                                   
T1/2: 574.3 (335.3; 
1081.5)                                              
T3: 468.6 (231.0; 
708.5) 
Zn:                                                                                               
T1/2: 13.1 (10.1; 
16.2)                                                                                 
T3: 13.3 (10.4; 
16.6) 
Thiamine:                                                                                                
T1/2: 0.85 (0.53; 
1.1)                                                                                     
T3: 0.81 (0.57; 1.1) 
Riboflavin:                                                                                
T1/2: 0.20 (0.13; 
0.34)                                                                                                   
T3: 0.25 (0.14; 0.5) 
Niacin:                                                                                                         
T1/2: 7.3 (5.2; 
10.0)                                                                        
T3: 7.8 (5.5; 10.3) 
Ph:                                                                                               
T1/2: 839.7 (616.9; 
1135.7)                                         
T3: 852.1 (670.7; 
1180.7) 
Vit A (µg/d):                                                                                              
T1/2: 118.9 (60.5; 
249.6)                                                                  
T3: 117.6 (53.8; 
242.3) 
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First Author, 
Year Country Main Objective(s) 
Sample 
Size 
Gestational 
Age 
MNS Measures [mean(SD)/ median(range)] 
Anthropometry Biomarkers Dietary Intake 
Measurement(s) Value(s) Type(s) Value(s) 
Energy, 
kcal/day 
Macronutrient(s)/ 
Fibre, g/day 
Micronutrient(s), 
mg/day 
Vit B6:                                                                
T1/2: 0.84 (0.63; 
1.14)                                                                                       
T3: 0.88 (0.68; 
1.26) 
Vit C:                                                                              
T1/2: 11.0 (5.7; 
21.2)                                                                                          
T3: 10.4 (6.1; 28.4) 
Mostert, 
2005 
South 
Africa 
i) To determine the 
dietary intake of poor 
rural women during 
pregnancy and lactation                                                              
ii) To determine the 
nutritional status and 
dietary intake of their 
infants at 6 months 
46 Anthropometry
: 1st visit (4-6 
months)  
                                                         
Dietary intake: 
during 2nd and 
3rd trimesters 
BMI, kg/m
2
 27.2 (5.5)    7760 
(2059)
a
 
CHO: 306.2 
(88.0) 
Fe: 9.6 (4.3) 
Protein: 66.8 
(30.3) 
Folate (µg/d): 
194.5 (75.3) 
Fat: 55.5 (47.3) Ca: 354.8 (245.5) 
Fibre: 21.7 (5.5) Zn: 8.1 (4.3) 
Vit A (µg/d): 574.2 
(428.4) 
Vit C: 34.7(26.6) 
Vit E: 5.6 (3.2) 
Vit B6: 0.87 (0.39) 
Niacin: 10.94 
(4.97) 
Assefa, 2012 Ethiopia To measure the 
incidence and 
determinants of LBW in 
a rural population 
956   MUAC <23 cm, 
n(%) 
504 
(52.7%) 
      
  MUAC ≥23 cm, 
n(%) 
452 
(47.3%) 
      
Elshibly, 
2008 (i) and 
Elshibly 
2009 (ii) 
Sudan i) To quantify the effect 
of maternal 
anthropometry, 
education and 
socioeconomic status on 
gestational age and birth 
weight                                                                                
1000 39.1 (1.8) Weight, kg 65.2 (13.0)      
Height, cm 159.6 (6.2) 
BMI, kg/m
2
 25.5 (4.8) 
MUAC, cm 26.9 (3.9) 
Lean body 
mass 
44.2 (4.9) 
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First Author, 
Year Country Main Objective(s) 
Sample 
Size 
Gestational 
Age 
MNS Measures [mean(SD)/ median(range)] 
Anthropometry Biomarkers Dietary Intake 
Measurement(s) Value(s) Type(s) Value(s) 
Energy, 
kcal/day 
Macronutrient(s)/ 
Fibre, g/day 
Micronutrient(s), 
mg/day 
ii) To investigate the 
relationship between 
maternal and newborn 
anthropometry 
Liu, 2013 Zambia To identify predictors 
and outcomes 
associated with a birth 
weight of 4000 g or 
more in Lusaka.  
Women were analysed 
according to those who 
gave birth to normal 
weight (N) compared to 
macrosomic (M) babies 
191834 First 
antenatal 
visit 
BMI, kg/m
2         
 N: 23.5 
(21.5–
26.1)
c
     
M: 26.2 
(23.4-
29.8)
c
 
      
Underweight 
(BMI <18.5 
kg/m
2
), n (%) 
N: 3289 
(2.8%)                 
M: 41 
(1.4%) 
Normal 
weight (BMI 
18.5-24.9 
kg/m
2
), n (%) 
N: 75 043 
(63.2%)               
M: 1 135 
(38.4%) 
Overweight 
(BMI 25-29.9 
kg/m
2
), n (%) 
N: 30 464 
(25.7%)          
M: 1 057 
(35.7%) 
Obese (BMI 
≥30 kg/m2), n 
(%) 
N: 9 934 
(8.4%)               
M: 724 
(24.5%) 
Hartikainen, 
2005 
Malawi   1032 23 (25th, 
75th 
percentiles: 
20, 26) 
Weight, kg 52 (48; 55)
d
       
Weight gain, 
g/week 
228 (111; 
355)
d
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First Author, 
Year Country Main Objective(s) 
Sample 
Size 
Gestational 
Age 
MNS Measures [mean(SD)/ median(range)] 
Anthropometry Biomarkers Dietary Intake 
Measurement(s) Value(s) Type(s) Value(s) 
Energy, 
kcal/day 
Macronutrient(s)/ 
Fibre, g/day 
Micronutrient(s), 
mg/day 
Nieuwoudt, 
2014 
South 
Africa 
To investigate whether 
differences exist in 
adverse pregnancy 
outcomes between 
morbidly obese (MO, 
BMI 40-49.9) and super-
obese (SO, BMI ≥50) 
women 
66 MO, 
46 SO 
MO: 29                                    
(range: 9 - 
40)                                               
SO: 29                                                    
(range: 10 - 
40) 
Height, cm MO: 160 
(142-175)          
SO: 159 
(136-172) 
      
Weight, kg MO: 114 
(89-144)            
SO: 135 
(111-193) 
Stephens, 
2014 
Ghana To establish the 
prevalence of pregnancy-
associated malaria and 
its associated 
consequences 
320 18.5 (95% 
CI: 17.12-
19.05) 
   Hb, g/dL 11.44 ( 95% 
CI 11.29 - 
11.80) 
   
Anaemia (Hb 
<11g/dL), n (%) 
102 (32%) 
Jackson, 
2010 
Liberia i) Estimate the 
proportion of LBW 
infants                           
ii) Study the relationship 
between mothers' health 
complaints and 
pregnancy outcomes                                                       
iii) Examine the 
relationship between 
GWG and pregnancy 
outcome                                                                                                   
iv) Determine the 
optimal weight gain 
associated with a 
favourable birth weight 
range 
80 6 and 9 
months  
3rd trimester 
GWG, kg 
3.18 Hb, g/dL 6 months: 9.9 
(1.1) 
   
3rd trimester 
GWG, kg/ 
week 
1.06 9 months: 11.5 
(1.2)
e
 
Abbreviations: LBW, low birth weight; GWG, gestational weight gain; BMI, body mass index; MUAC, mid-upper arm circumference; Fe, iron; Ca, calcium; Zn, zinc; Vit, vitamin; Hb, 
haemoglobin; Ph, phosphorus; Mg, magnesium                                                                                                                                                                                                                                                                                                                                                                                                     
a
Reported as kJ/day                                                                                                                                                                                                                                                                                                                                                                                      
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b
Based on serum Fe, ferritin, transferrin, Hb, hematocrit, mean corpuscular volume and red blood cell count                                                                                                                                                                                                                    
c
Median (interquartile range)                                                                                                                                                                                                                                                                                                                                                               
d
Median (25
th
, 75
th
 percentiles)                                                                                                                                                                                                                                                                                                                                                                   
e
Routine Fe supplementation received between 6 and 9 months  
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2.3.2 Associations between MNS (anthropometry) and fetal growth and birth, 
neonatal and infant outcomes (Table 3) 
Eight studies met the inclusion criteria (49,50,52,113,117,118,120,123).  The publication year 
ranged from 2005 to 2014.  Four studies followed a prospective cohort design 
(52,113,120,123), two studies used retrospective data (50,118) and two were cross-sectional 
studies (49,117).  The number of pregnant women included in the studies ranged from 80 to 
191 834.  Anthropometric measurements used to describe MNS in study participants included 
weight and height (52,123), BMI (50), gestational weight gain (GWG) (118,120), MUAC 
(113) and lean body mass; with two studies describing all of these variables in pregnant 
women (49,117).  All offspring outcomes were assessed at birth or within the first 30 days of 
life; with the most commonly examined outcomes being birth weight and gestational age 
(Table 3).     
In Sudan, postpartum maternal weight and BMI were positively associated with birth weight 
(P<0.001), but neither variable predicted risk of LBW (<2 500g) (117).  Although risk of 
LBW in Kenya was 2.4 times greater in infants born in farming than in pastoral communities, 
there was no difference in mean weight of the pregnant women during the third trimester of 
pregnancy (123).  GWG in the second and third trimesters showed a strong seasonality effect 
in rural Malawian women, with those delivering in the rainy season gaining significantly less 
weight than those delivering in temperate/dry months (100-200g/week compared to 250-300 
g/week; P<0.001); however this was not reflected as strongly in birth weight (P<0.05) and 
GWG was therefore only weakly correlated with birth weight (Pearson’s correlation 
coefficient 0.13; significance not reported) (118).  In contrast, although birth weight was 
correlated with maternal weight at 6 (r=0.54, P=0.01) and 9 months (r=0.53, P=0.01) in 
Liberia, there was a stronger, positive correlation with net weight gain between the two time 
points (β=0.059, P<0.001) (120).
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Table 3: Results from observational studies of the associations between maternal nutritional status (anthropometry) and fetal growth and birth, neonatal 
and infant outcomes 
First Author, 
Year Country 
Study 
Design 
Sample 
Size 
Participant 
Characteristics 
Anthropometry Outcome 
Conclusions Timing Measurement(s) 
Mean 
(SD)/ 
Median 
(range) Timing Variable 
Mean 
(SD)/ 
Median 
(range) 
Assefa, 2012 Ethiopia Prospectiv
e cohort 
956 Urban and 
rural 
Ethiopian 
pregnant 
women 
 MUAC <23 
cm, n (%) 
504 
(52.7%) 
Birth LBW, n (%) 271 
(28.3%) 
MUAC < 23cm significantly 
associated with LBW and 
increased odds of LBW by 1.6 
times (95% CI: 1.19, 2.19) 
MUAC ≥23 
cm, n (%) 
452 
(47.3%) 
Elshibly, 
2008 and 
Elshibly 
2009 
Sudan Cross-
sectional 
study 
1000 Urban non-
diabetic Sudan 
women with 
singleton 
births 
Birth, 39.1 
(1.8) 
weeks 
gestational 
age 
Weight, kg 65.2 (13.0) Neonatal 
(within 
24 hours 
of birth) 
Gestational age, 
weeks 
39.1 (1.8) Maternal height identified as 
strongest anthropometric 
predictor of neonatal 
outcomes; associated 
positively with gestational age 
(P<0.002), limb length 
(P<0.001) and birth weight 
(P<0.001) 
Height <156 cm increased RR 
of LBW by 52%                                                                    
Maternal weight, BMI and 
MUAC positively correlated 
with birth weight (p<0.001), 
but didn’t predict LBW                                                                                                          
Maternal BMI significantly 
associated with skinfold 
thicknesses (P<0.001)                                                                  
Postpartum maternal lean 
body mass positively 
associated with birth weight, 
body length and body 
circumference (P<0.001)                                                                                                                              
Height, cm 159.6 (6.2) Birth weight, g 3131.7 
(538.9) 
BMI, kg/m
2
 25.5 (4.8) LBW, n (%) 83 (8.3%) 
MUAC, cm 26.9 (3.9) Preterm, n (%) 57 (5.7%) 
Lean body 
mass 
44.2 (4.9) Supine Length, cm 49.3 (2.9) 
Crown-rump 
length, cm 
33.6 (2.2) 
Limb length, cm 15.0 (1.0) 
Head 
circumference, cm 
34.4 (1.7) 
Chest 
circumference, 
cm 
31.7 (2.4) 
Abdominal 
circumference, 
cm 
28.2(2.7) 
MUAC, cm 10.0 (1.1) 
Mid-thigh 
circumference, 
15.0 (1.7) 
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First Author, 
Year Country 
Study 
Design 
Sample 
Size 
Participant 
Characteristics 
Anthropometry Outcome 
Conclusions Timing Measurement(s) 
Mean 
(SD)/ 
Median 
(range) Timing Variable 
Mean 
(SD)/ 
Median 
(range) 
cm 
Triceps skinfold 
thickness, mm 
0.81 (0.21) 
Subscapular 
skinfold 
thickness, mm 
0.83 (0.24) 
Ponderal index, 
g/cm
3
 
2.61 (0.45) 
Liu, 2013 Zambia Retrospectiv
e cohort  
191 
834 
Women with 
singleton births 
>2500g and at 
least one 
documented 
prenatal visit.  
Analysed as 
two groups: 
normal birth 
weight      (N, 2 
500-3 999g) 
and 
macrosomia       
(M, ≥4 000g) 
First 
antenatal 
visit 
BMI, kg/m
2
 N: 23.5     
(21.5-26.1)
a
         
M: 26.2     
(23.4-29.8)
a
 
 
Birth Macrosomia, n 
(%) 
 
 
 
 
 
4 717 
(2.5%) 
Mean BMI higher in women 
who gave birth to macrosomic 
infants (P<0.01) 
Overweight and obesity at 
baseline associated with 1.72 
and 2.88 times greater odds of 
giving birth to a macrosomic 
infant respectively    
Underweight 
(BMI <18.5 
kg/m
2
), n (%) 
N: 3289 
(2.8%)                 
M: 41 
(1.4%) 
Normal weight 
(BMI 18.5-24.9 
kg/m
2
), n (%) 
N: 75 043 
(63.2%)               
M: 1 135 
(38.4%) 
Overweight      
BMI 25-29.9 
kg/m
2
), n (%) 
N: 30 464 
(25.7%)          
M: 1 057 
(35.7%) 
Obese                      
(BMI ≥30), n 
(%) 
N: 9 934 
(8.4%)               
M: 724 
(24.5%) 
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First Author, 
Year Country 
Study 
Design 
Sample 
Size 
Participant 
Characteristics 
Anthropometry Outcome 
Conclusions Timing Measurement(s) 
Mean 
(SD)/ 
Median 
(range) Timing Variable 
Mean 
(SD)/ 
Median 
(range) 
Hartikainen, 
2005 
Malawi Retrospectiv
e cohort 
1032 Rural 
Malawian 
women with 
singleton 
births 
23 weeks 
(25th, 75th 
percentiles
: 20, 26) 
Weight, kg 52 (48; 
55)
b
 
Neonatal 
(within 
30 days 
of birth) 
Birth weight, g 3400 Seasonal variation in maternal 
weight gain: highest in those 
who delivered in the third 
quarter of the year (250-300 
g/week) and lowest in the first 
quarter (100-200 g/week) 
(p<0.001) 
Weaker correlation for 
seasonality in newborn weight 
(p<0.05) 
GWG showed a modest 
correlation with newborn 
weight (Pearson's correlation 
coefficient: 0.13) 
Weight gain, 
g/week 
228 (111; 
355)
b
 
Gestational age, 
weeks 
40 (38; 
41)
b
 
Keverenge-
Ettyang, 
2006 
Kenya Prospectiv
e cohort 
122 P,                    
128 F  
Rural pregnant 
women in 
their third 
trimester from 
pastoral (P) 
and farming 
(F) 
communities 
3rd 
trimester 
(28-36 
weeks 
gestational 
age) 
Weight, kg P: 51.9 
(5.5)                                             
F: 51.6 
(7.1) 
Neonatal 
(within 7
days of 
birth) 
Birth weight, kg 2.856 
(0.314) 
Mean infant weight 
significantly lower in the 
farming communities (P<0.01) 
and LBW prevalence 
significantly higher in farming 
villages 
RR of death was 2.4 times 
greater for neonates born in 
farming compared to pastoral 
communities 
Height, cm P: 160 
(5.6)                   
F: 160 
(6.8) 
LBW, n (%) P: 19 
(16.8%)                  
F: 35 
(31.3%) 
Nieuwoudt, 
2014 
South 
Africa 
Prospectiv
e cohort 
66 MO, 
46 SO 
Pregnant 
women 
attending a 
high risk 
antenatal 
clinic with 
BMIs ≥40 
kg/m
2
 
Gestational 
age, weeks:              
MO: 29    
(range: 9-40)                                               
SO: 29      
(range: 10-40) 
Height, cm MO: 160 
(142-175)          
SO: 159 
(136-172) 
Neonatal Symphysis-fundal 
height ≥90th 
centile, n (%) 
MO: 44 
(66.7)                                      
SO: 28 
(60.9) 
Incidence of IUGR greater in 
the SO than the MO group 
(13% vs. 2%; p=0.02) 
No differences in macrosomia 
incidence between groups   Weight, kg MO: 114 
(89-144)            
SO: 135 
(111-193) 
IUGR, n (%) MO: 1 
(1.5%)                                                                           
SO: 6 
(13%) 
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First Author, 
Year Country 
Study 
Design 
Sample 
Size 
Participant 
Characteristics 
Anthropometry Outcome 
Conclusions Timing Measurement(s) 
Mean 
(SD)/ 
Median 
(range) Timing Variable 
Mean 
(SD)/ 
Median 
(range) 
  Macrosomia, n 
(%) 
MO: 5 
(7.6%)                                                                                  
SO: 3 
(6.5%) 
  Weight, g MO: 3200 
(525-4330)                                                                       
SO: 3430 
(640-4690) 
Jackson, 
2010 
Liberia Prospectiv
e cohort   
80 Generally 
healthy 
women with 
no previous 
antenatal care 
for current 
pregnancy 
6 and 9 
months 
3rd trimester 
GWG, kg 
3.18 Birth Birth weight, g 
(mean) 
3311 Infant birth weight weakly 
correlated with maternal 
weight at 6 (r=0.54, P=0.01) 
and 9 months (r=0.53, P=0.01)  
Net weight gain between 6 
and 9 months was strongly 
correlated with birth weight 
(b=0.059, P<0.001)  
3rd trimester 
GWG, kg/ 
week 
1.06 LBW, n (%) 1 (1.3%) 
Abbreviations: LBW, low birth weight; IUGR, intrauterine growth restriction; GWG, gestational weight gain; BMI, body mass index; MUAC, mid-upper arm circumference ; MO, 
morbidly obese (BMI 40-49.9 kg/m
2); SO, super obese (BMI ≥50 kg/m2);     RR, risk ratio                                                                                                                                                                                                                                                                                                                                                                                                                                 
a
Median (interquartile range)                                                                                                                                                                                                                                                                                                                                                               
b
Median (25
th
, 75
th
 percentiles)                                                                                                                                                                                                                                                                                                                                                                 
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In Zambia, where maternal overweight was more prevalent than the aforementioned studies, 
overweight and obesity were associated with 1.72 and 2.88 times greater odds of giving birth 
to a macrosomic infant respectively (50).  In South African women with BMIs ≥40kg/m2, 
incidence of IUGR was significantly higher in those who had BMIs ≥ 50kg/m2 than those 
with BMIs between 40 and 49.9kg/m
2
 (52). 
MUAC was associated with birth weight in two studies, with a MUAC <23cm (suggestive of 
maternal underweight) (128) increasing odds of LBW by 1.6 times (49,113).  In addition to 
the aforementioned findings, maternal height was identified as the strongest anthropometric 
predictor of neonatal outcomes in Liberia.  Maternal height had positive associations with 
gestational age (P<0.002), limb length (P<0.001) and birth weight (P<0.001), while height 
<156 cm increased the relative risk of LBW by 52%.  In the same study sample, positive 
associations were found between maternal lean body mass and birth weight, body length and 
body circumference within 24 hours of birth (P<0.001) (49).    
2.3.3 The associations between MNS (nutritional biomarkers) and fetal growth and 
birth, neonatal and infant outcomes (Table 4) 
Three studies met the inclusion criteria (120,123,127).  The publication years were 2006, 
2010 and 2014.  All studies included were prospective cohort studies and the sample size 
ranged between 80 and 320.  All studies used biomarkers to assess anaemia and/or iron status 
of pregnant women, with two studies using Hb concentrations only and one study including 
haematocrit and serum ferritin concentrations (123).  The latter also assessed maternal 
vitamin A status using serum retinol concentrations.  Birth weight was the outcome of 
interest in all studies (Table 4). 
 Data from Kenya reports pregnant women from pastoral communities having lower Hb 
concentrations and higher anaemia prevalences than those from farming communities 
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Table 4: Results from observational studies of the associations between maternal nutritional status (biomarkers) and fetal growth and birth, neonatal 
and infant outcomes 
First 
Author, 
Year Country 
Study 
Design 
Sample 
Size 
Participant 
Characteristics 
Biomarkers Outcome 
Conclusions Timing Type(s) 
Mean 
(SD)/ 
Median 
(range) 
Timin
g Variable 
Mean 
(SD)/ 
Median 
(range) 
Stephens, 
2014 
Ghana Prospective 
cohort 
320 Pregnant women 
from a low 
malaria 
transmission area 
of suburban, 
coastal Ghana 
who had not 
received 
Intermittent 
Preventive 
Treatment for 
malaria 
prevention at 
enrolment 
First 
antenatal 
visit, 18.5 
weeks 
gestation 
(95% CI: 
17.12-
19.05) 
Hb, g/dL 11.44 ( 
95% CI 
11.29 - 
11.80) 
Birth LBW, n 
(%) 
11 
(3.3%) 
 
 
 
None of the LBW babies were 
born  
to women who had anaemia in 
the  
first trimester Anaemia (Hb 
<11g/dL), n (%) 
102 (32%) 
Keverenge
-Ettyang, 
2006 
Kenya Prospective 
cohort 
122 
P,                    
128 F  
Rural pregnant 
women in their 
third trimester 
from pastoral (P) 
and farming (F) 
communities 
3rd 
trimester 
(28-36 
weeks 
gestational 
age) 
Hb, g/L P: 119 (11.3)                     
F: 124 (15.0) 
Within
7 days 
of 
birth 
Birth     
weight, kg 
P: 2.9 
(0.4)                                                                   
F: 2.8 
(0.4) 
Women from the pastoral 
community had lower Hb
concentrations (P<0.05) and 
higher anaemia prevalence 
(P<0.01), but higher serum 
ferritin concentrations 
(p<0.05)  There were no 
differences in serum retinol 
levels 
Mean birth weight was 
significantly lower (p<0.01) 
in the farming than in the 
Hematocrit P: 33 (3.95)                              
F: 32 (5.42) 
LBW,        
n (%) 
P: 19 
(16.8%)                  
F: 35 
(31.3%) 
Serum ferritin 
(SF), μg/L 
P: 25.8 (4.82)                
F: 24.4 (4.87) 
Serum retinol 
(SR), μmol/L 
P: 0.92 (0.43)               
F: 0.92 (0.35) 
Anaemia (Hb 
<110g/L), n (%) 
P: 49 (42.2%)               
F: 27 (21.8%) 
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First 
Author, 
Year Country 
Study 
Design 
Sample 
Size 
Participant 
Characteristics 
Biomarkers Outcome 
Conclusions Timing Type(s) 
Mean 
(SD)/ 
Median 
(range) 
Timin
g Variable 
Mean 
(SD)/ 
Median 
(range) 
Low Fe stores 
(SF <32 μg/L), 
n (%) 
P: 95 (77%)                
F: 110 
(85.9%) 
pastoral community and a 
significantly higher 
proportion of newborns in the 
farming community were 
LBW (P<0.05) 
Low Vit A 
status (SR <0.70 
μmol/L), n (%) 
P: 34 (27.9%)                  
F: 31 (24.2%) 
Jackson, 
2010 
Liberia Prospective 
cohort 
80 Generally healthy 
women with no 
previous antenatal 
care for the 
current pregnancy 
6 and 9 
months  
Hb, g/dL 6 months: 
9.9 (1.1) 
Birth Birth weight, 
g (mean) 
3311 There was a significant (but 
weak), positive correlation 
between Hb at 6 months and 
infant birth weight (P=0.042), 
but the correlation was not 
significant at 9 months 
9 months: 
11.5 (1.2)
a
 
LBW, n (%) 1 (1.3%) 
Abbreviations: LBW, low birth weight; Fe, iron; Vit, vitamin; Hb, haemoglobin                                                                                                                                                                                                                                                                     
a
Routine Fe supplementation received between 6 and 9 months 
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[(119g/L v. 124g/L, P<0.05); (42.2% vs. 21.8%, P<0.01)] respectively, but serum ferritin 
concentrations were higher in the pastoral community (25.8µg/L vs. 24.4µg/L, p<0.05).  
Mean infant birth weight was significantly lower (2.9 kg vs. 2.8 kg, P<0.01) and prevalence 
of LBW significantly higher (31.3% vs. 16.8%, P<0.05) for babies born to mothers from 
farming than from pastoral communities (123).  A positive correlation between maternal Hb 
concentrations at 6 months gestation and infant birth weight (P=0.042) was shown in Liberia; 
however this was not significant at 9 months (all women had been routinely supplemented 
with 180mg Fe/day between the 6 and 9 month assessment) (120).  In Ghana, none of the 
women who were anaemic in the first trimester of pregnancy gave birth to LBW babies (127). 
2.3.4 The associations between MNS (dietary intake) and fetal growth and birth, 
neonatal and infant outcomes  
No studies were identified which met the inclusion criteria. 
2.3.5 Randomised/quasi-randomised clinical trials on the associations between 
maternal nutritional interventions and fetal growth, birth, neonatal and infant 
outcomes (Table 5) 
Six studies met the inclusion criteria (129–134). The publication years ranged between 1997 
and 2011.  Four studies were double-blind randomised controlled trials (RCTs) (131–134), 
one was a cluster RCT (129) and one study used data from both a double-blind RCT and a 
cluster RCT (130).  The sample sizes ranged between 125 and 2 100 and gestational age of 
the subjects at baseline ranged between 20 and 28 weeks.  Interventions included iron (134), 
multiple micronutrient (133), calcium (130–132) and protein-energy supplementation 
(129,130) (Table 5).     
Protein-energy supplementation in chronically undernourished Gambian women from 20 
weeks gestational age was associated with 136g higher pregnancy weight gain than in the 
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Table 5: Results from randomized/quasi-randomized clinical trials on the associations between maternal nutritional interventions and fetal growth and 
birth, neonatal and infant outcomes 
First Author, 
Year Country 
Experimental  
Design Sample Size Baseline MNS 
Intervention 
Targeted 
Gestational 
Age at 
Initiation, 
weeks 
Intervention 
Prescribed, 
per day 
Intervention 
Duration 
Outcome 
Assessment Conclusions 
Preziosi, 
1997 
Niger Double-blind, 
randomized, 
placebo-
controlled trial 
197 pregnant 
women  
(99 
intervention, 
98 control) 
Apparently healthy 
low- or middle-
class civil 
servants and rural 
women with no 
obstetric 
complications.   
Fe 
supplementation 
28 (±21 days) 100 mg 
elemental Fe 
Until 
delivery 
Birth, 3, 6 
months 
postpartum 
No difference in birth 
weight   
Birth length significantly 
higher in intervention 
group (P<0.05) 
No differences in infant 
length at 3 or 6 months 
postpartum  
Serum ferritin 
concentrations higher in 
infants born to 
supplemented mothers at 3 
[99(63) vs. 80(53)µg/L] 
and 6 months [26(27) vs. 
15(20)µg/L] (P<0.05) 
Anaemia (Hb 
<110g/L):                                                                                                                       
Intervention: 65.7%                                                                       
Control: 69.4%                      
Kaestel, 2005 Guinea-
Bissau 
Double-blind 
randomized, 
controlled trial 
2100 
pregnant 
women 
Baseline BMI, 
mean (SD):                                                      
Micronutrient 
intervention (MN)-
1: 23.3 (3.4)                                                             
MN-2: 23.3 (3.3)                                      
Control: 23.2 (3.3)                                                                                                                              
Multiple 
micronutrient
supplementation 
Mean (SD):                                                                 
MN-1: 22.3 (6.6)                                                             
MN-2: 22.1 (6.8)                                          
Control: 21.9 
(6.9)
MN-1: one
RDA of 15
micronutrients                                                                       
MN-2: two 
RDA of 14 
micronutrients 
(Fe at one 
RDA)                                                                                                                      
Control: 
standard Fe-
folic acid 
supplement 
Until
delivery,                                     
mean (SD): 
16.6 (7.1) 
weeks 
Birth, 
neonatal
Mean birth weight was 
53g higher in MN-1 and 
95g higher in MN-2 than 
the control group 
Non-significant effect on 
LBW: 10.1% MN-2, 12% 
MN-1 and 13.6% control 
(P=0.33)
Birth weight increased by 
218g and risk of LBW 
decreased by 69% in 
anaemic women receiving 
MN-2 compared to the 
control group   
Anaemia (Hb 
<100g/L):                                                                                                                       
MN-1: 30%                                                                         
MN-2: 31%                                                                                 
Control: 31% 
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First Author, 
Year Country 
Experimental  
Design Sample Size Baseline MNS 
Intervention 
Targeted 
Gestational 
Age at 
Initiation, 
weeks 
Intervention 
Prescribed, 
per day 
Intervention 
Duration 
Outcome 
Assessment Conclusions 
No effect on perinatal 
mortality   
Ceesay, 
1997 
The 
Gambia 
Cluster 
randomized 
controlled trial 
1460 
pregnant 
women 
(yielded 
2047 live 
singleton 
births over 5 
years) 
Chronically 
undernourished, 
rural pregnant 
women 
Protein-energy 
supplement 
Intervention: 
20                
Control: after 
delivery 
Energy: 1015 
kcal                          
Protein: 22 g                                                         
Fat: 56g                                                                  
Calcium: 
47mg                                                                
Fe: 1.8mg 
Intervention: 
until delivery                                                                      
Control: 20
weeks
Birth, 
neonatal 
GWG increased by 136g 
in the supplementation
group (P<0.001): higher 
increases in the hungry 
(201g, P<0.001) than the 
harvest season (94g, 
P<0.01)                                                                                                  
Odds of LBW was 0.61 
(95% CI: 0.47-0.79, 
P<0.001) and head 
circumference was 3.1mm 
higher (P<0.01) in the 
supplemented group   
Supplementation reduced 
perinatal mortality: OR 
0.54 (95% CI: 0.35-0.85, 
P 0.01) for all deaths in 
first week of life 
Hawkesworth, 
2011 
1267 term 
births 
followed up   
Childhood                            
(11-17 years) 
No differences between 
groups childhood body 
composition (BMI, fat 
mass or lean mass), blood 
pressure, insulin or 
cholesterol concentrations  
Children of pregnancy-
supplemented mothers:        
-0.05 mmol/L (95% CI: -
0.10, -0.001 mmol/L) 
lower fasting plasma 
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First Author, 
Year Country 
Experimental  
Design Sample Size Baseline MNS 
Intervention 
Targeted 
Gestational 
Age at 
Initiation, 
weeks 
Intervention 
Prescribed, 
per day 
Intervention 
Duration 
Outcome 
Assessment Conclusions 
glucose 
Jarjou, 2006 The 
Gambia 
Double-blind, 
randomized, 
placebo-
controlled trial 
125 pregnant 
women 
(subsample 
of main 
study, 
n=536) 
Rural Gambian 
women with 
previously 
documented low 
calcium intakes 
(approximately 350 
mg/d) 
Calcium 20 1500 mg Until 
delivery 
Birth, 
neonatal, 
infant (birth, 
<5 days, 2, 
13, 52 weeks 
of age) 
No differences in birth 
weight between groups 
No differences in infant 
weight, body length, head 
circumference or bone 
mineral status in the first 
year of life 
Hawkesworth, 
2010 and 
Hawkesworth, 
2011 
350 term 
births 
followed up  
of main 
study sample 
      Chilldhood 
(5-10 years) 
No differences in blood 
pressure between infants 
born to supplemented 
compared to un-
supplemented mothers.   
No interaction between 
childhood BMI and 
supplementation for blood 
pressure variables 
Abbreviations: MNS, maternal nutritional status; LBW, low birth weight; Fe, iron; BMI, body mass index; OR, odds ratio                                                                                                                        
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control group (P<0.001) (129).  Increases were higher in the hungry (201g, P<0.001) than in 
the harvest season (94g, p<0.01).  Odds of perinatal mortality (death within the first 7 days of 
life) (OR: 0.54, 95% CI: 0.35;0.85, P<0.01)  and LBW (0.61 95%CI 0.47;0.79, P<0.001) 
were respectively lower in the supplementation group.  There was also a 3.1 mm increase in 
head circumference (P<0.01) in those who received the intervention (129).  During the 
follow-up study in 11-17 year olds, no differences  in BMI, fat mass, lean mass, blood 
pressure, insulin or cholesterol concentrations were found between those whose mothers had 
received protein-energy supplementation during pregnancy and controls; however those born 
to supplemented mothers had -0.05 mmol/L  (95% CI: -0.10, -0.001 mmol/L)  lower fasting 
glucose concentrations (130).   
In Gambian women, no differences in weight, body length, head circumference or bone 
mineral content between infants born to women who received calcium supplementation and 
those who received a placebo from 20 weeks gestational age were observed.  Follow-up of 
infants at 5-10 years of age showed no differences in blood pressure and no interaction 
between BMI and calcium supplementation for blood pressure variables (130,131). 
A trial of iron supplementation to a cohort of pregnant women with a high anaemia 
prevalence in Niger found no differences in birth weight between babies born to the 
intervention and control groups (134).  Birth length and Apgar scores were significantly 
higher in babies born to supplemented mothers; however the difference in length did not 
persist at 3 and 6 months.  Serum ferritin concentrations at 3 and 6 months of age were higher 
in infants whose mothers received iron supplementation compared to those whose mothers 
received the placebo (P<0.05) (134). 
Pregnant women in Guinea-Bissau received either one of two possible interventions: a tablet 
with one recommended daily allowance (RDA) of 15 micronutrients (MN-1) or a tablet with 
81 
 
two RDAs of the same micronutrients (but one RDA of iron) (MN-2), or a standard iron-folic 
acid supplement (control group) from approximately 22 weeks gestation (133).  Mean birth 
weight was 53g and 95g higher in the MN-1 and MN-2 groups respectively than in the 
control group, suggesting a dose-response effect of supplementation.  Supplementation had a 
positive effect on LBW, with 10.1%, 12% and 13.6% LBW prevalence found in the MN-2, 
MN-1 and control groups respectively; however this was not significant (P=0.33).  Birth 
weight was 218g higher and risk of LBW 69% lower for babies born to anaemic women in 
the MN-2 group compared to the control group (133).      
2.3.6 Randomised/quasi-randomised clinical trials on the associations between 
nutritional interventions in the first 2 years of life and any adolescent and/or 
adult health outcomes    
No studies were identified which met the inclusion criteria. 
2.4 Discussion 
Using a systematic approach, this review aimed to provide and report on available data on 
MNS among Africans and illustrate whether the first 1000 days of life are nutritionally 
important for Africa.  We focused on the role of MNS during this period and how it 
associates with fetal growth and birth, neonatal and infant outcomes.  The results are 
conveniently discussed by sub headings addressing each specific objective set for this review. 
2.4.1 MNS in Africa 
Using BMI most African women in the reported studies were within the normal weight to 
overweight category during pregnancy, with maternal overweight or obesity being more 
prevalent than underweight.  This was supported by high energy intakes in some countries; 
however mean energy intakes varied greatly between populations.  Carbohydrate, protein and 
fat contributed between 58-87%, 5.9-14.5% and 6.3-27.9% respectively to total energy intake 
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across study sites.  The most prevalent micronutrient deficiency in African pregnant women 
was iron.  
Studies included in this review indicate a low burden of maternal underweight, and 
comparatively high overweight and obesity prevalence, typical of the epidemiological health 
transition across African countries.  Although GWG was approximately half the Institute of 
Medicine (IoM) recommended level for normal weight women in Malawi (118), much higher 
weekly gain than recommended for any BMI category was found in Liberian pregnant 
women (25,120).    Though the above findings provide good proxies for maternal obesity 
status, interpretation of the findings should be done with care, as a limitation exits in that 
obesity status (being underweight, normal, overweight or obese) was categorized by using 
BMI cut-offs of non-pregnant women. 
Nutritional biomarkers showed a persisting high prevalence of micronutrient deficiencies in 
pregnant African women.  Data suggest anaemia and/or iron deficiency prevalence to be 
high.  Although comparison between rural and urban sites in Ghana suggests significantly 
higher anaemia prevalence in rural women, close to 30% of pregnant women were anaemic in 
urban settings (125).  This is a much higher than the prevalence seen in HICs (Europe: 
16.2%, America and the Caribbean: 15.2%) and other LMIC (Asia: 19.8%) settings (1).  This 
may be due to a chronic intake of low absorbable iron and insufficient iron stores to support 
both maternal and fetal requirements or to high levels of infection in African communities; or 
a combination of both (101).          
Reported dietary intakes of pregnant women varied significantly across African countries, 
with studies showing energy consumption below and above the American Dietetic 
Association recommended range of  2 200-2 900 kcal/d (135).  However, the shift towards 
higher energy intakes in populations with traditionally low food access was not reflected in 
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adequate protein intake, which was lower than the IoM’s recommended daily allowance 
(RDA, 71g) in all but one study (136).    Mean dietary iron intakes were much lower than the 
IoM RDA of 27 mg/d (137) in all but two studies (112,119).  Folate intake was much lower, 
on average, than the 600 µg/d recommended for pregnant women (138), with most studies 
reporting intakes less than half this.  Majority of the women studied either did not receive or 
did not comply with micronutrient supplementation during pregnancy, even in countries 
where iron and/or folic acid supplementation should have been a routine part of antenatal 
care.  Higher energy consumption, coupled with inadequate protein and micronutrient 
intakes, may be a result of poor diet quality and/or food availability in communities in 
transition.  This was demonstrated in South Africa where one study showed pregnant women 
to consume predominantly cereal-based diets high in energy and refined sugar, with low 
intakes of more expensive protein/micronutrient rich foods such as meat, poultry, and 
seafood, as well as legumes and non-starchy vegetables (122).  
2.4.2 Associations of MNS (using anthropometric parameters) and fetal growth and 
birth, neonatal and infant outcomes 
Maternal weight, BMI and weight gain during pregnancy were positively associated with 
birth weight in African studies.  However, maternal overweight and obesity increased the risk 
of macrosomia in Zambia (50) and higher BMIs were associated with increased risk of IUGR 
in a sample of very obese women from South Africa (BMI >40kg/m
2
) (52).    
These findings are consistent with studies from other parts of the world.  A systematic review 
including data from both HICs and LMICs showed a significant risk of LBW in women who 
were underweight during pregnancy compared to those who were within normal weight 
categories (104) and GWG has been positively associated with birth weight in a number of 
studies (139–141).    Substantial evidence supports the association between maternal obesity 
and macrosomia, with a 2-3-fold increase in risk of macrosomia being observed in obese 
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women (8,10,100).  There is also evidence to support the association between maternal 
obesity and IUGR; however fewer studies have documented this (142,143). 
Although the findings of this review have been supported by literature from other settings, 
the strength of and comparability between the included studies is limited due to differences in 
study design, exposure variables, and sample sizes which were relatively low in prospective 
cohort designs.  In addition, the timing in assessment of anthropometric parameters in 
pregnancy and outcome measurements varied greatly between studies, with maternal 
assessments being done between the first antenatal visit and delivery across studies and birth 
outcome measurements being taken any time between birth and the first 30 days of life.   
Although the underweight prevalence was low overall in African settings, risk of adverse 
fetal and birth outcomes remained high in populations where low pre-pregnancy weight is a 
key issue, for example in Ethiopia where 52.7% of women had MUAC measurements <23 
cm, LBW prevalence was high (28.3%).  However, as maternal overweight and obesity 
continue to rise, high pre-pregnancy weight and excessive GWG and their associated risks 
should become the pivotal focus for maternal and child nutrition.           
2.4.3 Associations of MNS (nutritional biomarkers) and fetal growth and birth, 
neonatal and infant outcomes 
Data on the associations between nutritional biomarkers and outcomes of interest were very 
limited.  The limited data available seem to suggest associations between low Hb and serum 
ferritin concentrations with lower birth weights in African settings (120,123). 
Global evidence associating nutritional biomarkers with outcomes of interest show mixed 
results.  Maternal anaemia in Indians was associated with increased risk of LBW and IDA 
predicted a three times higher risk of preterm birth (144). Low maternal Hb, but not serum 
ferritin concentrations were associated with lower birth weight in Iran (145).  However, in a 
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multicentre study across four HICs (New Zealand, Australia, England and Ireland), as well as 
in Sri Lanka (LMIC), there were no associations observed between anaemia (Hb <11 g/dL) 
and risk of preterm birth, LBW or small-for-gestational-age (SGA) infants (146,147). 
Although all included studies focused on the association between anaemia and birth weight 
using prospective cohort designs, the late assessment of biomarker status in two of the three 
studies provided poor proxies of pre-pregnancy status and the variation in timing of 
measurements between studies limited comparability.  Sample sizes were low in all studies, 
which may have limited the power to detect associations between the biomarker(s) and 
outcome(s) of interest. 
More evidence is needed to understand the associations between maternal micronutrient 
status and deficiencies on outcomes of interest in the first 1000 days; however use of 
individual biomarkers of nutritional status in isolation may be impractical in Africa where 
diet quality is poor and pregnant women are likely to experience multiple nutrient 
deficiencies.  Thus identifying nutritional biomarker patterns using dimension reduction 
techniques could be essential to employ in such studies. 
2.4.4 Associations of MNS (reported dietary intakes) and fetal growth and birth, 
neonatal and infant outcomes 
Although no articles were retrieved for Africa on associations between reported dietary 
intakes and outcomes of interest, the use of reported dietary assessment has a number of 
challenges.  Repeated 24 hour recalls and FFQs are the most commonly used methods for 
assessing habitual dietary intakes in Africa (148).  The inherent errors associated with 
reported dietary intakes and the strengths and limitations of different dietary assessment (DA) 
methods cannot be ignored (148).  Limitations include recall bias, assuming temporarily 
regular eating habits, seasonality and providing inaccurate estimations of portion size etc. 
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(149–151) However, very few DA tools used in Africa have been validated or tested for 
reliability which presents a huge challenge for effective assessment and monitoring of dietary 
intake, as well as for comparison of intakes within and between African settings (148). 
2.4.5 Randomised clinical trials of maternal nutritional interventions and fetal growth 
and birth, neonatal and infant outcomes 
Evidence from an African study suggests positive associations between protein-energy 
supplementation during pregnancy and higher GWG, birth weight and lower risk of perinatal 
mortality (129).  However, no longer term effects were seen on CVD risk during the 11-17 
year follow-up (130).  Multiple micronutrient supplementations had a dose-response effect on 
birth weight and significantly reduced LBW risk in anaemic women (133).  Although iron 
supplementation was associated with an increase in birth length, no improvement in birth 
weight was found (134). Prenatal calcium supplementation had no effect on any birth, 
neonatal, infant or childhood health outcomes (130–132).   
A review on protein-energy supplementation trials including both HICs and LMICs showed 
positive effects on birth weight in the supplemented compared to control groups, with the 
greatest effects seen in undernourished populations (152).  This supports the findings of the 
Gambian study where pregnant women were chronically undernourished at baseline (129).  
Similarly, a meta-analysis on multi-micronutrient supplementation trials (153) supported the 
data from Guinea-Bissau (133) by showing significant reductions in LBW, SGA incidence 
and  increased mean birth weight for women in the intervention compared to the control 
group (mostly receiving iron-folate supplements) (153).  Data from the iron supplementation 
trial in Niger (134) contradicted the general findings from a meta-analysis which showed that 
daily iron supplementation during pregnancy (alone or in combination with folate) reduced 
incidence of LBW by 20% compared to controls (154).  The effects of supplementation were 
most pronounced in populations with higher baseline anaemia prevalence (154).  Although 
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positive effects on birth length were seen in the supplementation group in Niger, the lack of 
improvement in birth weight in this population with high anaemia prevalence is not a 
common finding compared to the literature.  However, this finding could be, in part, 
attributed to the late start of the intervention during pregnancy (38 weeks, ±21 days) and/or 
the small sample size (134).  No studies in Africa were found which suggested any long term 
benefits of nutritional supplementation during pregnancy.   
RCTs are considered the most robust designs for assessing the relationship between exposure 
and outcome, because they ensure comparability between those exposed and those unexposed 
to the intervention and allow for causal links to be made since the intervention always 
precedes the outcome of interest.  However, variability between RCT designs can alter the 
strength of individual studies.  The following are important factors of concern associated with 
maternal nutritional intervention studies that make comparability of findings difficult: (i) 
sample size (ii) dose of intervention (iii) timing of intervention during pregnancy (iv) 
baseline nutritional status of pregnant woman and (v) an appropriate control group. 
Cumulatively the data available seems to suggest significant benefits of macronutrient and/or 
micronutrient supplementation during pregnancy on fetal/birth outcome (specifically birth 
weight), particularly in undernourished women. 
The results presented in this review illustrate that data available for Africa ranges from 18 
weeks gestational age onwards.  This highlights that an important critical phase (less than 18 
weeks) has not been investigated in this setting.     
2.4.6 The most important nutrients of concern for the first 1000 days for African 
women 
Energy and nutrient requirements increase during pregnancy in order to meet the needs of 
both the mother and the growing fetus.  Inadequate intakes of macro- and/or micronutrients 
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prior to, and during, pregnancy result in limited growth and development and therefore poor 
pregnancy outcomes.  Nutrient sufficiency is similarly required during early infancy to 
prevent growth faltering.  Certain nutrients are of particular importance, due to the critical 
functions that they perform and the plasticity during the first 1000 days of life.  Energy 
requirements increase during pregnancy to support increases in basal metabolic rate as a 
result of growth and expansion of new and existing tissue (fetus, placenta and maternal 
tissues), as well as the higher work rate of the maternal cardiovascular, respiratory and renal 
systems.  Adequate energy is also needed to support periods of rapid growth and 
development in the first two years of life.    Protein requirements are high during pregnancy 
and infancy for deposition and maintenance of maternal and fetal tissue (101,155).  Omega-3 
and omega-6 fatty acids are essential to new tissue formation, due to their structural role in 
cell membranes, with omega-3 fatty acids being particularly important for brain and central 
nervous system development (156).   Micronutrients of key concern in pregnancy are iron 
and folate, as they are unlikely to be in sufficient supply from the diet.  Additional iron is 
required to support the increase in red cell mass and ensure sufficient oxygen supply during 
tissue synthesis and growth.  Folate is an important co-factor in cellular function, including 
DNA and nucleic acid synthesis and cell division (101,157,158). 
2.4.7 Known consequences associated with poor MNS          
Inadequate maternal nutrition – underweight and overweight, as well as micronutrient 
insufficiency has been strongly linked with adverse maternal and infant outcomes, with both 
short and long term consequences.  Maternal obesity and adiposity and high GWG are 
associated with increased risk of GDM, preeclampsia, maternal weight retention post-partum 
and poor infant outcomes such as prolonged labour, birth trauma, neonatal death and 
contrasting burdens of both macrosomia and SGA.  Higher neonatal fat mass has been 
associated with adiposity in childhood and adulthood and therefore increased metabolic risk 
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in later life (10,109).  Premature delivery has been shown to be associated with both maternal 
underweight and overweight and is strongly associated with increased risk of perinatal 
morbidity and mortality, as well as impaired cognitive and emotional development later in 
childhood and adolescence (103,104,159).  Low maternal weight-for-height, poor GWG and 
micronutrient deficiencies such as IDA increase risk of IUGR which is associated with 
neonatal mortality in the short term and sub-optimal growth and development in the long 
term; e.g. in cognition, learning disabilities, academic achievement and psychosocial 
maturation (160).   For those infants defined as SGA, neonatal mortality risk is higher than 
those born appropriate for gestational age, even if born at term (101).  LBW, a result of 
preterm birth and/or growth restriction in utero, is associated with increased risk of perinatal 
morbidity and mortality, as well as of long term health risk.  Sufficient evidence exits to 
suggest that impaired growth in utero increases long term risk of NCDs such as T2DM, 
hypertension and CVD, with the highest level of risk being seen in those who subsequently 
experience rapid and/or excessive of weight gain (101).    
2.4.8 Challenges of appropriate interventions in the first 1000 days to reduce 
childhood obesity and adult NCDs in African women 
MNS, childhood obesity and adult NCD risk is complex and influenced by multiple factors at 
various life stages, making it difficult to reverse once highly prevalent in populations.  
Exposure to a poor nutrition environment in the first 1000 days (critical periods of plasticity) 
seems to have significant effects on body function, metabolism and a programming 
phenotypic effect thereby influencing susceptibility to obesity, as well as to NCDs, in the 
longer term.  This is of critical importance in the African setting where maternal obesity, 
coupled with poor micronutrient status and diet quality, continues to grow (1,161,162). 
Although the plastic nature of this period makes it vulnerable to poor environmental 
exposures, it also provides a unique window for intervention. Ensuring optimal growth and 
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development during this window, when women are highly motivated and tend to experience 
greater contact with health services, should therefore be prioritised in Africa to improve long 
term health trajectories (163). The main challenges for appropriate nutritional interventions in 
first 1000 days include, (i) when to intervene to get the best returns (pre-pregnancy vs. early 
pregnancy vs. after birth vs. infancy) and (ii) which nutrients and what doses to include. The 
Lancet series on maternal and child nutrition has provided a new conceptual framework that 
shows and elucidates on the means to optimum fetal and child growth and development (1). 
This framework outlines the dietary, behavioural, and health determinants of optimum 
nutrition, growth, and development, and how they are affected by various underlying 
conditions, which are in turn shaped by economic and social conditions, national and global 
contexts, capacity, resources, and governance. Additionally the series outlines and discusses 
how determinants can be changed to enhance maternal and childhood outcomes, including 
nutrition specific interventions that address the immediate and underlying causes of 
malnutrition  (164,165). 
There is a lack of data associating MNS with outcomes beyond birth in Africa. A need exists 
for longitudinal data from pregnancy through infancy to two years of age, and beyond. 
Without this evidence we cannot adequately influence policy or strengthen health systems.   
2.5  Conclusion 
Although improvements in MNS are evident in African countries, such as  low maternal 
underweight prevalences, rapid transition has widened the spectrum of risk associated with 
maternal and child health to include high levels of overweight and obesity alongside 
sustained macro- and micronutrient insufficiency (hidden hunger).  While robust evidence to 
support the associations between MNS and fetal, birth, neonatal and infant outcomes is 
limited in Africa, data does support the relationships seen globally between maternal 
anthropometry and outcomes in this setting.  In addition, the high prevalence of deficiencies 
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in critical pregnancy-related nutrients, as well as the benefits seen in supplementation trials of 
women does suggest that improvements in MNS could have significant effects on outcomes 
of interest.  This review therefore confirms the importance of the first 1 000 days within the 
African setting, but highlights that this area still remains under-researched as well as the need 
to focus on this window to optimise not only maternal and child health in the short term, but 
potentially reduce the burden of both undernutrition and NCD risk in current and future 
generations.  
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CHAPTER 3: Methodology 
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This chapter provides background context for the study, which took place in Soweto, 
Johannesburg, South Africa.  Although specific methods for the subsequent study objectives 
(objectives 2-4) are discussed within their respective chapters (chapters 4-6), this section 
provides an overall view of the study setting and design for more comprehensive 
interpretation of the study as a whole.   
3.1 Study setting 
South Africa is a middle income country in Sub-Saharan Africa with a total population of 
55.9 million people (166).  While the gross domestic product (GDP) was estimated at $294.8 
billion in 2016, growth in economic development has somewhat stagnated in recent years due 
to high dependence on international investment and markets, poor educational and training 
outputs, corruption, policy uncertainty and persistent inequality (166).  This has serious 
implications for the continued levels of unemployment and poverty in South Africa, and 
therefore for access to adequate and sustainable public health care in the context of an 
overburdened health system with limited resources (167,168).    
Soweto is a large urban area approximately 15 km from the inner city of Johannesburg in the 
Gauteng province (Figure 6). Although the name originated as an abbreviation for South 
Western Townships, it has also been believed to be derived from the phrase ―so where to?‖ 
due to its origins as an informal settlement for migrant mine workers and black people 
displaced from other areas of Johannesburg during the Apartheid era.  This cluster of 
townships grew rapidly and is now the most densely populated area in the country, with a 
predominantly black African population (98.5%) of approximately 1.2 million within an area 
of 200km
2
.  Although democracy was introduced in South Africa in 1994, the lasting 
inequality means that the income distribution between households is still one of the widest in 
the world (169).    The levels of inequality are clearly evident within Soweto itself; with 
homes ranging from affluent mansions in some areas to makeshift shacks (Figure 7).  
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However, regardless of some economic growth in the area, approximately a third of residents 
are unemployed and the majority still live in low income households – 40% of which are 
female-led - with poor access to basic services (170).   
 
 
Figure 6: Location of Soweto within the Gauteng province of South Africa (171) 
 
Soweto is a prime example of the nutrition transition taking place across Africa; where rapid 
urbanisation has resulted in a shift towards more energy dense westernised diets high in 
saturated fat, sugar, processed/convenience foods and edible oils and low in fibre and 
essential micronutrients, alongside low levels of physical activity (26,28).  A previous study 
of Sowetan adult women showed that they exhibit particularly high intakes of refined 
carbohydrates, added sugar and fat (particularly brick/hard margarine and sunflower oil), 
sugar sweetened beverages, processed meats and fast food products (172).  Such shifts in the 
nutrition environment and the growing overweight/obesity prevalence, alongside persisting 
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infectious diseases (HIV/AIDS and tuberculosis; TB) and emerging NCD burdens are 
particularly prevalent in adult women; making maternal and child health particularly 
vulnerable in this population (3,94).  This is further complicated by limited access to health 
education and services.    
 
 
Figure 7: Basic housing in Soweto (173) 
 
3.2 Study design and participants 
This PhD was nested within the wider Soweto First 1000-Day Study (S1000) conducted by 
the Medical Research Council (MRC)/University of the Witwatersrand (Wits) Developmental 
Pathways for Health Research Unit (DPHRU).  S1000 was a longitudinal maternal pregnancy 
cohort study with the overall aim of understanding the complexities between multiple 
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maternal factors and fetal and infant outcomes, and identifying the levers that could optimize 
maternal and child health within the first 1000 days, in an urban-poor African context.  This 
study recruited approximately 1000 pregnant women from Chris Hani Baragwanath 
Academic Hospital (CHBH) between 2013 and 2016.    
CHBH – based in Soweto – is the third largest hospital in the world, with approximately 
3 200 beds.  Approximately 60 000 patients attend the Maternity Hospital and 17 000 babies 
are delivered each year. CHBH is a tertiary public health facility which is government funded 
and acts as a teaching hospital for University of the Witwatersrand medical students.  This is 
the only hospital serving the residents of Soweto and therefore all primary healthcare 
facilities refer into CHBH; providing a sample of women that represent the range of co-
morbidities experienced by urban, black pregnant women living in Soweto.  In addition, it is 
the only healthcare facility offering fetal ultrasounds.  For this reason, CHBH provided the 
only option for accurate assessment of gestational age via ultrasound at recruitment.     
Women were recruited into the wider S1000 study according to the following inclusion 
criteria: pregnant with a singleton, naturally conceived pregnancy, 18 years or older, resident 
of Soweto, or the Greater Soweto area, <18 weeks gestational age at recruitment, non-
epileptic, non-diabetic, and able to give consent.  Additionally, women were excluded if they 
had any detected fetal abnormalities.   
3.3 Data collection 
S1000 was separated into two main components: the Soweto Fetal Growth Study (SFGS) and 
the Soweto Baby Growth Study (SBGS).  Data collection for SFGS took place at six time 
points during pregnancy (<14 weeks; 14–18 weeks; 19–23 weeks; 24–28 weeks; 29–33 
weeks and 34–38 weeks) and at delivery.  SBGS followed up both mother and infant at eight 
time points after delivery (<14 days; 6 weeks; 2 months; 3 months; 6 months; 12 months; 18 
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months and 24 months).  S1000 collected a vast range of data on both the mother and infant 
across the study visits; including demographics, behavioural factors (diet and physical 
activity), anthropometry, body composition, health and psychosocial factors and 
neurocognitive development, as well as collection of biological samples (e.g. blood, urine and 
faeces) (Appendix A and B).  The flow of participants through this PhD sub-study, as well as 
attrition rates across the longitudinal follow up (from recruitment through to delivery and 
neonatal data collection) are depicted in Figure 8.  Data collection sheets and questionnaires 
for PhD specific data collection are included in Appendices C-E.  However, detailed 
descriptions of the data collection methods for the variables used in this PhD are provided in 
the individual objective chapters to follow (Chapters 4-6).         
3.4 Ethical approval 
All women were provided with information and consent sheets prior to their inclusion in 
SFGS (Appendix F and G), as well as prior to the inclusion of themselves and their infants 
SBGS (Appendix H and I).  Where necessary a trained member of research staff explained 
these documents to them in their native language.  Written informed consent was then 
provided by all women prior to enrolment in each study component.  All questionnaires were 
coded to ensure that participant names are not used and confidentiality was maintained.  A 
document containing the coding ―links‖ was kept separately by the Principal Investigator of 
SFGS and SBGS.  Ethical approval was obtained from the University of the Witwatersrand’s 
Research Ethics Committee (Medical) for both components of the wider S1000 study (SFGS: 
M120524 and SBGS: M130905) (Appendix J and K) as well as for this PhD (M150720) 
(Appendix L).              
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Figure 8: Flow chart of participants within the Soweto First 1000-Day Study (S1000) at 
Chris Hani Baragwanath Academic Hospital (CHBH)                                                                    
a
Of eligible women approached at the Fetal Medicine Unit at Chris Hani Baragwanath 
Academic Hospital (CHBH), 85% consented to participate. Women who refused to participate 
were not different in age, BMI, or education, but participants were more likely to be married                                                                                                                                                     
b
Mother-neonate pairs excluded from the final analyses were not different in any baseline 
maternal characteristics: age, parity, HIV/treatment status, smoking, marital status, education, 
household SES, weight, height, BMI 
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CHAPTER 4: A comparison of body composition 
estimates using dual-energy X-ray absorptiometry 
and air-displacement plethysmography in South 
African neonates2 
 
 
 
 
 
 
 
 
 
 
___________________________________________________________________________ 
2
Wrottesley SV, Pisa PT, Micklesfield LK, Pettifor JM, Norris SA. A comparison of body 
composition estimates using dual-energy x-ray absorptiometry and air-displacement 
plethysmography in South African neonates. Eur J Clin Nutr. 2016 Nov;70(11):1254-1258. 
(174) 
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4.1 Introduction 
Fetal growth and subsequently birth weight, have been shown to be key determinants of 
neonatal, infant and childhood growth and development, as well as, long-term risk of non-
communicable diseases (NCDs) in adulthood; with both insufficient and excessive growth in 
utero increasing the risk of adverse outcomes across the life course (10,175–178).   Although 
birth weight is the most commonly utilised measure of prenatal growth, particularly in low-or 
middle-income countries (LMICs), it provides a crude estimate which does not differentiate 
between the various components of body composition i.e. fat mass and fat-free mass.  As a 
result, objective body composition measures at birth, and particularly neonatal adiposity, are 
becoming increasingly important outcomes to assess, as they are more sensitive markers of 
fetal nutrition and growth and therefore possibly stronger predictors of future metabolic 
health risk (84,179).  Furthermore, neonatal and infant body composition assessments can 
better inform early and targeted interventions during pregnancy and early infancy to reduce 
metabolic disease risk during the life course.  
The most common methods used to assess neonatal body composition are dual-energy x-ray 
absorptiometry (DXA) and, more recently, air displacement plethysmography (ADP) using 
the Peapod, due to ease and efficiency of use, low operator skill requirements and the non-
invasive nature of the techniques  (85,88,180).  Although DXA has been shown to reliably 
estimate fat mass and fat-free mass during repeated neonatal measurements, validation 
studies in piglets found that fat mass was overestimated in smaller subjects (88,181–183).  In 
addition, the risk of radiation exposure and the need to prevent movement of the subject 
during assessment have limited the use of DXA in paediatric populations.  In contrast, ADP 
has been shown to provide accurate and reliable estimates of %fat in infants when compared 
to both deuterium dilution and a 4-compartment model, independent of body size and infant 
behavioural state (9,10).  Although the Peapod is only suitable for assessment of infants up to 
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6 months of age and for body weights under 8 kg (86,185),  which restricts its use in 
longitudinal studies, it may be a more practical and reliable method of body composition 
assessment in early life.   
In a USA sample of 84 infants, strong correlations were observed between DXA and ADP 
measurements at 6 months of age, however, ADP estimates were significantly lower than 
those by DXA for fat mass and body-fat percentage (%fat), and significantly higher for fat-
free mass (89).  This suggests that, although the two methods are able to reliably detect 
increases or decreases in fat and fat-free mass, there are large inter-method differences in 
absolute and relative fat and fat-free mass measurements.  To our knowledge, this is the only 
study comparing these techniques in infants, with no published data available for neonates.  
Comparison of DXA and ADP is important for neonates due to the increasing use of neonatal 
adiposity to assess fetal growth and future metabolic risk, the documented differences in ADP 
and DXA body composition estimates in older infants and the inaccuracies in DXA estimated 
fat mass in small subjects, as well as the concerns around the safety and practicality of using 
the techniques in this population. 
Assessment of body composition during infancy by ADP and DXA has been limited in 
LMICs and the accuracy and reliability of the techniques has never been explored in African 
paediatric populations.  These comparisons are important for this unique setting where rapid 
urbanization is characterised by a triple burden of disease, including infection-related under-
nutrition illnesses, human immunodeficiency virus (HIV)/acquired immune deficiency 
syndrome (AIDs) and tuberculosis, and the emergence of NCDs (111).  Pilot data from our 
on-going Soweto First 1000-Day Study (S1000) shows that urban black South African 
women exhibit a high clustering of disease during pregnancy, including 67% overweight and 
obesity, 14% gestational diabetes mellitus (GDM), 31% anaemia and 30% HIV prevalence 
(Norris et al, unpublished).  In addition, black women demonstrate different patterns of body 
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fat distribution and associated metabolic risk than their white counterparts in both South 
Africa and the USA (186–188).  The presence of these co-morbidities, together with the 
adiposity and risk profiles, in black South African women may influence in utero phenotypic 
programming of fetal growth and tissue deposition and have distinct effects on neonatal body 
composition.   
The aim of this study was therefore to compare estimates of fat mass and fat-free mass by 
ADP and DXA in black South African neonates within the first two weeks of life and to 
determine whether the techniques provide comparable measurements of neonatal body 
composition.    
4.2 Methods 
4.2.1 Study setting and participants 
Body composition data was collected for 92 neonates born to women from the S1000 study 
which is currently in progress in Soweto, Johannesburg, South Africa.  S1000 is a 
longitudinal maternal pregnancy cohort study with the overall aim of understanding the 
complexities between multiple maternal factors and fetal and infant outcomes, and 
identifying the levers that could optimize maternal and child health within the first 1000 days, 
in an urban-poor African context.  Women are considered eligible for inclusion in the study if 
they live in Soweto, or the Greater Soweto area, and are <20 weeks gestational age at 
recruitment, non-epileptic, non-diabetic, 18 years or older and pregnant with singleton, 
naturally conceived pregnancies.  Neonates were included in this sub-study if they had body 
composition measurements using ADP and DXA within the first two weeks of life before the 
end of June 2015.  All testing took place on the same day and infants who were not asleep on 
arrival were typically fed prior to body composition assessments.  All mothers gave written 
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informed consent for their infants to participate and ethical approval was obtained from the 
University of the Witwatersrand’s Research Ethics Committee (Medical) (M130905).   
4.2.2 Neonatal measurements 
Neonatal crown-to-heel length was measured in duplicate using a calibrated Harpenden 
Infantometer.  Weight of nude neonates was measured using the scale on the ADP Peapod 
machine (Cosmed, USA) and fat mass, fat-free mass and %fat were estimated using both the 
Peapod and DXA (Hologic DiscoveryA S/N 86254, APEX software version 4.0.2, Hologic 
Inc., USA). 
4.2.2.1 ADP 
Body composition assessments using the Peapod were performed according to standard 
procedures as previously described (86,189,190).  Participants were placed inside the Peapod 
chamber wearing only a wig cap if necessary.  ADP measurements lasted approximately 2 
minutes, during which body volume was estimated using pressure and volume changes (air 
displacement) within the chamber.  Neonatal body density was calculated using body mass 
and volume measurements, and fat mass, fat-free mass and %fat were subsequently derived 
using sex-specific equations.  All included ADP assessments passed the quality check on the 
Peapod machine.   
4.2.2.2 DXA 
Standard procedures for performing infant DXA scans are described elsewhere (191).   
Neonates were placed supine on the scanning bed wearing only a disposable diaper and 
swaddled in a cotton blanket.  Scans were performed according to standard procedures and 
were satisfactory for use if the participant’s body lay within the scanning region and there 
was minimal movement during the procedure.  Whole body measurements of fat mass, fat-
free mass and %fat were extracted for use in analyses.  All outliers for the comparison 
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between ADP and DXA fat mass measurements were identified and checked against their 
raw DXA assessments for scan quality.  Where the quality of a DXA scan was compromised, 
i.e. excessive movement or inappropriate positioning of the neonate on the scanning bed or 
folding of the arms or legs, these results  were  excluded from body-composition analyses. 
4.2.3 Statistical analysis 
Continuous and categorical variables were summarised as mean (SD) and n (%) respectively.  
Sex and gestational age independent standard deviation scores were calculated for neonatal 
weight and height using the International Fetal and Newborn Growth Consortium for the 21st 
Century (INTERGROWTH-21st) Project standards (192).  Paired t-tests were used to 
compare differences between DXA and ADP on the following estimated body composition 
variables: (i) fat mass (ii) fat-free mass and (iii) %fat.  Scatter plots with 95% confidence 
intervals were generated for each body composition variable from both techniques, and 
Pearson correlation coefficient analyses were used to determine the association between these 
variables measured using ADP and DXA. The level of agreement between DXA and ADP 
measurements of fat mass, fat-free mass and %fat were assessed using Bland-Altman 
analyses.  Data were analysed using Stata 13.0 (StataCorp, USA) and p-values less than 0.05 
were considered statistically significant. 
4.3 Results 
Four outliers were excluded from ADP and DXA comparisons due to the compromised 
quality of their DXA scans.  A total of 88 neonates were therefore included in all further 
analyses.  Growth and body composition variables measured by ADP and DXA are presented 
in Table 6.  ADP estimates of fat mass and %fat were significantly higher (p<0.001), and fat-
free mass estimates significantly lower (p<0.001) than those by DXA.    Specifically, ADP 
estimates were 21.1% higher for fat mass and 9.7% lower for fat-free mass than those by 
DXA.  
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Table 6: Growth and body composition variables in South African neonates (n=88) 
Variable  Mean (SD) 
Gestational age at birth (weeks) 38.7 (1.8) 
Age at scanning (days) 7.6 (3.8) 
Sex, % 
 Male  55.7 
Female 44.3 
Anthropometry  
Weight (g) 3089 (456) 
Weight SDS
a
 -0.11 (0.88) 
Length (cm) 49 (2.4) 
Length SDS
a
 0.09 (1.09) 
Body composition   
ADP fat mass (g) 408 (172)* 
ADP fat-free mass (g) 2681 (348)* 
ADP %fat 12.9 (4.4)* 
DXA fat mass (g) 337 ( 165) 
DXA fat-free mass (g) 2969 (375) 
DXA %fat 9.9 (4) 
Abbreviations: ADP, air displacement plethysmography; DXA, 
dual-energy x-ray absorptiometry; SDS, standard deviation 
score 
a
Independent of sex and gestational age 
*p<0.001 ADP vs. DXA 
 
Scatter plots of ADP and DXA body composition estimates for fat mass, fat-free mass and 
%fat showed a positive linear relationship between the two methods for all of the variables 
(Figure 9).  The corresponding Pearson correlation coefficients indicated significant 
correlations between ADP and DXA measurements of fat mass, fat-free mass and %fat 
(p<0.001)  However, fat-free mass estimates showed much stronger positive correlations 
between the two methods than those for fat mass and %fat.  88.7% of the variance in DXA 
fat-free mass was therefore explained by ADP fat-free mass; whereas ADP estimates 
predicted only 58.7% and 39.7% of the variability in DXA fat mass and %fat respectively.    
Bland-Altman analyses of fat mass, fat-free mass and %fat estimates by ADP and DXA are 
presented in Figure 10.  DXA showed a tendency to under-predict fat-mass (mean difference, 
95% limits of agreement; 72 g, -159 g to 302 g) and  %fat (mean difference, 95% limits of 
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agreement; 3%, -4.2% to 10.2%) in comparison to ADP.  There were no correlations between 
the differences in ADP and DXA estimates and their averages for fat mass (r=0.062, 
p=0.565) or %fat (r=0.101, p=0.348) and therefore no bias shown across the range of fatness 
between the two methods.  Fat-free mass was over-predicted by DXA in comparison to ADP 
for all subjects (mean difference, 95% limits of agreement; -288 g, -541 g to -35 g).  There 
was a significant correlation between the difference in fat-free mass measured by ADP and 
DXA and the average of these estimates (r= -0.220, p<0.05), suggesting a bias (i.e. a 
systematic difference in measurements) between the techniques for fat-free mass estimates.        
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Figure 9: Scatter plots of air displacement plethysmography (ADP) versus dual-energy x-ray 
absorptiometry (DXA) with 95% confidence intervals and Pearson correlation coefficients for 
body composition variables of interest; (a) fat mass, (b) fat-free mass, and (c) %fat
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Figure 10: Bland–Altman analyses between air displacement plethysmography (ADP) and 
dual-energy x-ray absorptiometry (DXA) estimates of body composition variables of interest; 
(a) fat mass, (g); (b) fat-free mass, (g); and (c) %fat 
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4.4 Discussion 
This study aimed to determine whether ADP and DXA provide comparable measurements of 
fat mass and fat-free mass in black South African neonates. We found that, while body 
composition variables were highly correlated, fat mass and %fat estimates were significantly 
higher and fat-free mass was significantly lower when measured by ADP compared to DXA.  
Fat-free mass estimates showed stronger agreement between the two methods, with DXA 
estimated fat-free mass being consistently higher than that by ADP compared to fat and %fat 
estimates where the differences between methods were less predictable.  To our knowledge, 
this is the first study comparing these increasingly popular methods of infant body 
composition assessment in neonates, as well as in an African population. 
Although both ADP and DXA have been suggested to provide reliable estimates of fat mass 
and fat-free mass in infants (88,180,184), accessibility of these methods in LMICs is limited. 
Use of DXA has also been restricted below two years of age, due to the difficulties in 
preventing movement of infants during scanning.  While use of the Peapod does not have 
these limitations, it can only be used in infants up to approximately 6 months of age and/or 
8kg body weight, which restricts its use in longitudinal follow-up and comparisons.  In 
addition, ADP does not distinguish between lean mass and bone constituents of fat-free mass 
which has been suggested as a source of inaccuracy in fat-free mass estimates when 
compared to DXA (193).  Due to the strengths and limitations of DXA and ADP, as well as 
the lack of data to support the use of one method over the other, the best practice for body 
composition assessment in neonates is currently not known.   
Our findings are in contrast to those in US 6 month old infants, where fat mass and %fat were 
significantly lower and fat-free mass was significantly higher when estimated by ADP 
compared to DXA (89).  In addition, although similarly strong correlations were shown 
between fat-free mass estimates by ADP and DXA in these studies, fat mass and %fat 
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estimates by the two techniques were more highly correlated in the older US population (r = 
0.925-0.969).  A possible explanation for the differences may be the age of the participants 
studied, with Fields et al (2012) demonstrating larger inter-method differences in those 
infants who were younger and smaller (89).   
Early life growth and development of body tissues, including fat and lean mass deposition 
and bone mineralisation, is rapid, with the greatest increases in %fat seen between birth and 6 
weeks of age (194).  The substantial changes in tissue development and formation may affect 
the accuracy with which measurement techniques are able to distinguish between the 
different components of body mass at different stages of infancy. This is particularly relevant 
for DXA, which has documented improvements in the accuracy of body composition 
estimates in larger subjects, particularly with higher bone mineral content (BMC) and fat 
mass (181).     
This is supported by DXA validation studies in piglets which show that, while DXA provides 
reasonable estimates of lean tissue irrespective of body size, accuracy in bone and fat mass 
estimates is less consistent (181–183).  Similarly, and unlike our sample, studies conducted in 
both obese and non-obese children and adolescents show an overestimation of %fat measured 
by DXA in comparison to ADP (195–198).   
The aforementioned studies focused on the accuracy and comparability of ADP and DXA 
estimates of whole body fat mass, rather than in detection of fat and fat-free mass across 
different body compartments.  In adult women, DXA has been shown to underestimate trunk 
fat and overestimate thigh lean mass, particularly in those with greater adiposity (199).  This 
may be due to reduced accuracy in distinguishing between fat and fat-free tissue and 
potentially the inclusion of adipose tissue in the fat-free mass measurement in certain body 
regions.  At birth, the trunk constitutes the largest proportion of neonatal body weight and 
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therefore fat mass, with the limbs contributing comparatively little (200).  If fat mass is 
underestimated in this region, and fat-free mass overestimated in the limbs, it may explain the 
differences seen in neonates compared to older infants who have experienced rapid changes 
in body proportions and fat deposition.  This suggests that ADP-estimated body composition, 
based on total body mass and volume, may provide more reliable estimates of fat and fat-free 
mass in early life when the ability of DXA scans to accurately depict fat mass is not 
consistent.  ADP validation studies support this, showing Peapod to provide accurate and 
reliable estimates of %fat in infants, independent of body size and fatness, compared to both 
deuterium dilution and a 4-compartment model (180,184).   
Another potential contributor to the differences in body composition estimates by ADP and 
DXA could be the effect of movement and/or material (i.e. cotton blanket swaddling) 
artefacts on DXA accuracy during scanning.  Animal studies show tightly bound swaddling 
to be included in DXA scans as fat and tissue mass, with disproportionately higher inclusion 
(63-95%) as lean mass (201), thereby reducing the accuracy of tissue estimates.  However the 
systematically lower estimates of fat mass by DXA compared to ADP suggest a minimal 
effect of any inconsistencies in movement or placing of neonatal swaddling on DXA 
accuracy.   
Both ADP and DXA fat mass estimates are based on the assumption that hydration of fat-free 
mass remains constant.  This has been proposed as a possible source of error in paediatric 
body composition assessment by the two methods, as the level of tissue hydration is high and 
rapidly changing during infancy (202).  However, studies examining the effects of changes in 
tissue hydration on ADP and DXA accuracy show only marginal fluctuations in fat mass 
estimates (184,202).   As neonatal ADP and DXA measurements in our study were taken on 
the same day, tissue hydration changes would be minimal and unlikely to make a substantial 
contribution to the differences in body composition estimates by the two methods.   
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In addition to comparison of ADP and DXA techniques, our study provided novel data on 
neonatal body composition in South Africa suggestive of higher %fat at birth than has been 
seen elsewhere in Africa.  Although data in African populations is scarce, Ethiopian neonates 
have comparatively lower ADP fat mass and %fat (boys, girls: 7%, 7.6%) at similar total 
body mass (boys, girls: 3106 ± 407 g, 2973 ± 414 g) than shown in our South African 
sample, regardless of whether ADP or DXA estimates are used (92).  Body composition 
estimates in our sample were more comparable to those in HICs such as USA, where 
neonates have an estimated 14% body fat (203).  This provides unique insight into the effects 
that the rapid nutritional transition and resulting co-morbidity profile experienced by South 
African pregnant women may have had on neonatal body composition and potentially on 
longer-term metabolic risk.  Further research into the effects of this clustering of risk factors 
during pregnancy on both maternal and infant health and disease risk, as well as on accurate, 
reliable and practical methods of assessment and intervention in African settings, is critical 
and on-going in the S1000 cohort.        
4.5 Conclusion 
In conclusion, our study showed that, although estimates of fat and fat-free mass by ADP and 
DXA were highly correlated, fat mass and %fat were significantly lower and fat-free mass 
was significantly higher when measured by DXA in South African neonates.  These findings 
are the opposite to those by Fields et al (2012) in infants at 6 months of age (89).  This may 
be due to a limited ability to distinguish between different body tissues (fat mass, lean mass 
and bone) in early life and suggests a preferential basis for use of the Peapod in neonatal 
body composition assessment.  However, further investigation is needed to elucidate on the 
mechanical basis for these differences and to determine how inter-method differences may be 
minimised so that body composition assessment is comparable across longitudinal study 
follow-up.      
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5.1 Introduction 
Maternal nutritional status (MNS), principally defined by body mass index (BMI) prior to 
pregnancy, is a strong predictor of maternal and infant health; with both underweight and 
overweight/obesity being associated with increased risk of maternal complications during 
pregnancy and delivery, sub-optimal fetal growth and adverse birth outcomes 
(1,5,10,11,99,100). In addition to the immediate risks posed to mother and infant, adverse 
exposures such as malnutrition during critical periods of developmental plasticity—including 
fetal growth and development—have been shown to alter gene expression, thereby modifying 
growth and development of body tissues (110). Such changes may lead to permanently 
altered metabolism and body function and increased susceptibility to non-communicable 
diseases (NCDs) including obesity, type 2 diabetes mellitus (T2DM) and cardiovascular 
disease (CVD) in later life (107,108,110,205). 
In addition to pre-pregnancy BMI, weight gain during pregnancy has been shown to 
independently influence both maternal and infant outcomes; with inadequate weight gain, 
according to the Institute of Medicine (IoM) BMI-specific recommended ranges, increasing 
the risk of preterm birth, low birth weight (LBW) and small-for-gestational-age (SGA) 
infants (48,206). In contrast, excessive gestational weight gain (GWG) is associated with an 
increased risk of pregnancy-induced hypertension, pre-eclampsia, fetal macrosomia and 
requiring an emergency caesarean delivery (48,55,207). Additionally, women who gain 
excessive weight during pregnancy are at higher risk of postpartum weight retention, which 
may influence their susceptibility to developing overweight and obesity in the longer term 
and increase their risk profile in subsequent pregnancies (5,57,58).  
Studies indicate that overweight and obese pregnant women are more likely to gain excessive 
weight than their normal-weight counterparts (56,208,209). This is particularly relevant for 
low- or middle-income countries (LMICs) such as South Africa, where the prevalence of 
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overweight and obesity has increased substantially as a result of rapid urbanisation and a 
nutrition transition characterised by a shift towards typically westernised diets high in 
saturated fat, sugar, salt, processed foods and edible oils, as well as decreased levels of 
physical activity (27,28). Pilot data from our Soweto First 1000-Day Study (S1000) shows 
that urban black South African women exhibit a high clustering of disease during pregnancy, 
including 67% overweight and obesity, 14% gestational diabetes mellitus (GDM), 31% 
anaemia and 30% human immunodeficiency virus (HIV) prevalence (Norris et al., 
unpublished). This high-risk profile is coupled with the poor quality, predominantly cereal-
based diets that are high in energy and refined sugar and low in protein and micronutrient-
rich foods such as meat, poultry, seafood, legumes and non-starchy vegetables that have been 
demonstrated in South African pregnant women (122). 
In high income countries (HICs) some studies have shown that a high protein: carbohydrate 
ratio, partly driven by a reduced added-sugar intake, is associated with lower GWG and that 
high adherence to a margarine, sugar and snacks dietary pattern is associated with excessive 
GWG when compared to low adherence to this pattern (210,211). Additionally, in Puerto 
Rican women, frequent consumption of high-sugar fruit drinks was associated with excessive 
GWG (212). To our knowledge, however, dietary patterns and their relationships with MNS 
prior to and during pregnancy are yet to be explored in urban African populations where the 
associations may be further complicated by existing co-morbidities, such as the high burden 
of HIV, which may independently predict low pre-pregnancy BMI, poor GWG and 
micronutrient deficiencies (95,96,213,214). 
While the relationship between maternal anthropometry prior to and during pregnancy and 
maternal and infant outcomes is well documented, the influence of dietary intake and patterns 
on BMI-specific GWG, and therefore maternal and infant outcomes, is unclear. Hence in this 
study, we aimed to identify patterns of habitual dietary intake in urban, black South African 
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pregnant women and further explored their associations with first trimester BMI and GWG in 
the context of HIV and other sociodemographic factors. 
5.2 Methods  
5.2.1 Study setting and participants 
This study was nested within a larger longitudinal pregnancy cohort study (Soweto First 
1000-Day Study; S1000), based at the CHBH in Soweto, Johannesburg, South Africa. The 
overall aim of S1000 was to understand the complexities between multiple maternal factors 
and fetal and infant outcomes, and to identify the levers that could optimise maternal and 
child health within the first 1000 days in an urban-poor African context. Women were 
considered eligible for inclusion in the study if they lived in Soweto, or the Greater Soweto 
area, and were <20 weeks gestational age at recruitment, non-epileptic, non-diabetic, 18 years 
or older and pregnant with singleton, naturally conceived pregnancies. Data collection for 
S1000 took place at six time points during pregnancy: <14 weeks; 14–18 weeks; 19–23 
weeks; 24–28 weeks; 29–33 weeks and 34–38 weeks. All the women provided written 
informed consent prior to their inclusion in the study and ethical approval was obtained from 
the University of the Witwatersrand’s Research Ethics Committee (Medical) (M120524). 
5.2.2 Demographic, health and socioeconomic variables 
Maternal demographic and socioeconomic variables were collected using an interviewer-
administered questionnaire at the first visit (<14 weeks gestational age). All questionnaires 
were administered by trained members of research staff. Socioeconomic status (SES) was 
assessed using a household asset index which scored each participant according to the 
number of assets that they possessed out of a possible 9 (electricity, radio, television, 
refrigerator, mobile phone, personal computer, bicycle, motorcycle/scooter, car). Maternal 
education was assessed according to the highest level of education (primary, secondary or 
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tertiary) completed. Parity was defined as the number of times a subject had given birth to a 
fetus with a gestational age of 24 weeks or more, regardless of whether the child was born 
alive or was stillborn, and smoking status was assessed according to whether the participant 
reported smoking and/or chewing tobacco at baseline. HIV status was determined via self-
report at each pregnancy visit and, if HIV-positive, the date of antiretroviral treatment (ART) 
initiation was recorded. According to South Africa’s national Prevention of Mother-to-Child 
Transmission (PMTCT) guidelines during this time, all HIV-positive pregnant women, if not 
already on treatment, were initiated on lifelong ART regardless of their CD4 count and 
therefore all HIV-positive participants were receiving ART. HIV-positive women were 
therefore stratified according to whether they were initiated prior to pregnancy (pre-
pregnancy ART) or during the current pregnancy (antenatal ART).  
5.2.3 Anthropometry 
Maternal weight was measured to the nearest 0.1 kg using a digital scale at each pregnancy 
visit and maternal height was measured to the nearest 1 mm using a wall-mounted 
Stadiometer (Holtain, UK) at the first visit. Weight at the first visit (<14 weeks) was used as a 
proxy for pre-pregnancy weight and, together with height, used to calculate maternal BMI 
(weight (kg)/height (m
2
)). As there were no underweight women in this sample, BMI was 
classified as either normal weight (18.5–24.9 kg/m2), overweight (25–29.9 kg/m2) or obese 
(≥30.0 kg/m2). GWG (kg/week) was calculated as: (weight at last visit − weight at 
recruitment)/duration of follow-up. Women were classified as having inadequate, adequate or 
excessive GWG using the BMI-specific IoM recommended ranges (25). 
5.2.4 Dietary intake 
Habitual dietary intake was assessed using an interviewer-administered quantitative food-
frequency questionnaire (QFFQ) during the second pregnancy visit (14–18 weeks). The 
QFFQ has been extensively utilised in this setting and results are published elsewhere 
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(172,215). Data was collected retrospectively on the previous week’s intake of local South 
African foods, including convenience food products. Frequency and quantity—defined using 
a combination of household measures, two-dimensional life-size drawings of foods and 
utensils and three-dimensional food models, as described by Steyn et al. (216), and then 
converted to an average intake in grams per day—of each food item consumed was recorded 
during the interview and captured electronically using REDCap electronic data capture tools 
hosted at The University of the Witwatersrand (217). 
5.2.5 Statistical analysis 
Data were analysed for 538 pregnant women with complete data using Stata 13.0 (StataCorp, 
College Station, TX, USA). Principal component analysis (PCA) was the dimension 
reduction technique used to depict dietary patterns (218). This is a statistical method that 
provides a set of coefficients for each of the food items/groups which reflect intakebased on 
the level of correlation with each other; thereby forming new linear components that 
represent the combinations (patterns) of intake in a population (73,219). PCA was conducted 
on the weekly frequency of consumption of the food items listed in the QFFQ, classified into 
48 food groups according to their nutrient composition and usage. These groupings were 
based on those used and described extensively by Crozier et al. (76,220). PCA was applied 
using orthogonal (varimax) rotation and the Kaiser-Meyer-Olkin measure of sampling 
adequacy (0.65) and Bartlett’s test of sphericity (p<0.001) confirmed PCA to be an 
appropriate dimension reduction technique to apply in this sample. Eigen values, as well as 
their visual inflections on a scree plot (i.e. those values situated above the point where the 
downward curve levels off; Supplementary Figure F1; Appendix M), and the total variance 
explained (percentages) were used to identify retained patterns. As described elsewhere, 
foods or food groups that had factor loading scores ≥0.2 on the PCA matrix reflected strong 
associations with principal components and these were used to name dietary patterns (211). A 
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dietary pattern score for each pattern was generated for all participants by multiplying factor 
loadings by the intake of each food/food group and standardising the summed scores. Mean 
factor scores for the patterns were zero; with positive and negative scores therefore 
representing high and low intakes of each dietary pattern respectively (219). 
Maternal characteristics of the sample are presented as median (interquartile range) and 
percentages (%) for continuous and categorical variables respectively. The Kruskal-Wallis 
and chi-squared tests were used to compare all continuous and categorical variables 
respectively across the three IoM defined BMI-specific GWG categories; namely inadequate, 
adequate and excessive weight gain. Potential covariates for the associations between dietary 
patterns and GWG were identified by comparing factor scores for each pattern using either an 
independent t-test (two categories) or analysis of variance (ANOVA) (more than two 
categories) according to the following maternal factors: maternal age, parity, HIV status, 
education, marital status, SES, BMI at recruitment and GWG. Furthermore, in cases where 
there were more than two categories for a given characteristic, a Tukey post-hoc test was 
carried out to identify where the differences occurred between categories (data presented as a 
supplementary Table S1; Appendix M). 
The associations between depicted dietary pattern scores and GWG were tested using 
multivariable linear regressions and multinomial logistic regressions for the total sample and 
then across three BMI categories; namely normal weight, overweight and obese. Linear 
regression analyses were based on continuous dietary pattern scores (exposure) and GWG 
(g/week) (outcome) and multinomial logistic regression analyses were based on dietary 
pattern scores (exposure) and adequacy of GWG according to the IoM recommended ranges 
(inadequate and excessive GWG vs. adequate GWG; reference) (outcome). Due to the fact 
that the diet patterns are not mutually exclusive and it is possible for individuals to have high 
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scores for multiple patterns, all regression analyses (crude and adjusted models) included all 
diet patterns.  
Regression coefficients for linear regressions are therefore presented for a 1 SD increase in 
dietary pattern scores across three models namely; Model 1 (M1): crude analysis adjusted for 
the other diet patterns; Model 2 (M2): M1 adjusted for covariates shown to be significantly 
associated with dietary patterns and Model 3 (M3): M2 adjusted for total energy intake. Due 
to the similarities observed between M1 and M2 during multinomial logistic regression 
analyses, odds ratios are presented for only two models; i.e., replacing M2 with M3. 
5.3 Results 
5.3.1 Maternal characteristics 
Maternal demographic, health, SES and anthropometric variables stratified according to IoM 
BMI-specific GWG categories are presented in Table 7. 24%, 21% and 55% of women were 
categorised as experiencing inadequate, adequate and excessive GWG respectively. Median 
maternal age decreased across GWG categories (p=0.038); however there were no significant 
differences in the distribution of women across age range categories between the GWG 
groups. HIV status was significantly associated with GWG, with HIV-negative women being 
more likely to exhibit excessive weight gain and HIV-positive women more likely to exhibit 
inadequate weight gain; regardless of whether they had been initiated on ART prior to the 
current pregnancy. Household SES increased across categories of GWG. Median BMI was 
lowest in women who gained adequate weight during pregnancy, with the prevalence of 
excessive weight gain being significantly higher in overweight and obese women than in their 
normal weight counterparts who were more likely to gain either inadequate or adequate 
weight. There were no significant differences in parity, smoking status, education or marital 
status across GWG adequacy groups. 
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Table 7: Maternal characteristics of South African women according to Institute of Medicine (IoM) BMI-specific gestational weight gain categories 
Variable BMI-Specific Gestational Weight Gain (kg/week) p-value 
a
 
Total Inadequate Adequate Excessive 
(n = 538) (n = 128) (n = 113) (n = 297) 
Maternal characteristics      
Age, year 30 (25–34) 31 (27–36) 30 (26–35) 29 (25–34) 0.038 
<25 115 (21) 19 (15) 25 (22) 71 (24) 0.216 
25–29 153 (29) 39 (30) 28 (25) 86 (29)  
30–34 137 (26) 31 (24) 31 (28) 75 (25)  
35–39 99 (18) 25 (20) 23 (20) 51 (17)  
≥40 34 (6) 14 (11) 6 (5) 14 (5)  
Parity      
Para 0 134 (25) 22 (17) 33 (29) 79 (26) 0.189 
Para 1 236 (44) 62 (49) 44 (39) 130 (44)  
Para ≥2 168 (31) 44 (34) 36 (32) 88 (30)  
HIV status      
HIV-negative 357 (66) 66 (52) 72 (64) 219 (74) <0.001 
HIV-positive (pre-pregnancy ART) 65 (12) 22 (17) 15 (13) 28 (9)  
HIV-positive (antenatal ART) 116 (22) 40 (31) 26 (23) 50 (17)  
Smokes/chews tobacco      
No 467 (87) 108 (84) 100 (88) 259 (87) 0.612 
Yes 71 (13) 20 (16) 13 (12) 38 (13)  
Socioeconomic characteristics      
Maternal education      
Primary 10 (2) 4 (3) 2 (2) 4 (1) 0.214 
Secondary 377 (70) 96 (75) 82 (72) 199 (67)  
Tertiary 151 (28) 28 (22) 29 (26) 94 (32)  
Marital status (n = 529)      
Single 326 (62) 73 (59) 70 (62.5) 183 (62) 0.771 
Married/cohabiting 203 (38) 51 (41) 42 (37.5) 110 (38)  
Household SES      
Low 77 (14) 25 (20) 16 (14) 36 (12) 0.048 
Medium 430 (80) 100 (78) 86 (76) 244 (82)  
High 31 (6) 3 (2) 11 (10) 17 (6)  
Anthropometry      
Height, cm 158.3 (154.5–162.4) 156.7 (153.5–161.3) 158.8 (154.8–162.8) 159 (154.8–163) 0.042 
Weight at recruitment, kg (<14 weeks) 68.8 (59.7–78.4) 66.9 (57.7–76.4) 64 (56.5–76.4) 70.8 (62–79.3) <0.001 
BMI at recruitment, kg/m
2
 (<14 weeks) 27.5 (23.9–31.0) 27.3 (23.28–30.9) 25.4 (22.2–29.5) 28.2 (25.1–31.2) 0.001 
Normal weight (BMI 18.5–24.9 kg/m2) 182 (34) 54 (42) 54 (48) 74 (25) <0.001 
Overweight (BMI 25–29.9 kg/m2) 190 (35) 38 (30) 32 (28) 120 (40)  
Obese (BMI ≥30 kg/m2) 166 (31) 36 (28) 27 (24) 103 (35)  
GWG, kg/week 0.40 (0.27–0.55) 0.14 (0.06–0.22) 0.32 (0.27–0.42) 0.54 (0.42–0.64) <0.001 
Data are summarised as median (IQR) or n (%); IoM gestational weight gain (GWG) ranges (kg/m
2
), Inadequate: normal weight < 0.35, overweight < 0.23, obese < 0.17; Adequate: 
normal weight 0.35–0.50, overweight 0.23–0.33, obese 0.17–0.27; Excessive: normal weight > 0.50, overweight > 0.33, obese > 0.27;                                                                                                                    
a
Kruskal-Wallis test (continuous variables), Chi2 test (categorical variables).
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5.3.2 Identification and description of depicted dietary patterns 
Three distinct dietary patterns were identified which explained 20.5% of the variation in food 
intakes (Table 8 and Supplementary Figure F1; Appendix M). The first principal component 
(PC) was characterised by high factor loadings for energy dense, processed, high sugar/fat 
foods (white bread, processed and red meat, roast potatoes and chips, sweets and chocolate, 
soft drinks and cheese) and was labelled the ―western‖ pattern (8.7% variance). The second 
PC, labelled the ―traditional‖ pattern, had high factor loadings for beans and legumes, 
vegetables, traditional meats and porridge/pap (6.4% variance). The final PC was 
heterogeneous in composition, with both classically healthy foods such as whole grains, nuts 
and dairy as well as high sugar items (added sugar and sweet spreads) loading high (5.4% 
variance). This was labelled the ―mixed‖ pattern.  
5.3.3 Associations between maternal demographic, health, SES and anthropometric 
characteristics and dietary pattern scores 
Of the maternal demographic, HIV status, SES and anthropometric variables tested as 
potential confounders or effect modifiers of the association between dietary patterns and 
GWG, only parity and marital status were shown to conclusively influence diet; with younger 
women with no previous births consuming a more ―western‖ pattern and married/cohabiting 
women consuming a more ―traditional‖ diet vs. single women who scored higher for the 
―western‖ diet pattern (data not shown; Supplementary Table S1; Appendix M). 
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Table 8: Factor loadings of various foods or food groups characteristic to the principal 
dietary components identified in pregnant South African women (n = 538) 
Food or food group 
PC1 PC2 PC3 
Western pattern Traditional pattern Mixed pattern 
White bread 0.318   
Cheese and cottage cheese 0.244   
Red meat 0.212   
Processed meat 0.335   
Roast potatoes and chips 0.353   
Sweets and chocolate 0.245   
Soft drinks 0.249   
Miscellaneous (soup powder,  
condiments, sauces, etc.)  
0.325   
Maize, sorghum and oat porridge  0.229  
Offal and traditional meats  0.251  
Salad vegetables  0.262  
Green vegetables  0.336  
Root vegetables  0.248  
Other vegetables  0.340  
Vegetable dishes  0.251  
Beans and pulses  0.273  
Boiled and baked potatoes  0.207  
Other fruit  0.211  
Brown and wholemeal bread   0.325 
Breakfast cereals   0.208 
Full-fat milk   0.368 
Reduced-fat spread   0.307 
Nuts and nut spreads   0.259 
Added sugar (teaspoons)   0.361 
Sweet spreads   0.327 
Decaffeinated tea and coffee   0.211 
Explained variance (%)  8.7 6.4 5.4 
Cumulative explained variance (%)  8.7 15.1 20.5 
Abbreviations: PC, principal component                                                                                                                                    
Foods or food groups presented had factor loadings ≥0.2 and were therefore used to 
describe each dietary pattern 
 
5.3.4 The effect of identified dietary patterns on GWG 
In the total sample of pregnant women, only the ―mixed‖ diet pattern showed a significant, 
positive association with rate of GWG in both crude (M1: 22 (7.3) g/week; p=0.003) and 
adjusted models (M2: 22 (7.3) g/week; p=0.003; M3: 22 (7.6) g/week; p=0.004) (Table 9). 
This positive association was maintained in obese women for all models (M1: 25 (11.4) 
g/week; p=0.029; M2: 23 (11.4) g/week; p=0.042; M3: 24 (11.6) g/week; p=0.041), but was 
not shown in normal weight or overweight women. While the ―western‖ diet pattern was not 
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associated with rate of GWG in the total sample of pregnant women or in the 
overweight/obese subsamples, it was significantly associated with higher weight gain in 
normal weight women in all models. The ―traditional‖ pattern showed significant, inverse 
associations with GWG in M1 (−27 (11.1) g/week; p=0.015) and in M2 (−27 (11.5) g/week; 
p=0.02); however, this association was no longer significant after adjustment for total energy 
intake.  
During crude multinomial logistic regression analyses, a higher ―western‖ diet pattern score 
was associated with an increased odds of excessive weight gain in normal weight women 
(M1: 1.30; p=0.014) (Table 10). However, this association was not maintained after 
adjustment for covariates. A 1SD increase in ―traditional‖ diet pattern score was associated 
with a 19% reduction in the odds of excessive weight gain in the total sample after 
adjustment for covariates (M2: 0.81; p=0.006). This association was similarly shown in the 
normal weight women in both crude (M1: 0.77; p=0.021) and adjusted models (M2: 0.68; 
p=0.003). ―Mixed‖ diet pattern scores were not associated with GWG adequacy in the total 
sample, or across any BMI categories. 
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Table 9: Associations between dietary pattern scores and rate of gestational weight gain in 
South African women 
Dietary 
pattern 
Gestational weight gain (g/week) 
Total (n = 538) 
Normal weight  
(n = 182) 
Overweight  
(n = 190) 
Obese (n = 166) 
Β SE p-valuea Β SE p-valuea Β SE p-valuea Β SE p-valuea 
Western             
Model 1 8 5.8 0.181 27 10.6 0.013 5 9.9 0.588 -7 9.3 0.469 
Model 2 4 5.9 0.527 25 10.9 0.025 -1 10.2 0.887 -7 9.4 0.443 
Model 3 4 8.6 0.640 35 14.9 0.021 -8 14.5 0.593 -4 15.9 0.795 
Traditional             
Model 1 -12 6.8 0.077 -27 11.1 0.015 -3 12.0 0.787 -5 11.8 0.683 
Model 2 -7 7.0 0.311 -27 11.5 0.020 4 12.5 0.751 -1 12.0 0.935 
Model 3 -7 7.5 0.353 -23 12.2 0.063 2 13.1 0.900 1 13.7 0.964 
Mixed             
Model 1 22 7.3 0.003 17 13.3 0.215 20 12.8 0.111 25 11.4 0.029 
Model 2 22 7.3 0.003 15 13.7 0.281 21 12.9 0.107 23 11.4 0.042 
Model 3 22 7.6 0.004 19 14.4 0.182 18 13.7 0.187 24 11.6 0.041 
Values are regression coefficients (β) with standard errors (SE) that represent the difference in rate of 
gestational weight gain (g/week) for a 1SD increase in dietary pattern scores                                                                    
a
Multivariable linear regression analyses; significant results presented in bold (p<0.05)                             
Model 1: crude analysis, adjusted for other diet patterns; Model 2: M1 adjusted for parity and marital status; 
Model 3: M2 adjusted for total energy intake. 
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Table 10: Associations between dietary pattern scores and adequacy of gestational weight gain in South African women 
Dietary 
pattern 
Gestational weight gain category 
Total (n = 538) Normal weight (n = 182) Overweight (n = 190) Obese (n = 166) 
Inadequate Excessive Inadequate Excessive Inadequate Excessive Inadequate Excessive 
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI 
Western                                 
Model 1 0.98 0.85; 1.12 1.06 0.94; 1.19 0.98 0.78; 1.24 1.30 1.06; 1.61 0.94 0.72; 1.23 1.05 0.84; 1.31 0.98 0.77; 1.25 0.91 0.74; 1.13 
p-value
a
  0.717  0.334  0.877  0.014  0.658  0.666  0.892  0.403 
Model 2 0.82 0.66; 1.02 0.84 0.70; 1.01 0.81 0.58; 1.12 1.07 0.78; 1.45 0.86 0.56; 1.31 0.80 0.56; 1.15 0.83 0.52; 1.30 0.70 0.47; 1.05 
p-value
a
  0.077  0.068  0.202  0.682  0.471  0.224  0.410  0.084 
Traditional                             
Model 1 1.03 0.89; 1.20 0.90 0.79; 1.03 0.97 0.79; 1.21 0.77 0.62; 0.96 1.09 0.81; 1.48 0.90 0.69; 1.17 1.16 0.83; 1.61 1.18 0.89; 1.57 
p-value
a
  0.700  0.132  0.803  0.021  0.560  0.426  0.383  0.256 
Model 2 0.90 0.75; 1.07 0.81 0.69; 0.94 0.85 0.67; 1.09 0.68 0.53; 0.87 0.92 0.64; 1.33 0.77 0.56; 1.04 1.04 0.70; 1.54 1.07 0.77; 1.50 
p-value
a
   0.216   0.006  0.205  0.003  0.675  0.090  0.853  0.681 
Mixed                             
Model 1 0.95 0.80; 1.13 1.03 0.90; 1.19 0.94 0.72; 1.21 0.87 0.68; 1.12 1.00 0.70; 1.44 1.31 0.97; 1.78 0.95 0.69; 1.30 0.99 0.69; 1.30 
p-value
a
  0.557  0.651  0.619  0.273  0.994  0.077  0.744  0.952 
Model 2 0.89 0.74; 1.07 0.96 0.82; 1.12 0.83 0.61; 1.12 0.77 0.58; 1.03 0.96 0.64; 1.44 1.25 0.89; 1.75 0.93 0.67; 1.28 0.94 0.71; 1.25 
p-value
a
  0.231  0.597  0.213  0.078  0.836  0.201  0.648  0.669 
Values are odds ratios with 95% confidence intervals that represent the association between a 1 SD increase in dietary pattern scores and inadequate or excessive gestational 
weight gain relative to adequate weight gain (reference);                                                                                                                                                                                                      
a
Multinomial logistic regression analyses; significant results are presented in bold (p<0.05)                                                                                                                                              
Model 1: crude analysis, adjusted for other diet patterns; Model 2: M1 adjusted for parity, marital status and total energy intake.
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5.4 Discussion 
To our knowledge this is the first study to identify dietary patterns in urban, black South 
African pregnant women and to explore their relationships with first trimester BMI and 
GWG. We found that, higher intake of a ―mixed‖ diet pattern was associated with increased 
rate of GWG in both the total sample and in the subgroup of obese women, while a ―western‖ 
diet pattern was associated with higher weight gain in normal weight women. In addition, 
high intake of a ―traditional‖ diet pattern was associated with a reduction in the odds of 
excessive GWG, predominantly in normal weight women. 
Observed positive associations between both the ―western‖ and ―mixed‖ diet patterns and rate 
of GWG are supported by Uusatilo et al. who found that greater adherence to a ―fast food‖ 
diet pattern—characterised by high intakes of fast food items such as hamburgers and pizza, 
as well as sweets, soft drinks and added sugar—was positively associated with maternal 
weight gain (221). Although our ―mixed‖ diet pattern was heterogeneous in nature, the high 
added sugar content may be driving this association and potentially negate some of the 
benefits of the healthier items such as whole grains and nuts. This is supported by previous 
studies in which higher intakes of a ―margarine, sugar and snacks‖ diet pattern and more 
frequent consumption of high-sugar fruit drinks have been positively associated with 
excessive GWG (211,212). 
The association identified between the ―traditional‖ diet pattern and adequacy of GWG is 
unique to this study and, to our knowledge, has not been shown in other settings. Previous 
studies have reported contrasting findings for associations between the  typically healthy 
dietary patterns identified; with Uusitalo et al. showing no association between a ―healthy‖ 
diet pattern (high in vegetables, fish, poultry, legumes, fruit and eggs) and rate of GWG and 
Tielemans et al. showing a positive association between a ―vegetable, oil and fish‖ pattern 
and GWG (211,221). However, when assessing diet using a quality index (i.e., level of 
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adherence to a pre-defined ―healthy‖ diet; in this case a diet high in fruit, vegetables, whole 
grains, potatoes, fish, game and milk) Hillesund et al. found that diets of higher nutrient 
density and healthier macronutrient distribution were associated with reduced odds of 
excessive GWG in normal weight women (222). As with our study, the associations between 
maternal diet and GWG adequacy were not seen in overweight/obese women. 
While high ―mixed‖ diet pattern scores were significantly associated with higher rate of 
weight gain in both the total sample and the obese subgroup, we found that high ―western‖ 
pattern intake was only associated with lower GWG in the normal weight women. In 
addition, the reduction in odds of excessive GWG associated with a ―traditional‖ diet pattern 
in the total sample was evident in normal weight, but not in overweight or obese women after 
stratification. Differential associations between diet patterns and GWG across BMI categories 
have been shown previously, with both Tielemans et al. and Hillesund et al. finding that the 
associations between diet patterns and either rate of weight gain or GWG adequacy were 
specific to normal weight women (211,222). Due to the complexity of the relationship 
between diet patterns, BMI and GWG, the reason for this is difficult to ascertain; however it 
is possible that the effects of diet quality on GWG may be somewhat negated if quantity 
remains high; particularly in overweight/obese women who are already at an increased risk of 
higher weight gain. In addition, overweight and obese women have a reduced capacity for 
weight gain according to IoM recommended ranges than their normal weight counterparts 
and this may limit the effect of improved diet quality on adequacy of weight gain in these 
women (222). Differences may also be a result of the higher degree of under-reporting of 
dietary intake associated with increasing BMI (223). Although under- and over-reporting has 
largely focused on overall energy and macronutrient intakes, women have been shown to 
preferentially under-report foods that they believe to be unhealthy or fattening—such as high 
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sugar and snack foods—which may result in greater inaccuracies in the dietary data reported 
by overweight and obese women when compared to those of normal weight (224,225). 
As previously mentioned, the relationship between diet and weight gain during pregnancy is 
complex; as reflected by the effect of adjusting for identified covariates in the regression 
models. Both dietary patterns and GWG are associated with a number of other 
sociodemographic and health factors which may confound or modify the associations 
between identified patterns and weight gain. In our sample of pregnant women we show that, 
although HIV status is not associated with dietary patterns, HIV-positive women are more 
likely to gain inadequate weight during pregnancy than their HIV-negative counterparts; 
regardless of whether they were initiated on ART prior to, or during, the current pregnancy. 
Although inadequate weight gain is not the key focus in this highly overweight/obese 
population, the high prevalence of HIV (34%) and increased risk of adverse birth outcomes 
associated with inadequate weight gain during pregnancy (1) highlight a need to tailor dietary 
advice to promote higher weight gain where necessary, while potentially monitoring weight 
gain throughout pregnancy, in this vulnerable population. 
Alongside HIV status, our results highlight additional factors which should be considered 
when tailoring advice or interventions to promote improved diet quality and optimal weight 
gain in urban black South African pregnant women. We found that younger, nulliparous, 
single women had higher adherence to a ―western‖ (i.e. ―less healthy‖) pattern, while women 
who had a previous birth and were married or cohabiting had higher adherence to a 
―traditional‖ (i.e. ―healthier‖) diet pattern. Similar results have been shown previously for age 
and marital status (219,226,227). 
Although less convincing than the contrasting associations we have shown between 
―western‖ and ―traditional‖ diet patterns and both parity and marital status, we found that 
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―western‖ diet pattern scores were higher in more educated women. This is opposite to 
relationships shown between patterns of dietary intake and education in HICs; with more 
educated women being more likely to consume the studies respective ―healthy‖ diet pattern in 
these cases (219,226). This may be due to the influence of urbanisation in our setting, where 
improved education and higher household SES have been positively associated with obesity 
risk; potentially as a result of increased intakes of more refined, high fat foods and reduced 
levels of physical activity (228,229). This is reflected by the positive association identified 
between household SES and the ―mixed‖ diet pattern in our study which was high in full fat 
dairy, margarine and added sugar. 
While dietary intake has been explored in pregnant South African women, studies have been 
limited to the use of traditional analyses that assess macro- and micronutrient or food item 
intakes in isolation rather than overall patterns of dietary intake. This is a widely recognised 
flaw in the classic approaches to dietary assessment, as diets consist of multiple combinations 
of foods/nutrients consumed together, nutrient intakes are highly correlated and individual 
nutrients may have very small effects (73,219). This makes independent nutrient-outcome 
associations difficult to ascertain, while limiting their practicality and relevance for use in 
public-health messaging. Use of PCA to depict dietary patterns therefore provides strength to 
our study in that we are able to capture both the diversity and quality of population diets and 
therefore contribute to a more comprehensive understanding of the relationships between 
habitual eating behaviours and outcomes of interest. In addition, it provides a more accessible 
basis for comparison with food based dietary guidelines, as well as for recommendations to 
the public who may have limited understanding of the nutrient composition of foods 
(73,227). However, this approach is not free from limitations; with the majority being linked 
to the subjective nature of decisions made on the grouping of food items and formatting of 
the input variables, as well as the number and naming of the derived patterns (230,231). 
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Further limitations of our study included the use of BMI at recruitment to classify maternal 
pre-pregnancy BMI status. Although first trimester weight has been identified as an adequate 
proxy for pre-pregnancy weight, BMI specific differences in the amount of weight gained—
although low overall—have been shown in black women and may result in a degree of 
misclassification (232,233). In addition, differences in the timing of anthropometric 
measurements resulted in variations in follow-up duration for GWG assessment between 
participants which were dependent on gestational age at both recruitment and the final visit 
prior to delivery. However, this was addressed through using the rate of gain per week rather 
than total gain through pregnancy; thereby increasing accuracy and comparability of GWG in 
the sample. While we included a number of covariates in our study which were shown to be 
associated with diet pattern(s) and/or GWG, we did not have data on all behavioural factors 
which may influence these relationships; for example physical activity which, alongside 
change in dietary intake and smoking, has been proposed as a determinant of GWG (234). 
Lastly, although our sample size was sufficiently robust for analysis of associations between 
diet and GWG in the total sample, the numbers of women within specific BMI categories 
were substantially lower and may be a contributing factor to the differences in the 
associations observed after stratification. 
5.5 Conclusion 
Our findings suggest that increased intakes of a ―traditional‖ diet pattern – high in whole 
grains, legumes, vegetables and traditional meats and low in processed foods - and reduced 
intakes of highly refined diets - high in fat, added sugar and convenience food products - may 
significantly reduce gestational weight gain (including risk of excessive weight gain) in urban 
black South African women.  However, due to the high prevalence of overweight and obesity 
in this population, these results emphasize the need for early intervention to improve diet 
quality and promote a healthy weight prior to conception. This would not only reduce the risk 
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of excessive GWG inherently associated maternal obesity, but enhance the effects of good 
quality diets on weight gain adequacy during pregnancy to potentially improve both maternal 
and infant outcomes. 
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6.1 Introduction 
Maternal pre-pregnancy body mass index (BMI) and gestational weight gain (GWG) are 
established predictors of fetal growth and birth outcomes; with both obesity and excessive 
weight gain being associated with high birth weight and large-for-gestational age (LGA) 
deliveries, as well as with obesity and cardiometabolic disease risk in later life 
(1,5,10,99,235).  Although the effects of anthropometrically defined maternal nutritional 
status on birth weight have been well documented, the influence of dietary patterns on birth 
size – particularly in increasingly urbanised low-and-middle income countries (LMICs) such 
as South Africa – is not known.  In addition, the predominant use of birth weight as a proxy 
for fetal growth fails to elucidate the effects of diet on adiposity (i.e. fat vs. fat-free mass) and 
therefore provides only a weak indication of newborn metabolic risk (84,236).  Studies have 
shown that adiposity in early infancy tends to track through childhood and is associated with 
long term risk of central adiposity, as well as of elevated triglyceride levels and insulin 
resistance (237,238).  Finally, the extent to which high human immunodeficiency virus (HIV) 
and antiretroviral treatment (ART) exposure in this setting prior to, and during, pregnancy 
may impact these associations is yet to be explored.       
During a previous study in urban, black South Africans, we used principal component 
analysis (PCA) to identify three distinct dietary patterns in pregnant women; namely 
―western‖, ―traditional‖ and ―mixed‖ (204).  These patterns were consistent with those 
expected for a transitioning African population experiencing a shift towards increasingly 
westernised diets high in saturated fat, sugar, salt, processed/convenience foods and edible 
oils and low in essential micronutrients (26,28).  We further showed that adherence to the 
―traditional" dietary pattern – characterised by high intakes of vegetables, beans and legumes, 
traditional meats and whole grains - was associated with lower rate of GWG and reduced 
odds of excessive weight gain.  These associations remained evident in women of normal 
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weight after stratification, but not in overweight or obese subgroups.  This suggests that the 
relationship between diet and maternal adiposity may be modified by baseline BMI.  
However, whether ―traditional‖ pattern intake is similarly associated with beneficial 
reductions in neonatal adiposity – either independently or via interactions with maternal 
nutritional status - is not known.    
The maternal high risk profile in this setting – where 66% of women are overweight or obese 
and 55% experience excessive gestational weight gain - is further complicated by a 33% 
prevalence of HIV (204).  While ART initiation is mandatory in South Africa for all HIV 
positive pregnant women not yet receiving treatment, and this has had undeniable benefits in 
the prevention of vertical transmission, the metabolic consequences for both mother and 
infant are not clear.  Both HIV infection and ART exposure have been positively associated 
with weight and fat distribution changes and  altered glucose and lipid metabolism in both 
adults and children, as well as with adverse birth outcomes (17–19,239,240).  However, little 
is known about the possible effects of HIV/treatment on fetal growth and adiposity, as well 
the risk of non-communicable disease in the long term.   
The aim of this study was therefore to examine the associations between maternal 
―traditional‖ dietary pattern adherence and HIV/treatment with neonatal size and adiposity in 
urban, black South Africans, as well as how specific maternal factors - i.e. BMI and GWG - 
may influence these associations. 
6.2 Methods 
6.2.1 Study setting and participants 
This study was nested within a large pregnancy cohort study (Soweto First 1000-Day Study; 
S 1000), based at the Chris Hani Baragwanath Hospital in Soweto, Johannesburg, South 
Africa between 2013 and 2016. Overall, S 1000 aimed to understand the complex 
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associations between multiple maternal factors and fetal and infant outcomes in an urban-
poor African context, and to identify the levers that could optimise maternal and child health 
within the first 1000 days. Inclusion criteria for S 1000 were as follows: resident of Soweto, 
or the Greater Soweto area, <20 weeks gestational age at recruitment, non-epileptic, non-
diabetic, 18 years or older and pregnant with a singleton, naturally conceived pregnancy. 
Data collection for S 1000 took place at six time points during pregnancy (<14 weeks; 14–18 
weeks; 19–23 weeks; 24–28 weeks; 29–33 weeks and 34–38 weeks) and eight time points 
after delivery (<14 days; 6 weeks; 2 months; 3 months; 6 months; 12 months; 18 months and 
24 months) . All women provided written informed consent prior to their inclusion in the 
pregnancy component of the study (Soweto Fetal Growth Study), as well as prior to the 
inclusion of themselves and their infants in the post-delivery follow-up (Soweto Baby 
Growth Study).  Ethical approval was obtained from the University of the Witwatersrand’s 
Research Ethics Committee (Medical) for both components of S 1000 (M120524 and 
M130905).  559 women were recruited into this sub-study and had dietary intake assessed at 
14-18 weeks. 
6.2.2 Maternal variables 
6.2.2.1 Demographic, health and socioeconomic variables 
Maternal demographic and socioeconomic variables were collected by trained members of 
research staff using interviewer-administered questionnaires at the first pregnancy visit (<14 
weeks gestational age).   Parity was defined as the number of previous births at a gestational 
age of 24 weeks or more - regardless of whether the infant was born alive or was stillborn.   
Smoking and/or chewing tobacco was reported at baseline.  HIV-status was self-reported at 
each pregnancy visit and confirmed using the results recorded in the participant’s antenatal 
clinic card.  According to South Africa’s national Prevention of Mother-to-Child 
Transmission (PMTCT) guidelines, routine HIV counselling and testing is required during 
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pregnancy; for any HIV-positive woman who is not already receiving treatment, ART is 
initiated.   All HIV-positive participants in this study were therefore receiving ART and were 
stratified according to whether they had been initiated on ART prior to pregnancy (pre-
pregnancy ART) or during the current pregnancy (antenatal ART).  Household 
socioeconomic status (SES) was assessed using an asset index which scored each participant 
according to the number of assets that they possessed out of a possible 9 (electricity, radio, 
television, refrigerator, mobile phone, personal computer, bicycle, motorcycle/scooter, car).  
This was based on standard measures used in the Demographic and Health Surveys 
household questionnaire (available at: www.measuredhs.com) and has been extensively 
utilised in this setting (241,242).  Asset index scores were subsequently grouped into low 
(<5), medium (5-7) and high (>7) SES categories.  Maternal education was defined according 
to the highest level of completed (primary, secondary or tertiary).  
6.2.2.2  Anthropometry 
A wall-mounted Stadiometer (Holtain, UK) was used to measure maternal height to the 
nearest 1 mm at baseline.  Maternal weight was measured to the nearest 0.1 kg at each visit 
during pregnancy using a digital scale.  Weight at recruitment (<14 weeks) was used as a 
proxy for pre-pregnancy weight and, together with height, was used to calculate maternal 
BMI (weight (kg)/height (m
2
)).  There were no underweight women in this sample and 
therefore BMI was classified according to the following categories: normal weight (18.5–
24.9 kg/m
2
), overweight (25–29.9 kg/m2) or obese (≥30.0 kg/m2). GWG (kg/week) was 
calculated as: [(weight at final pregnancy visit − weight at recruitment)/duration of follow-
up].  GWG was classified as inadequate, adequate or excessive according to the BMI-specific 
Institute of Medicine recommended weight gain ranges (25). 
6.2.2.3 Dietary intake 
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Habitual dietary intake was assessed at the second pregnancy visit (14-18 weeks) using an 
interviewer-administered quantitative food-frequency questionnaire (QFFQ).  This nationally 
utilised QFFQ was developed by the South African Medical Research Council (SAMRC) 
based on analyses of 11 dietary surveys conducted in rural and urban South Africa and 
includes all foods consumed by at least 3% of the population (243).  Retrospective data was 
collected on the frequency and quantity of food and beverage intake during the previous week 
using food flash cards (high quality photographs of food items) and a combination of 
household measures, two-dimensional life-size drawings of foods and utensils, and three-
dimensional food models as described and validated by Steyn et al (216).  According to the 
criteria developed by Dennis et al, this QFFQ is a very high quality tool – scoring a total of 
13 points (high quality classified as a score of seven or higher) (244).  This QFFQ has been 
extensively piloted and utilised in this setting and results are published elsewhere 
(172,204,215). QFFQ data was captured electronically using REDCap electronic data capture 
tools hosted at The University of the Witwatersrand (217). 
6.2.3 Neonatal variables 
Neonates were included in this study if they were born at term (≥37 weeks) and had complete 
delivery outcome data.  Additionally, body composition was analysed for a sub-sample who 
had assessments via either air displacement plethysmography (ADP) using the Peapod 
(Cosmed, USA) or dual-energy x-ray absorptiometry (DXA; (Hologic DiscoveryA S/N 
86254, APEX software version 4.0.2, Hologic Inc., USA) within the first two weeks of life.     
6.2.3.1 Birth outcomes 
Gestational age at delivery (weeks) was calculated as: [duration of pregnancy follow-up (date 
of delivery – date of baseline ultrasound dating scan) + gestational age at baseline (crown-to-
rump length measured by ultrasound; days)].   Birth weight and length were measured by 
trained research nurses within 24 hours of delivery for 82% of neonates.  Where assessment 
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within this window was not possible – for example due to the infant being admitted to the 
hospital for observation – measurements were taken within 48 hours.  Weight to length ratio 
(WLR; kg/m) was calculated to represent the best anthropometric predictor of neonatal body 
composition (fat-free mass and fat mass) as described by Villar et al (245). 
6.2.3.2 Neonatal body composition 
Weight and length were measured and fat mass and fat-free mass estimated for nude neonates 
within 14 days of birth.  According to a previous study in which we demonstrated the level of 
agreement between ADP and DXA estimated body composition in this population, ADP was 
utilised where available (174).  In cases where a neonate had only DXA measurements, fat 
mass and fat-free mass were converted to their ADP equivalent estimates using the following 
linear equations: 
Fat mass (ADP equivalent) = 139.8311 + 0.7974718 * DXA fat mass  
Fat-free mass (ADP equivalent) = 89.40371 + 0.8728309 * DXA fat-free mass 
These equations were generated for the population from the regression of ADP on DXA 
measurements in the aforementioned ADP/DXA comparison study and provided reliable 
ADP equivalent estimates (174).  Fat mass index (FMI; kg/m
3
) was calculated from these 
estimates to describe adiposity in neonates.  As described by Villar et al, the applicability of 
exponents in body composition indices to address the relationship between body composition 
and size may vary across populations (245).  We therefore regressed fat mass on length (data 
in natural logarithms) to confirm that this index (kg/m
3
) provided the best description of the 
relationship between weight and length in the study population. This was indeed confirmed - 
regression power exponent: 2.8±0.6 (SE) (246).  
ADP 
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Peapod assessments were performed according to standard procedures as previously 
described (86,189).  Participants were placed inside the Peapod chamber wearing only a wig 
cap if necessary.  Body volume was estimated using pressure and volume changes (air 
displacement) within the chamber and body density calculated using body mass and volume 
measurements.  Fat mass, and fat-free mass were subsequently derived using gender-specific 
equations developed by Fomon et al (247).   
DXA 
DXA scanning was performed according to standard procedures as described elsewhere 
(191).   Typically, neonates were fed prior to DXA scanning and were sleeping during the 
procedure. Neonates were placed supine on the scanning bed wearing only a disposable 
diaper and swaddled in a cotton blanket.  Scans were satisfactory for use if the subject’s body 
lay within the scanning region and there was minimal movement during assessment.  Whole 
body measurements of fat mass and fat-free mass were extracted for use in analyses.                  
6.2.4 Statistical analysis 
Data were analysed for 393 mother-neonate pairs with complete data using Stata 13.0 
(StataCorp, College Station, TX, USA).  As previously described, the flow of participants 
through the sub-study to reach the final sample sizes for the primary and secondary outcomes 
(WLR and FMI respectively) is depicted in Figure 8.  Mother-neonate pairs included in the 
final analyses did not differ in any baseline maternal characteristics (demographics, SES and 
anthropometry) from those excluded.   
The dietary patterns previously identified in this population – namely ―western‖, ―traditional‖ 
and ―mixed‖ – were confirmed in this sub-sample using PCA as described elsewhere (204).  
PCA was conducted using orthogonal (varimax) rotation on the weekly frequency of 
consumption of the QFFQ food items, classified as 48 food items/groups based on those 
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described by Crozier et al (76,220). The Kaiser-Meyer-Olkin measure of sampling adequacy 
(0.68) and Bartlett’s test of sphericity (p<0.001) confirmed PCA as an appropriate dimension 
reduction technique for use in this sample.  Eigen values, as well as their visual inflections on 
a scree plot, and the percentage of total variance explained were used to retain patterns.  
Specifically, those Eigen values situated above the point where the downward curve levels 
off on the scree plot were considered for retention (Supplementary Figure F1; Appendix M).  
As described elsewhere, foods or food groups with factor loadings ≥0.2 reflected strong 
associations with principal components and were used to name the dietary patterns (211).  
Dietary pattern scores for each pattern were generated by multiplying factor loadings by the 
intakes of each food/food group and then generating standardised summed scores. Mean 
factor scores for the patterns were zero; with positive and negative scores representing high 
and low adherence respectively of each dietary pattern (219).  Due to the associations 
previously demonstrated between the ―traditional‖ diet pattern and odds of excessive GWG in 
this population, as well as the independent associations demonstrated between excessive 
weight gain and both birth size and neonatal adiposity in other studies (248,249), maternal 
diet was classified according to adherence to the ―traditional‖ pattern (―traditional‖ pattern 
score) in all subsequent study analyses.   
Maternal and neonatal characteristics of the sample are presented as median (interquartile 
range) and percentages (%) for continuous and categorical variables respectively. The 
Kruskal-Wallis test was used to compare neonatal WLR and FMI according to the following 
maternal and infant factors: maternal age, parity, HIV/treatment status, smoking status, 
education, marital status, SES, BMI at recruitment, GWG, ―traditional‖ diet pattern 
adherence, neonate sex and gestational age at birth.   
Based on known associations between maternal factors and birth size, as well as previously 
described associations in this population (204), we proposed a conceptual framework for the 
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associations between maternal ―traditional‖ pattern adherence (continuous: diet pattern 
score), BMI (categorical: normal weight (ref) vs. overweight and obese), GWG (continuous: 
kg/week), HIV/treatment status (categorical: HIV negative (ref) vs. HIV positive (antenatal 
ART) and HIV positive (pre-pregnancy ART) and neonatal WLR (continuous: kg/m) and 
FMI (continuous: kg/m
3
).   The bivariate associations between these maternal factors and 
each neonatal outcome were tested using linear regression analyses.   
In order to identify the independent associations between diet, BMI, GWG, HIV/treatment 
status and WLR and FMI we performed hierarchical regression analyses per outcome.  
Covariates included in analyses were maternal or infant variables conclusively associated 
with infant outcome(s) (namely parity, newborn sex and gestational age at birth).  
Additionally, for FMI, age at scan (days) was included to adjust for variation across the two 
week assessment period.  Regression coefficients and R
2
 values are therefore presented 
across three models for WLR and FMI.  Variables included in the models were as follows: 
Model 1 (M1): neonate sex and ―traditional‖ diet pattern score; Model 2 (M2): M1 with 
HIV/treatment status, BMI and GWG; Model 3 (M3): M2 with parity and gestational age at 
delivery (and age at scan for FMI).  In order to test for an interaction between BMI and 
dietary pattern adherence, a fourth model per outcome was run as follows: M3 with the 
interaction term BMI category*traditional pattern score (data not shown).  P-values less than 
0.05 were considered statistically significant.     
6.3 Results 
Maternal and infant characteristics are presented in Table 11.  The median age of pregnant 
women was 30 years.  35% and 30% of women were overweight and obese at recruitment, 
respectively, while 58% gained excessive weight according to the IoM BMI-specific 
guidelines.  34% of women were HIV positive; with 23% in total being initiated on ART 
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during the current pregnancy.  52% of newborns were male.  Neonates had a median birth 
weight of 3100 g and WLR and FMI were 6.4 kg/m and 3.6 kg/m
3
 respectively.      
As previously described, for the purpose of this study maternal diet was classified according 
to ―traditional‖ diet pattern adherence (i.e. ―traditional‖ diet pattern score).  This dietary 
pattern was characterised by high factor loadings for vegetables, beans and legumes, 
traditional meats and porridge/pap (Supplementary Table S2; Appendix M).   
Of the maternal variables described as potential covariates in this population, only parity was 
consistently associated with neonatal outcomes; with higher WLR and FMI seen in infants 
born to mothers who had experienced at least one previous birth (Supplementary Table S3; 
Appendix M). Female neonates had significantly higher FMI than males and WLR increased 
with gestational age.  
Conceptual models for the bivariate associations between maternal ―traditional‖ diet pattern, 
BMI, GWG and HIV/treatment status and outcomes of interest are presented in Figures 1 
(WLR) and 2 (FMI).  Compared to those of normal weight at recruitment, overweight and 
obese women exhibited significantly lower GWG.  GWG was also lower in HIV positive 
(antenatal ART initiation) vs. HIV negative women.  Additionally, in HIV positive women, 
pre-pregnancy ART initiation was associated with higher adherence to the ―traditional‖ diet 
pattern.  Maternal obese vs. normal weight BMI was positively associated with WLR during 
bivariate analyses, while HIV positive (pre-pregnancy ART) status was positively associated 
with FMI when compared to HIV negative status.        
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Table 11: Maternal and neonatal characteristics of urban, black South Africans (n=393) 
  Median (IQR) or % 
Maternal variables 
 Demographic and health characteristics 
 Maternal age, y 30 (25-35) 
Parity 
 Para 0 25 
Para 1 45 
Para ≥2 30 
HIV status 
 HIV-negative 66 
HIV-positive (antenatal ART) 23 
HIV-positive (pre-pregnancy ART) 11 
Smokes/chews tobacco 
 No 87 
Yes 13 
Socioeconomic characteristics 
 Maternal education 
 Primary 2 
Secondary 70 
Tertiary 28 
Marital status [n=387] 
 Single 61 
Married/cohabiting 39 
Household SES 
 Low 13 
Medium 80 
High 7 
Anthropometry 
 BMI at recruitment, kg/m
2
 (<14 weeks) 27.2 (23.8-30.9) 
Normal weight (18.5-24.9) 35 
Overweight (25-29.9) 35 
Obese (≥30) 30 
GWG, kg/week 0.41 (0.28-0.56) 
Inadequate 22 
Adequate 20 
Excessive 58 
Neonatal variables 
 Sex 
 Male 52 
Female 48 
Gestational age at delivery, weeks 39 (38-40) 
Anthropometry 
 Birth weight, g 3100 (2850-3365) 
Birth length, cm 48.9 (47.3-50.3) 
Weight to length ratio (kg/m)  6.4 (5.9-6.8) 
Body composition [n=171]
a
 
 Age at scanning, d 8 (4) 
Fat mass, g 435 (331-548) 
Fat-free mass, g 2774 (2530-2929) 
Fat mass index, kg/m
3
 3.6 (2.9-4.6) 
Abbreviations: BMI, body mass index; GWG, gestational weight gain; ART,                                                                                   
antiretroviral treatment                                                                                                                                                        
IoM GWG ranges (kg/week): inadequate, normal weight <0.35, overweight                                                                                                           
<0.23,  obese  <0.17; adequate, normal weight 0.35-0.50, overweight 0.23-0.33,                                                                                                  
obese  0.17-0.27; excessive, normal weight >0.50, overweight >0.33,                                                                                                                
obese  >0.27                                                                                                                                                                       
a
Measured by air displacement plethysmography (ADP; Peapod) or dual-                                                                                                           
energy x-ray absorptiometry (DXA) corrected for the measurement                                                                                                    
differences between techniques                   
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Figure 11: Conceptual model with bivariate associations between maternal factors and 
neonatal weight-to-length ratio (kg/m) in urban, black South Africans                                                                                                                                                                                         
Abbreviations: GWG, gestational weight gain; HIV-, HIV negative; HIV+a, HIV positive 
(antenatal ART); HIV+b, HIV positive (pre-pregnancy ART); NW, normal weight; OW, 
overweight; Ob, obese; Vs, versus (i.e. compared to the following reference category); WLR, 
newborn weight-to-length ratio                                                                                                                   
Values are regression coefficients with standard errors [β(SE)] from linear regression 
analyses; significant results presented in bold (P<0.05)                                                                                                                                                                                                
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Figure 12: Conceptual model with bivariate associations between maternal factors and 
neonatal fat mass index (kg/m
3
) in urban, black South Africans                                                                                                                                                                                                    
Abbreviations: FMI, neonatal fat mass index; GWG, gestational weight gain; HIV-, HIV 
negative; HIV+a, HIV positive (antenatal ART); HIV+b, HIV positive (pre-pregnancy ART); 
NW, normal weight; OW, overweight; Ob, obese; Vs, versus (i.e. compared to the following 
reference category)                                                                                                                                                  
Values are regression coefficients with standard errors [β(SE)] from linear regression 
analyses; significant results presented in bold (P<0.05)                                                                                                                                                                                                           
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Table 12 presents the results of hierarchical regression analyses of maternal variables on 
newborn WLR.  In fully adjusted models (M3: adjusted for neonate sex, ―traditional‖ diet 
pattern score, HIV/treatment status, BMI, GWG, parity and gestational age at delivery) a 1 
SD increase in ―traditional‖ diet pattern score was inversely associated with newborn WLR (-
0.04 kg/m; P=0.033).  In addition, compared to a normal weight BMI at recruitment, maternal 
obesity was positively associated with WLR (M3: 0.25 kg/m; P=0.008) and a 1 kg/week 
increase in GWG was associated with a 0.48 kg/m increase in newborn WLR (M3: P=0.002).  
M3 explained approximately 14% of the variation in newborn WLR.    
The results of hierarchical regression analyses of maternal variables on newborn FMI are 
presented in Table 13.  ―Traditional‖ diet pattern adherence was associated with lower FMI (-
0.13 kg/m
3
 per +1 SD; P=0.027) after full adjustment for covariates (M3: adjusted for 
neonate sex, ―traditional‖ diet pattern score, HIV/treatment status, BMI, GWG, parity, 
gestational age at delivery and age at scan).  HIV positive (pre-pregnancy ART) vs. HIV 
negative status was associated with 1.18 kg/m
3
 (P=0.001) higher neonatal FMI in M2 
(adjusted for neonate sex, ―traditional‖ diet pattern score, HIV/treatment status, BMI, GWG).  
This association remained significant in the fully adjusted model (M3: 1.11 kg/m
3
; P=0.002).  
Approximately 19% of the variation in newborn FMI was explained in M3.   
Although BMI and GWG were not associated with newborn FMI in any of the presented 
regression models; we confirmed an interaction between ―traditional‖ diet pattern adherence 
and maternal BMI on FMI (vs. normal weight: overweight*traditional diet pattern, P=0.203; 
obese*traditional diet pattern, P=0.024).  Therefore, while dietary pattern adherence was 
associated with a significant reduction in FMI for infants born to normal weight women (-
0.32 kg/m
3
; P=0.005), these effects were not seen among newborns of overweight or obese 
women (data not shown).   
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Table 12: Hierarchical regression for the associations between maternal factors and neonatal weight to length ratio (n=393) 
WEIGHT TO LENGTH RATIO (kg/m) 
Independent variables 
Model 1 Model 2 Model 3 
Β 95% CI p-valueb Β 95% CI p-valueb Β 95% CI p-valueb 
Neonate sex 
         
Male Ref Ref Ref 
Female -0.02 -0.17; 0.13 0.769 -0.05 -0.19; 0.10 0.533 -0.06 -0.20; 0.08 0.396 
Maternal dietary pattern 
         
Traditional pattern score -0.04 -0.08; 0.00 0.078 -0.04 -0.08; 0.00 0.081 -0.04 -0.08; -0.00 0.033 
HIV/treatment status 
         
HIV negative 
   
Ref Ref 
HIV-positive (antenatal ART) 
   
0.07 -0.11; 0.25 0.422 0.07 -0.10; 0.24 0.436 
HIV-positive (pre-pregnancy ART) 
   
0.01 -0.23; 0.26 0.906 -0.02 -0.26; 0.21 0.833 
BMI category 
         
Normal weight 
   
Ref Ref 
Overweight 
   
0.09 -0.09; 0.26 0.343 0.09 -0.08; 0.26 0.301 
Obese 
   
0.27 0.08; 0.46 0.005 0.25 0.07; 0.43 0.008 
Gestational weight gain 
      
. 
  
Rate, kg/week 
   
0.36 0.05; 0.67 0.024 0.48 0.18; 0.78 0.002 
Parity 
         
Para 0 
 
  
   
Ref 
Para 1 
      
0.33 0.15; 0.50 <0.001 
Para ≥2 
      
0.32 0.13; 0.52 0.001 
Gestational age 
         Gestational age at birth, weeks 
      
0.18 0.12; 0.24 <0.001 
R2 per model 0.008 0.035 0.137 
Values are regression coefficients with 95% confidence intervals                                                                                                                                                                                                                                         
a
Multiple linear regression analyses; significant results are presented in bold (p<0.05) 
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Table 13: Hierarchical regression for the associations between maternal factors and neonatal fat mass index (n=171) 
FAT MASS INDEX (kg/m
3
) 
Independent variables 
Model 1 Model 2 Model 3 
Β 95% CI p-valueb β 95% CI p-valueb Β 95% CI p-valueb 
Neonate sex 
         
Male Ref Ref Ref 
Female 0.44 0.04; 0.84 0.033 0.40 0.00; 0.79 0.049 0.39 0.01; 0.78 0.044 
Maternal dietary pattern 
         
Traditional pattern score -0.09 -0.22; 0.03 0.130 -0.10 -0.22; 0.02 0.086 -0.13 -0.25; -0.02 0.027 
HIV/treatment status 
         
HIV negative 
 
Ref Ref 
HIV-positive (antenatal ART) 
   
0.37 -0.10; 0.84 0.123 0.29 -0.17; 0.75 0.218 
HIV-positive (pre-pregnancy ART) 
   
1.18 0.48; 1.87 0.001 1.11 0.42; 1.81 0.002 
Gestational weight gain 
         
Rate, kg/week 
   
0.44 -0.29; 1.18 0.238 0.46 -0.26; 1.18 0.213 
BMI category 
         
Normal weight 
   
Ref Ref 
Overweight 
  
 
0.17 -0.30; 0.65 0.469 0.20 -0.26; 0.66 0.390 
Obese 
  
 
0.37 -0.13; 0.87 0.147 0.24 -0.25; 0.74 0.335 
Parity 
  
       
Para 0 
  
    
Ref 
Para 1 
      
0.76 0.27; 1.25 0.002 
Para ≥2 
      
0.64 0.11; 1.17 0.018 
Neonate age 
         Gestational age at birth, weeks 
      
0.09 -0.08; 0.26 0.286 
Age at examination, days       0.05 0.00; 0.10 0.035 
R2 per model 0.043 0.121 0.194 
Values are regression coefficients with 95% confidence intervals                                                                                                                                                                                                                                         
a
Multiple linear regression analyses; significant results are presented in bold (p<0.05) 
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6.4 Discussion 
To our knowledge this is the first study to explore the relationships between maternal 
nutritional status, dietary patterns and HIV/treatment exposure in African women and to 
examine their effects on neonatal adiposity within the first two weeks of life.  We found that, 
although maternal obesity and GWG were associated with neonatal body composition, they 
predicted overall birth size rather than increased fat mass in particular.  In contrast, adherence 
to a ―traditional‖ dietary pattern during pregnancy was associated with lower WLR and FMI; 
suggestive of a predominant effect on fat mass in the neonate.  Finally, we showed that 
duration of ART exposure (pre-pregnancy vs. antenatal initiation) in HIV positive women 
was positively associated with newborn adiposity in this setting.   
Our findings build on data previously reported on the association between ―traditional‖ 
dietary pattern adherence and reduced GWG (including odds of excessive weight gain) in this 
population (204).  Here we show that, not only is a dietary pattern high in vegetables, beans 
and legumes, traditional meats and whole grains associated with beneficial reductions in 
maternal adiposity during pregnancy, but also in fetal fat deposition.  Such effects have 
important implications for the long term health trajectory of the infant; with previous studies 
showing a tendency towards tracking of adiposity through infancy, as well as of an increased 
risk of obesity and elevated metabolic risk profiles (including higher fasting triglyceride 
concentrations and insulin resistance) in later life (237,238).  In addition, while Catalano et al 
demonstrated a significant correlation between body fat percentage at birth and at childhood 
follow up (mean age: 8.8 ± 1.8 years), there was no correlation in total weights at these two 
time points (238).  This highlights the importance of neonatal adiposity as a potential 
predictor for longer-term obesity and metabolic disease risk.     
Although the associations between a ―traditional‖ diet pattern and neonatal WLR and FMI 
are unique to our study, they are supported by Starling et al who found that intake of a diet 
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pattern with lower consumption of green vegetables and dairy and higher in refined grains 
was associated with higher birth weight, fat mass and body fat percentage in the US (93).  
However, conflicting results have also been shown; with typically healthier diet patterns 
(―Mediterranean‖ and ―traditional‖) being associated with higher birth weight and reduced 
SGA risk, while more processed or ―western‖ dietary patterns have been associated with 
increased risk of SGA and lower weight-for-age z-score in some high income settings (77–
80,250). 
The relationship between maternal diet and birth size and adiposity is complex and the 
variation in findings across populations may reflect an influence of baseline nutritional status 
on these associations.  For example, while energy dense, processed diets have been shown to  
restrict fetal growth and increase SGA risk in certain populations, they may increase the risk 
of high birth weight and adiposity in others (80,81,250).  As both ends of the spectrum - i.e. 
being born too small or too large for gestational age – are associated with long term disease 
risk (205,251–253), identifying patterns of intake which facilitate optimal fetal growth and 
limit excess fat deposition in increasingly urbanised African populations, is critical.  Given 
the high level of urbanisation in Africa - and particularly South Africa - to date, as well as the 
representativeness of the study population to that of an urban-poor community, our findings 
contribute substantially to understanding these contexts.   Here we confirm that, not only do 
the effects of maternal dietary patterns on GWG differ across BMI categories (204), but the 
association between ―traditional‖ diet pattern adherence and neonatal adiposity is similarly 
modified by maternal BMI at baseline; with the effects seen predominantly in the normal 
weight subgroup.  This suggests that, in increasingly obesogenic populations, the beneficial 
effects of improved diet quality may be limited in women who exhibit excess adiposity and 
associated metabolic risk profiles prior to conception.  Obesity induces a chronic 
inflammatory state that has been suggested as a key driver of insulin resistance and may 
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intensify the naturally occurring insulin resistant profile during pregnancy (84,254,255).  
Reduced insulin sensitivity in the obese pregnant woman – and the subsequent increase in 
availability of glucose and lipids – may potentially facilitate excess substrate transfer to the 
fetus and, thus, fat deposition irrespective of the current dietary pattern.     
While we found no differences in WLR or FMI between infants born to HIV positive women 
with antenatal ART initiation compared to their HIV negative counterparts, we showed a 
significant increase in FMI for infants whose mothers were HIV positive and initiated on 
ART prior to the current pregnancy.  These associations were independent of baseline BMI, 
GWG and diet and therefore suggest a strong treatment effect in this population.  ART 
associated metabolic complications have been widely documented in HIV positive patients, 
with fat redistribution (reduced subcutaneous and increased central adiposity), impaired 
glucose tolerance and insulin resistance, as well as dyslipidaemia being common side effects 
(256,257).  Such changes may substantially impact the metabolic risk profile of women prior 
to conception; further exacerbating the pregnancy associated insulin resistant state and 
increasing the risk of gestational diabetes mellitus (GDM) and associated complications.  
These findings have important implications for HIV positive pregnancies in South Africa, 
during which duration of ART exposure (increasing with each subsequent pregnancy) may 
elevate the risk profile for both mother and infant in an already high risk population.  
Targeted monitoring and care strategies are therefore needed in order to minimise the adverse 
effects of treatment exposure on adiposity and associated metabolic risk in the newborn; with 
interventions designed to optimise nutritional status and diet quality pre-conception being 
potentially more vital in these women.       
Although we showed significant effects of maternal nutritional status, diet and HIV/treatment 
exposure on birth size and/or neonatal adiposity, our final models explained only 14% and 
19% respectively of the variability in infant outcomes.  While maternal adult size, adiposity 
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and metabolic profile are predictive of infant outcomes, these characteristics are highly 
influenced by a mothers own growth and development; with studies showing strong 
intergenerational associations between maternal and offspring birth weight (258–261).  This 
suggests that the gestational environment of the mother – and the resulting consequences on 
maternal birth size and longer term metabolic risk profile – may be an important factor in 
further explaining differences in neonatal size and adiposity in our study.  In addition, there 
may be other behavioural factors which require exploration in these models, such as physical 
activity.  Although there was no association found between physical activity and birth 
outcomes (including birth weight and ponderal index) in a previous study of this population 
(262), any potential indirect effects on birth size – for example through reductions in GWG 
and/or risk of GDM – as well as possible associations with fetal fat deposition and neonatal 
adiposity should be explored (51–53).   
Other limitations of our study include the use of baseline BMI as a proxy for pre-pregnancy 
BMI and the variation in timing of maternal anthropometric measurements for assessing 
maternal GWG as previously described (204).  Although first trimester weight has been 
identified as an adequate proxy for pre-pregnancy weight – correctly classifying 91-95% of 
women according to pre-pregnancy BMI - BMI specific differences in weight gain during 
trimester one have been shown (232,233). While use of baseline weight may have resulted in 
a degree of misclassification in our study, any effects on study findings were likely to be 
negligible due to the low overall amount of weight gained prior to 14 weeks; particularly in 
black women at higher BMIs (233).  In addition, although the categorisation of pregnant 
women into three HIV/treatment status groups (i.e. HIV negative, HIV positive (antenatal 
ART) and HIV positive (pre-pregnancy ART)) allowed for effective comparison of overall 
treatment exposure in our sample, inclusion of additional measures of duration and/or 
adherence to ART would allow for more robust comparison of ART exposure on a 
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continuous scale.  While we present strong evidence for an effect of ART exposure on 
neonatal adiposity, use of an objective measure such as viral load – an established proxy for 
ART adherence/effectiveness (266) - would be beneficial in further explaining the influence 
of treatment on fetal fat deposition and metabolic risk in future research.  Given the focus of 
our study and the differential patterns of growth (both in fat mass and fat free mass) between 
pre-term and term infants, we included only term neonates in our analyses (245).  While this 
reduced the final sample size, it allowed for better interpretation of the effects of maternal 
factors (principally diet and HIV/treatment status) on newborn adiposity.  However, future 
studies should explore these associations in pre-term infants in order to further elucidate the 
relationships with newborn size and adiposity according to gestational age.  Lastly, neonatal 
body composition was measured using two techniques (Peapod and DXA) within the first 
two weeks of life which may reduce comparability across the sample; particularly due to the 
reduced sample size for these objective assessments.  However, the comparability between 
techniques previously shown in this population allowed for correction of DXA to Peapod 
measurements and therefore equivalent fat mass estimates in the sub-sample (174).  Although 
the variation in day of neonatal body composition assessment  must be considered - with 
physiological weight loss occurring during this period – any changes in body composition are 
predominantly due to reductions in body water and would therefore have little effect on the 
comparability of fat mass estimates between subjects (267).   
6.5 Conclusion 
Our findings suggest that increased adherence to a ―traditional‖ diet pattern - high in whole 
grains, beans and legumes, vegetables and traditional meats and low in 
processed/convenience foods— may reduce neonatal adiposity in urban, black South 
Africans.  However, early intervention to ensure a healthy BMI prior to pregnancy is needed 
in order to optimise the beneficial effects of diet quality on adiposity and associated 
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metabolic risk for both mother and infant.  Although ART initiation and adherence is critical 
for both maternal and infant health, the effects of treatment exposure on maternal metabolic 
risk and neonatal adiposity highlights the vulnerability of HIV positive pregnant women and 
the importance of tailored care in this population.  Targeted monitoring and management 
strategies are therefore necessary to limit treatment-associated effects on in utero fat 
deposition and to potentially reduce metabolic risk profiles and poor health trajectories of 
infants in both the short and longer term. 
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CHAPTER 7: Discussion and conclusion
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7.1    Introduction 
Overall, this thesis described MNS and dietary patterns in urban, black South African women 
and examined their associations with birth size and neonatal adiposity using the critical 
framework of the first 1000 days and its implications for optimal growth and development 
and reduced risk of metabolic disease in the long term.  The South African setting was of 
particular relevance to the study findings, as it provided an opportunity to explore these 
associations within the context of rapid urbanisation and transitioning nutrition environments 
in Africa.  These epidemiological shifts have serious consequences for the clustering of 
disease burdens experienced by pregnant women in these unique and vulnerable populations.   
Chapter 1 provided the theoretical framework for the research and established the important 
role that nutrition plays in maternal and child health.  However, it highlighted the need for a 
holistic approach to examining the associations between maternal nutrition and outcomes that 
are highly influenced by multi-level health determinants, such as demographics, SES and 
baseline burdens of disease.  In addition, it presented the findings of objective one of this 
thesis: a review of the literature base for Africa in particular.  This review highlighted the 
extensive gaps in our understanding of the importance of maternal nutrition in the first 1000 
days in rapidly urbanising African settings (Figure 13).  In terms of MNS, these gaps 
included a focus on nutrient intakes and biomarkers in isolation and a lack of understanding 
of the effects on GWG and maternal metabolic outcomes.  For the infant, the predominant 
use of birth weight as a study outcome provided limited interrogation of both the short- and 
long-term metabolic consequences of sub-optimal growth and development.  While it was 
outside the scope of this thesis to address all of these gaps, we were able to add significantly 
to the understanding of these relationships within an urban-poor African context by providing 
novel data on dietary patterns in pregnant South African women and the association between 
these patterns and both maternal and neonatal adiposity (Chapters 4-6).              
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This final chapter presents a consolidated overview of the thesis, specifically summarising 
the key findings according to each individual study objective and highlighting the 
overarching themes that emerge.  In addition, it provides interpretation of the thematic areas, 
with particular focus on recommendations for intervention.  Lastly, it discusses the strengths 
and weaknesses of the study design and methods, as well as potential routes for future 
research.   
 
 
Figure 13: Research gaps identified in existing African literature and those addressed in the 
current study (illustrated in black) 
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Table 14: Summary of research findings per study objective 
Thesis chapter Study objective Key findings 
Chapter 2 To review and report on maternal nutritional 
status (MNS) in African women and its 
associations with fetal, birth, neonatal and 
infant outcomes in the first 1000 days. 
 
  
MNS in Africa showed features typical of the epidemiological health transition; i.e. low burdens of maternal 
underweight and comparatively high overweight/obesity prevalences, as well as persistently high prevalences of 
micronutrient deficiencies.  Additionally, reported maternal dietary intakes were high in energy-dense foods and 
low in protein/micronutrient-rich foods.   
Robust evidence to support associations between MNS and fetal, birth, neonatal and infant outcomes was 
limited in Africa; however available data supported the globally observed relationships between maternal BMI 
and birth outcomes (particularly birth weight) in this setting.  A high prevalence of deficiencies in critical 
pregnancy-related nutrients (particularly iron), as well as benefits observed in micronutrient supplementation 
trials of undernourished pregnant women suggest that improvements in MNS could have significant effects on 
outcomes of interest. 
However, this review highlighted a need for data examining the associations between maternal dietary intakes 
and patterns and offspring outcomes, as well as longitudinal infant-outcome data through to two years of age. 
Chapter 4 To compare body composition 
measurements using two methods, namely 
(i) dual-energy x-ray absorptiometry (DXA) 
and (ii) air displacement plethysmography 
(ADP; Peapod), in black South African 
neonates. 
ADP and DXA estimates of fat and fat-free mass were highly correlated; however fat mass and %fat were 
significantly lower and fat-free mass was significantly higher when measured by DXA in South African 
neonates.  This may potentially be explained by a limited ability to distinguish between different body tissues 
(i.e. fat mass, lean mass and bone) in early life and therefore suggests a preferential basis for use of the Pea Pod 
in neonatal body composition assessment. 
Chapter 5 To characterise, depict and report on 
maternal dietary intakes and patterns during 
pregnancy using multivariate dimension 
reduction techniques in urban black South 
African women.  
At recruitment (<14 weeks gestational age) 66% of pregnant women were overweight/obese.  In addition, 24%, 
21% and 55% of women were categorised as experiencing inadequate, adequate and excessive GWG 
respectively, according to Institute of Medicine (IoM) guidelines.   
Three distinct dietary patterns were identified which explained 20.5% of the variation in food intakes: ―western‖ 
(energy dense, processed, high sugar/fat foods), ―traditional‖ (beans and legumes, vegetables, traditional meats 
and porridge/pap) and ―mixed‖ (whole grains, nuts and dairy as well as high sugar items).   
―Western‖ and ―mixed‖ diet patterns were associated with 35 g/week (per 1 SD; p=0.021) and 24 g/week (per 1 
SD; p=0.041) higher GWG in normal-weight and obese women respectively.  
A 1 SD increase in ―traditional‖ diet pattern score was associated with reduced odds of excessive weight gain in 
the total sample (OR: 0.81; p=0.006) and in normal-weight women (OR: 0.68; p=0.003). 
Chapter 6 To examine the associations between 
maternal dietary intakes and patterns with 
neonatal body composition and how specific 
modifying factors i.e. HIV, maternal BMI 
and GWG modify or confound these 
associations. 
Maternal obesity and GWG were associated with 0.25 kg/m (P=0.008) and 0.48 kg/m (P=0.002) higher 
newborn WLR, while ―traditional‖ diet pattern score was associated with lower newborn WLR (-0.04 kg/m per 
1 SD; P=0.033).  Additionally, ―traditional‖ pattern score was associated with 0.13 kg/m3 (P=0.027) and 0.32 
kg/m
3
 (P=0.005) lower FMI in the total sample and in newborns of normal-weight women, respectively.   
HIV-positive (pre-pregnancy ART) vs. HIV-negative status (ref) was associated with 1.11 kg/m
3
 (P=0.002) 
higher newborn FMI.   
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7.2 Summary of study findings 
An overview of the study findings per objective is provided in Table 14. Overall, two main 
themes emerged from these finding, as follows: (1) typical transition-associated dietary 
patterns are firmly established in pregnant South African women and influenced by multiple 
maternal factors, and (2) the associations between MNS, dietary patterns (and overall 
metabolic health profiles) and adiposity are highly complex and play a fundamental role in 
maternal and child health.  Together, these themes highlight the need for early interventions 
that take a holistic approach to improving nutritional status and diet quality while ensuring 
the optimal health and wellbeing of women prior to, and during, pregnancy, as well as in the 
post-partum period.    
7.2.1 Expanded empirical study findings: maternal dietary patterns 
From data presented in empirical chapters (specifically Chapter 5 and 6) it is important to 
expand on the possible determinants of maternal dietary patterns.  Although outside the scope 
of the individual objectives of these chapters and therefore only briefly touched on in the 
chapters themselves, understanding the factors that may drive dietary behaviour in urban 
African women is an important component which should not be overlooked.  While 
urbanisation and subsequent nutrition transitions are well-established in African settings, with 
increases in obesity and NCD burdens documented across the continent, the maternal factors 
associated with depicted dietary patterns and the potential consequences for MNS and fetal 
growth have not been thoroughly explored.   
The three dietary patterns identified in pregnant South African women in this study – namely 
―western‖, ―traditional‖ and ―mixed‖ – typify those of a transitioning population and confirm 
urbanisation-associated changes in patterns of intake in this setting (Chapter 5). Specifically, 
the findings demonstrate the continued presence of a ―traditional‖ dietary pattern high in 
163 
 
staple grains (predominantly maize porridge/pap), vegetables, beans and legumes and 
traditional meats, alongside substantial emergence of a ―western‖ pattern characterised by 
energy-dense, refined, high-sugar/fat and convenience foods. While such dietary shifts 
typically result in considerable increases in energy intake – and therefore a positive energy 
balance and weight gain – they are also associated with intakes of poor nutritional value.  For 
this reason, populations such as this demonstrate a form of malnutrition known as ―hidden 
hunger‖, in which two thirds of women are overweight or obese in early pregnancy, yet 
micronutrient deficiencies are common.  This has serious implications for pregnant women, 
who may demonstrate energy-dense/nutrient-poor dietary patterns, excess adiposity and 
increased risk of GDM and fetal adiposity, while simultaneously being deficient in the 
essential micronutrients required to support optimal fetal growth and development.   
Of the maternal factors included as potential confounders in this study, parity and marital 
status were conclusively associated with dietary pattern adherence, with married/cohabiting 
women who had had two or more previous pregnancies demonstrating higher adherence to 
the ―traditional‖ diet pattern.  In contrast, ―western‖-pattern adherence was higher for single 
women with no previous births.  As one would expect, these women also tended to be 
younger.  Similar relationships have been shown in previous studies, with diets high in 
refined grains, confectionery, processed/convenience food products and sugar-sweetened 
beverages associated with younger maternal age and the absence of a partner; a ―health 
conscious‖ diet negatively associated with being single; and a ―traditional‖ diet associated 
with increasing age and parity (226,227,268).   
These findings suggest that younger women who are single and have not yet had their first 
baby may be more susceptible to the shift towards western diets.  This may be the result of 
more limited experience of traditional dietary practices and greater exposure to the 
urbanisation-associated effects of food promotion and availability in their experience than in 
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the experience of their older counterparts (269,270).  In addition, these women may be less 
financially stable and more likely to work (and to work longer hours), resulting in less stable 
lifestyles (271).  This may reduce the likelihood of household-based food preparation and 
increase consumption of convenience and fast-food products that are quickly and easily 
accessible, as well as more affordable.  Lastly, the pregnancy period is a key healthcare 
access point for women in South Africa, who may otherwise have little or no contact with the 
health system.  Nutrition education and support is limited within the South African public 
health system and it is possible that increased access to healthcare services and health 
information would play a role in encouraging healthy lifestyles – including healthy dietary 
patterns – in the population as a whole. Such access might be particularly effective during 
pregnancy, when women are more motivated to make health improvements.      
Although higher educational attainment and SES are associated with improvements in diet 
quality and decreased obesity risk in HICs, rural-to-urban transition facilitates the opposite 
effects in LMICs.  In the landscape of poverty and deprivation in these settings, economic 
improvement, western acculturation and weight gain are viewed as symbols of status and 
wealth – as well as of an absence of disease (predominantly HIV and/or TB) –  which fuels 
the obesity epidemic (272,273).  This has been shown in a previous study of rural South 
African adolescents, with higher education driving improvements in household SES and, 
subsequently, obesity risk (111).  Although no significant associations were shown between 
household SES and either the ―western‖ or ―traditional‖ diet patterns in our study, there was a 
positive association between SES and the ―mixed‖ pattern score.  While this pattern was 
labelled according to its heterogeneous nature – i.e. mixing both classically healthy and 
unhealthy foods/food groups – high levels of sugar and sugar-sweetened products represented 
a dominant transition-associated influence.   
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The move towards high intakes of empty calories is of concern, with our study showing a 
significant association between the ―mixed‖ pattern and maternal adiposity. While 
improvements in education and SES are critical to alleviating poverty in South Africa, they 
need to be coupled with nutrition education to shift the persisting cultural perceptions driving 
obesogenic dietary habits.         
Overall, these findings highlight the importance of promoting improvements in diet quality 
early (i.e. prior to a woman’s first pregnancy) in order to reach those most susceptible to poor 
dietary practices, as well as to optimise health benefits for the woman and for any (or all) 
future pregnancies.  In addition, they emphasise the need to take a holistic approach to 
tackling obesity and improving diet quality and MNS, as substantial and sustained 
improvements cannot be made without targeted, multi-level approaches that incorporate 
individual and societal determinants.         
7.3 MNS, dietary patterns and adiposity: a complex paradigm   
As described by the DOHaD theory, neonatal size is an important predictor of long-term 
susceptibility to disease.  However, the significance of adiposity (i.e. ―fatness‖) in early life – 
although recognised as a more robust indicator of the in utero nutrition environment and 
newborn metabolic risk profile – has been widely overlooked, particularly in African settings.  
While data describing the associations between MNS (and, to a lesser extent, dietary intake) 
and birth weight exists, this study provided novel data on the influence of maternal pre-
pregnancy anthropometry and dietary patterns on both maternal adiposity and particular 
parameters of fetal growth and, therefore, newborn size and body composition.  In addition, 
these relationships were established within the context of high HIV/ART exposure in South 
African women, adding an additional, unique level of complexity.   
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While the conceptual models proposed in Chapter 6 – built according to the conceptual 
frameworks for this thesis as a whole (with the literature to support these),  as well as the 
findings in Chapter 5 – suggested comparable relationships between maternal factors and 
newborn size (WLR) and adiposity (FMI), our final analyses highlighted considerable 
differences per outcome. This allows for outcome-specific tailoring of the models and 
presentation of a refined framework for the associations between the maternal factors studied 
and WLR and FMI (Figure 14). Insight into the individual predictors of body size and 
adiposity is critical in order to ensure that excess fat deposition is minimised without 
compromising linear fetal growth.   
Overall, these models confirm the importance of maternal pre-pregnancy BMI and weight 
gain in predicting overall birth size in urban African women, with maternal obesity and 
increased GWG potentially increasing the risk of fetal overgrowth.  In addition, they show 
that adherence to the ―traditional‖ dietary pattern is associated with beneficial reductions in 
maternal adiposity and birth size; with its predominant effect on newborn fat mass.   
A possible explanation for these associations is related to improvements in the metabolic 
profile of women prior to, and during, pregnancy, which affect glycaemic control and 
therefore risk of GDM.  While obesity is a well-established risk factor for GDM, maternal 
dietary intake and dietary patterns are increasingly being linked to impaired glucose tolerance 
and insulin resistance during pregnancy; with dietary patterns high in refined grains, fat and 
sugar and low in fruit and vegetables being associated with increased odds of GDM (274). 
The resulting hyperglycaemic state during pregnancy – further amplified by obesity/GDM 
co-morbidity – is associated with fetal overgrowth and, more particularly, with  a tendency 
towards central fat deposition (275).   
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Figure 14: Revised conceptual model for the associations between maternal factors and neonatal size (weight-to-
length ratio, kg/m) and adiposity (fat mass index, kg/m
3
)                                                                               
Solid arrows indicate associations between model variables, with + (red) and – (blue) symbols depicting positive and 
negative associations respectively. Dashed arrows represent effect modification of the identified association.  
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This link between the maternal glycaemic profile and newborn adiposity is further supported 
by Veena et al, who showed that even women who are not diagnosed with diabetes during 
pregnancy, but deliver higher birthweight babies with greater adiposity, are at increased risk 
of developing diabetes approximately nine years later (276).  The effects on long-term 
disease risk are not limited to the mother, with studies showing significant associations 
between maternal hyperglycaemia and newborn adiposity and increased risk of 
overweight/obesity, abnormal glucose tolerance and higher blood pressure in children up to 
five years of age (277,278). 
The association observed between maternal HIV/treatment exposure and neonatal adiposity 
adds an additional level of complexity to our model.  The independent effect of ART on 
neonatal adiposity suggests that documented effects on maternal adiposity and glucose and 
lipid metabolism may exacerbate the maternal risk profile, potentially amplifying the 
pregnancy-associated effects (256,257).  As HIV-positive women are increasingly exposed to 
ART – often initiated in their first pregnancy, when HIV is most likely to be diagnosed – this 
may have serious implications for maternal and infant health, particularly when coupled with 
obesity and poor-quality diets.   
Our findings provide important and unique insights into potential intervention strategies, with 
promotion of a shift away from the urbanisation-associated dietary practices and towards 
more traditional patterns (dominated by coarse grains, vegetables, beans and legumes and 
lean, unprocessed meat) potentially improving the body composition and metabolic profile of 
mothers and newborns without adverse consequences for fetal growth.  However, such 
intervention will be effective only if promotion of healthy pre-pregnancy weight is 
prioritised, thereby reducing obesity-related risk while optimising the beneficial effects of 
improved diet quality on both maternal and neonatal adiposity.  In addition, special care must 
be taken when it comes to HIV positive women, whose exposure to ART makes them even 
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more susceptible to the advanced metabolic changes that increase the risk of excess adiposity 
in the newborn.     
7.4 Recommendations for interventions 
Poor diet quality and subsequent malnutrition – including under- and overweight – is the 
leading driver of the global disease burden, with approximately 88% of countries 
experiencing dual – or even triple – burdens of malnutrition (childhood stunting, anaemia in 
women of reproductive age, and/or overweight in adult women) (279).  While tackling 
childhood undernutrition is an established global priority and was at the forefront of the 
Millennium Development Goals (MDGs) – with some countries successfully meeting targets 
aimed at eradicating extreme hunger – universal progress has been slow and has somewhat 
stagnated (279,280).  In addition, the growing obesity epidemic – and subsequent NCD 
burdens – pose a serious threat to growth and development, with NCDs being the leading 
cause of morbidity and mortality worldwide (281).  Although this has more recently been 
incorporated into global development plans – with the Sustainable Development Goals 
(SDGs) including targets to end malnutrition in all its forms and to reduce premature 
mortality from NCDs by one third by 2030 – little progress has been made towards 
integrating these targets into effective intervention planning and implementation strategies at 
country levels (280).     
Evidence shows that implementation of prevention strategies to minimise behavioural risk 
factors (the greatest being poor diet and nutrition status), alongside effective care and 
management programmes, can successfully diminish NCD burdens.  In addition, the benefits 
for health, productivity, economic growth and poverty reduction greatly outweigh the cost of 
preventative intervention (281).  This is the basis upon which the United Nations (UN) has 
declared 2016-2025 the ―Decade of Action on Nutrition‖, the overarching aim being to 
achieve scalable nutrition impact and ultimately eliminate all forms of malnutrition and, in 
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turn, nutrition-related NCDs.  However, as emphasised by the findings of this thesis, the 
success of the UN declaration will depend on multi-level approaches to improving nutrition 
determinants and outcomes across sectors, including education, agriculture and food systems, 
health systems, water and sanitation and social protection (282).  In particular, strengthening 
the health system to support the implementation of effective interventions, early risk 
assessment and monitoring and surveillance strategies will play a critical role in improving 
nutrition and disease outcomes.   
In South Africa, malnutrition and NCD burdens – as well as the critical link between the two 
– are acknowledged at government levels and strategic plans have been developed in 
response to these.   In the Strategic Plan of the National Department of Health 2015/16-
2019/20, it is acknowledged that ―strengthening the effectiveness of the health system is the 
foundation on which successful interventions to improve health outcomes must be built‖ 
(283).  This is aligned with the National Development Plan for 2030, which was proposed by 
the National Planning Commission to ―eliminate poverty and reduce inequality‖ through 
multi-sector action (284) as well as implementation of the World Health Organisation’s 
(WHO’s) Health Systems Strengthening Framework (285).  However, regardless of the 
prioritisation of health-system strengthening in multiple government – particularly  
Department of Health – strategic plans over the years, little progress has been made in 
translating these plans into health-system reform.  Commitment to, and directed and enforced 
action towards, strengthening health systems – particularly public healthcare services – is 
therefore a critical platform for maternal and child nutrition interventions. 
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7.4.1 Health system strengthening for maternal and child nutrition 
7.4.1.1 Strategies, targets and indicators 
Improvements in dietary intake (and other lifestyle factors) are important at all stages of the 
lifecycle; however, substantial progress in nutrition and health outcomes can be achieved 
only via adoption of defined targets and interventions in high-risk – and therefore high-
impact – groups.  In South Africa, multi-faceted health burdens and thinly stretched resources 
present a challenge for effective prioritisation and implementation of health-system 
strategies.  As a result, strategic plans aimed at addressing various health issues (e.g. maternal 
and child health, obesity and NCDs) are developed continually in response to international 
research and health agendas, as well as local disease burdens and healthcare needs.  However, 
these strategies tend to be compartmentalised, focusing on specific health outcomes across 
different timelines, and are therefore not sufficiently aligned with targets that facilitate the 
greatest impact on overall population health.  Additionally, plans do not necessarily build on 
the strategies and progress (or lack thereof) that came before, and tend to provide very limited 
guidance on implementation at provincial, district and community levels.  As a result, public 
healthcare systems have become overburdened with goals, objectives, targets and indicators 
that they do not have the knowledge or capacity to implement and drive within facilities. To 
achieve the maximum impact on malnutrition and associated disease burdens across the life 
course, it is essential to ensure that national strategic plans are aligned and prescribe globally 
relevant targets.  In addition, targets must be supported by evidence-based and culturally 
relevant interventions that can be implemented effectively via the public healthcare system.  
Lastly, measurement indicators per target are critical to ensuring effective monitoring and 
evaluation of progress, as well as to facilitate responsive updates to future planning.        
The WHO’s Comprehensive Implementation Plan for Improving Maternal, Infant and Young 
Child Nutrition (MIYCN) (286) provides a universally recognised platform for effectively 
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addressing the double burden of malnutrition by prioritising adequate early-life nutrition to 
optimise growth and development and reduce the associated risk of disease throughout the 
life course.  This plan specifies six targets, which broadly aim to reduce maternal anaemia 
and LBW, reduce stunting, wasting and overweight in children under the age of five, and 
increase exclusive breastfeeding rates (Table 15).  All six of the targets – and their respective 
indicators – are highly influenced by MNS, making interventions that improve nutritional 
status and dietary intake prior to, and during, pregnancy critical drivers of reduced 
malnutrition at individual country levels.   
Although some equivalent targets and indicators exist within South Africa’s strategic plans 
for maternal and child health and the prevention and control of both obesity and NCDs, 
streamlining health-system targets to better complement these, and ensuring that effective 
interventions are put in place, could substantially improve maternal and infant nutritional 
status and optimise health trajectories.  Additionally, this would ensure that effective existing  
intervention strategies are prioritised, while the process is underway to establish specific, 
measurable, achievable, relevant and time-bound (SMART) targets and indicators that allow 
for globally comparable monitoring of progress.  SMART commitments to, and targets for, 
improving nutrition are critical to ensuring that the focus on these commitments is maintained 
while accountability at stakeholder level is enforced (282). 
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Table 15: Global targets and indicators to improve nutritional status and behaviours within the 
structure of the health system 
Targets for maternal, infant and young child nutrition (MIYCN) (2025) 
Target 1 Achieve a 40% reduction in the number of children under 5 who are stunted 
Under-5 stunting Stunting
a
 among children under 5 years of age 
Target 2 Achieve a 50% reduction of anaemia in women of reproductive age 
Anaemia Women aged 15–49 years with haemoglobin <12 g/dL (non-pregnant) or <11 g/dL (pregnant) 
Target 3 Achieve a 30% reduction in low birth weight 
Low birth weight Infants born with a birth weight <2,500 g 
Target 4 Ensure that there is no increase in childhood overweight 
Under-5 overweight Overweight
b
 among children under 5 years of age 
Target 5 Increase the rate of exclusive breastfeeding in the first 6 months up to at least 50% 
Exclusive 
breastfeeding 
Infants 0–5 months of age who are fed exclusively with breast milk 
Target 6 Reduce and maintain childhood wasting to less than 5% 
Under-5 wasting Wasting
c 
among children under 5 years of age 
a
Stunting, length/height-for-age z-score >2 SD below the median of the WHO Child Growth Standards                              
b
Childhood overweight, weight/height-for-length z-score >2 SD above the median of the WHO Child Growth Standards 
c
Wasting, weight-for-length/height z-score >2SD below the median of the WHO Child Growth Standards 
 
7.4.1.2 Nutrition education and health promotion 
The WHO has shown that, alongside promotion of good breastfeeding and complementary 
feeding practices in the first two years of life, improving nutrition in pregnant and lactating 
women is critical to achieving the targets set out in the Comprehensive Implementation Plan 
for Improving MIYCN (286,287).  In addition, the Global Nutrition Report 2017 recognised 
that ―a well-functioning health system is vital not just to treat, but to deliver preventative 
interventions at scale‖ and that at universal levels ―much more effort and focus is needed for 
health systems to include nutrition and diet-related NCD programmes and interventions in 
universal health coverage‖ (279).  In order to facilitate improvements in nutrition targets and 
indicators – and therefore reductions in morbidity and mortality – the South African health 
system must play an active role in preventative (rather than strictly curative) healthcare 
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services.  The only nutrition-based intervention for pregnant women currently being 
implemented in the South African health system is routine iron/folic acid supplementation. 
While this is important, there is a lack of focus on improving dietary intakes and patterns in 
order to optimise overall nutritional status during pregnancy and lactation.  Healthcare 
practitioners should therefore be trained to educate women about the importance of nutrition 
– including weight management and diet quality – at the earliest opportunity; for example, 
via family planning services when possible. Although addressing overweight/obesity and diet 
prior to pregnancy will ensure optimum benefits, pregnancy itself should be treated as a key 
target period for intervention, due to the relatively low access that women have to pre-
conception care in low-to-middle income settings such as this (288).  Improving patterns of 
dietary intake at this time would not only incur benefits for maternal and neonatal adiposity 
in the current pregnancy, but could have knock-on effects for maternal weight management 
and metabolic health in the future, as well as for fetal and infant health during subsequent 
pregnancies. In addition, women tend to adopt healthier lifestyle behaviours during 
pregnancy (e.g. reducing smoking and alcohol intake), making it an optimal period for 
promoting and establishing better dietary practices (289). 
Many women – and healthcare providers themselves – may not be aware of the strong 
association between diet and fetal growth and development.  Additionally, even when women 
are aware that certain foods are unhealthy, they may not know the best options for replacing 
these foods in their diet.  The findings of this study therefore provide a good foundation for 
tailoring dietary advice and, specifically, encouraging a reduction in typically westernised 
diets high in processed, high-sugar and fatty foods, as well as convenience food products, and 
a shift towards dietary patterns dominated by whole grains, beans and legumes, vegetables 
and lean/unprocessed meat.   
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7.4.1.3   Identification and monitoring of high risk women 
While universal education aimed at improving nutrition and health behaviours is important 
for pregnant women, identification of those at high risk (e.g. obese, GDM-positive and HIV-
positive women) is important for the effective monitoring of maternal and fetal health during 
pregnancy, as well as for the tailoring of dietary advice. The independent association 
identified between ART exposure and neonatal adiposity, as well as the established risks 
associated with obesity and GDM for both mother and infant, mean that improvements in diet 
quality and management of weight gain is even more critical in these groups.   
However – while the risks associated with maternal obesity for both maternal and infant 
health are widely established – research into optimal management of these women is limited; 
with available guidelines and recommendations during pregnancy being largely based on 
women of normal weight.  While the IoM guidelines do provide overweight- and obese-
specific GWG ranges, appropriate nutrition (and physical activity) based strategies for 
managing and monitoring MNS in these cases is needed.  As the increasing majority of 
pregnant women attending health facilities in South Africa are overweight or obese, the 
development of guidelines for optimising maternal nutrition – both in terms of weight and 
micronutrient and metabolic profiles - during pregnancy is critical.           
7.4.1.4 Facility-level accountability and service delivery   
While streamlining targets and health indicators and prioritising nutrition-based interventions 
at national, provincial and district levels is important, successful implementation will not be 
possible without effective dissemination and buy-in across the health system.  High disease 
burdens, coupled with insufficient and poorly allocated resources and ineffective 
management strategies in the South African public health system, place extremely high 
burdens on the physicians and healthcare practitioners working at ground level (290).   
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In such environments – in which the provision of basic day-to-day reactive care is a challenge 
– maintaining preventative education and health-promotion efforts, consistent and accurate 
recording of data, and monitoring and evaluation of nutrition and health indicators is close to 
impossible.  In addition, the nurses and midwives who provide frontline care during 
pregnancy are often not sufficiently educated about the social, economic and environmental 
determinants of malnutrition and associated diseases, as well as the role that lifestyle 
intervention must play on reducing NCD burdens.  The importance of preventative nutrition 
education and counselling, as well as of accurate data entry, indicator monitoring and 
evaluation of health promotion programmes and outcomes is therefore widely overlooked by 
those responsible for these activities (290,291).  Therefore, ensuring that healthcare providers 
have sufficient knowledge and understanding to facilitate ownership of, and accountability 
for, nutrition-based interventions and monitoring strategies, and that they have the capacity to 
effectively and consistently implement these efforts, must be critical components of any plan  
to strengthen health systems going forward.    
7.5 Strengths, limitations and research gaps 
This study is the first to examine nutritional status and dietary patterns in pregnant African 
women and to explore the associations with birth size and neonatal body composition in 
the context of HIV.  It presents not just novel data on the current status of pregnant South 
African women and the benefits that improved diet quality – alongside healthy pre-
pregnancy BMIs – could have on both maternal and neonatal adiposity in this setting, but 
evidence of the complexity that HIV/treatment brings to the relationships between MNS, 
metabolic risk and newborn adiposity.   
MNS and dietary patterns were assessed in pregnant women from the larger S1000 study.  As 
CHBH is the only hospital serving the Soweto area, recruitment from the Fetal Medicine Unit 
allowed us access to a sample of pregnant women who were experiencing the full range of 
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co-morbidities currently experienced by the population. This recruitment process also 
provided the opportunity for regular pregnancy monitoring, accurate pregnancy dating via 
ultrasound, and timely and accurate measurement of birth outcomes after delivery.  However, 
due to a lack of recruitment at clinic level and the specifically urban-poor setting, this was a 
convenient sample which was not representative of the Sowetan pregnant population as a 
whole, or of South African women living in higher-income or rural settings.  In addition, the 
homogeneous nature of the sample – particularly with respect to race, education and SES–- 
may have restricted diversity of food access and dietary behaviours and the associated risk 
profiles, thereby limiting the scope for generalising the findings and subsequent development 
of nationally inclusive interventions. However, given the high risk profiles of urban, black, 
low-to-middle income women of reproductive age in South Africa, as well as the increasing 
exposure to urban contexts and their consequences, the importance of interventions within 
such population groups is undeniable.     
Maternal dietary assessment via reported dietary intakes was useful in our study, as these 
questionnaire-based methods can be applied to large samples, including illiterate populations 
via interview, and they place a relatively low burden on the respondent.  In addition, our 
QFFQ provided data on the reported consumption of local South African foods – including 
convenience-food products – which could then be used to derive habitual dietary patterns via 
PCA.  While the use of dietary-pattern analysis techniques such as PCA have limitations – 
including subjectivity in the grouping of food items and  in selecting the number and names 
of the derived patterns (230,231) – this method added substantial strength to our study when 
compared to classic dietary assessment methods.  This was due to the ability of dietary 
patterns to capture the diversity and quality of overall diets within the sample and to provide 
an accessible basis for interventions and public recommendations based on foods, rather than 
on individual macro- and micronutrients (73,227).       
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It is widely acknowledged that using a QFFQ such as ours has a number of limitations; 
including being prone to recall bias, assuming regularity of eating habits over time, and 
providing inaccurate estimations of portion size (145–147).  Additionally – as with the 
majority of reported dietary assessment tools currently used in Africa – our QFFQ has not 
been validated or tested for reliability (144).  However, by using a seven-day recall period 
(including assessment of week- and weekend-day intakes) and incorporating frequency 
(rather than quantity) of consumption into our analyses, we were able to reduce the 
probability of inaccurate and biased recall, as well as the risks associated with portion-size 
estimation. Further, while not validated, the criteria developed by Dennis et al for assessing 
the quality of FFQs used in observational studies,  classifies our questionnaire as a very high-
quality tool, with a total of 13 points (high quality is classified as a score of seven or higher) 
(Table 16) (244).   
Dietary patterns – although useful – provide only a subjective measure of dietary intake, 
which does not directly reflect nutritional status in the population studied.  It is also widely 
acknowledged that under- and over-reporting is common in FFQs; with women tending to 
under-report intakes of unhealthy high-fat and high-sugar foods (224,225).  This is 
particularly relevant where overweight and obese women are concerned, making reported 
dietary data potentially less accurate in highly obese populations such as ours (223).  While 
assessment of nutritional biomarkers is scarce in Africa, due to the expensive nature of 
sample collection and analysis, use of these objective measures is critical for more accurate 
assessment of nutritional status.  Not only would it provide a useful validation tool for 
reported intakes, but it would facilitate more accurate assessment of nutritional status – 
particularly in pregnancy, when micronutrient levels are critical for fetal growth and 
development.   
179 
 
Table 16: Evaluation of the MRC/Wits Developmental Pathways for Health Research Unit 
(DPHRU) Food Frequency Questionnaire (FFQ; SA MRC) according to criteria adapted from 
Dennis et al (244) 
Assessment items 
Scoring categories Total 
category 
score 
FFQ 
summary 
score 
Points Criteria 
Is the FFQ a quantitative 
instrument? 
0 Frequency only 2 2 
1 Frequency (including average 
amount consumed) 
2 Quantitative 
How many food items are measured 
by the FFQ? 
 
0 Not stated or unknown 4 4 
1 ≤ 70 items 
2 71-110 items 
3 111-150 items 
4 > 150 items 
Is the FFQ completed by an 
interviewer or is it self-
administered? 
0 Not stated or unclear 2 2 
1 Self-administered 
2 Interviewer administered 
Has the FFQ been pretested in the 
study population? 
 
0 Not stated or unknown 1 1 
1 Yes 
Is the FFQ a validated instrument 
(either by the authors or has a 
standard FFQ been used)? 
 
0 Not stated or unknown 2 0 
2 Yes or referenced use of 
Willet, Block or Jain FFQ 
Does FFQ coding make use of a 
nutrient database that is specified 
and can be referenced? 
0 Not stated or unknown 1 1 
1 Yes 
Is there any measure of quality 
control incorporated into the FFQ 
tool? 
0 Not stated 1 1 
1 Any measure incorporated 
Is the FFQ focused on a recalled 
dietary period that predates any 
diagnosis? 
0 Not stated or unclear 1 1 
1 Yes or not applicable to study 
design 
Can the survey completion time be 
stated for either the FFQ or the 
whole questionnaire? 
0 No 1 1 
1 Yes 
Total  15 13
a
 
a
Total quality score: low < 7; high ≥7 
 
While this study provides information on maternal dietary patterns and their determinants, it 
was outside the scope of our research to explore the knowledge and perceptions of 
healthy/unhealthy eating that may be driving certain food choices.  In addition, dietary 
patterns in this population may be highly influenced by both the availability and expense of 
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healthy food choices in urban-poor environments such as Soweto. An understanding of the 
reasons why women make particular dietary choices – including the influence of social, 
cultural, economic and environmental factors – is a critical component of developing 
acceptable, realistic and sustainable interventions. 
As previously mentioned, current nutrition guidelines and recommendations for pregnant 
women are largely focused on normal weight women; with a lack of understanding of 
appropriate management of obese women.  In addition our findings show that, while 
improving diet quality during pregnancy may have beneficial effects on both maternal and 
neonatal adiposity, these benefits are substantially reduced in overweight and obese women.  
While strategies aimed at ensuring appropriate maternal weight pre-pregnancy in South 
African women are critical, further research needs to focus on the development of guidelines 
for nutritional management of the substantial number of overweight and obese pregnant 
women for which this is not possible.  In addition, while our findings identified the potential 
interaction between dietary intake and pre-pregnancy BMI on neonatal adiposity (FMI); this 
could not be further explored using stratification due to the sample size available for body 
composition analyses.  Future research should therefore expand on these analyses by 
investigating how the effect of diet on FMI may change across BMI categories.  In order to 
accurately elucidate the effects of diet on FMI, study design should focus on adiposity as a 
primary outcome and ensure that sample size is calculated to achieve sufficient power to 
detect differences in FMI within stratified groups (i.e. a minimum of n=171 per group; with a 
confidence level of 5% and a power of 80%; calculated using Stata 13.0, StataCorp, USA).     
Our study highlights the importance of HIV/ART exposure in predicting fetal fat deposition, 
potentially via changes in maternal metabolic profiles and therefore fetal programming in 
utero.  As ART exposure was not the main focus of our study, objective measures of 
treatment duration and/or adherence to treatment – for example, measurements of viral load – 
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were not collected. Such measures are important if we are to further understand the 
associations between HIV/ART exposure and neonatal adiposity in the future.  Additionally, 
they should be complemented by exploration of the potential effects on maternal metabolism 
– for example, glucose and lipid profiles – in order to elucidate possible mechanisms to 
explain these relationships.     
As previously described, studies in the African setting have been largely focused on the 
outcome of birth weight, with data lacking on neonatal adiposity, as well as on the influence 
of MNS and diet on infant outcomes to two years (and beyond).  While our study begins to 
fill these gaps, long-term follow-up to two years (and beyond) was not possible within the 
scope of the study.  Longitudinal data is therefore needed in this population, in order to 
explore whether the effects on adiposity are propagated through infancy and into childhood, 
thereby influencing metabolic trajectories and risk of obesity and NCDs in the longer term. 
The hierarchical regression models used in our study provide a good basis for the differential 
associations between maternal factors and neonatal size and adiposity and, therefore, support 
the development of the refined conceptual framework proposed in Figure 14.  However, 
future work using techniques such as structural equation modelling (SEM) - able to pull 
together the multiple exposures and outcomes (as well as confounding factors) into a single 
model - should be explored in order to more adequately test the framework as a whole.      
7.6 Future research 
Given the limitations of this thesis, future work should aim to fill the identified research gaps, 
particularly building on our findings in the following ways: 
i. Explore the associations between MNS, dietary patterns and neonatal size and 
adiposity across other South African population subgroups, focusing 
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particularly on other ethnic groups, geographical areas (e.g. rural settings) and 
levels of SES.  
ii. Assess MNS using objectively measured nutritional biomarkers, particularly 
examining biomarker patterns in pregnant women.   
iii.  Expand understanding of determinants of dietary patterns in South Africa, 
including a) research into the economic and environmental determinants – 
including household and community-level food availability and access, and b) 
qualitative research into the social and cultural determinants – particularly norms 
and beliefs about body size, food choices and perceived barriers to healthy eating. 
iv. Investigate the potential interaction between diet and maternal BMI on both 
maternal and neonatal adiposity through robust stratified analyses across BMI 
categories 
v. Examine the effects of objectively measured maternal HIV/ART-exposure on 
maternal metabolism (glucose and lipid profiles) and infant growth and 
adiposity from birth to two years (and beyond). 
vi.  Explore the associations between MNS and dietary patterns and infant growth 
and adiposity from birth to two years (and beyond). 
vii. Explore the associations between MNS and dietary patterns, and adiposity and 
NCD risk factors (e.g. blood pressure, glucose and lipid profiles) in 
childhood/adolescence 
7.7 Conclusion 
In conclusion, this thesis shows that promotion of a ―traditional‖ diet pattern—high in whole 
grains, legumes, vegetables and traditional meats and low in processed foods – alongside a 
healthy preconception weight in urban, black African women would significantly improve 
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both maternal and infant adiposity profiles.  This may have substantial benefits in reducing 
long-term risk of NCDs in both current and future generations.   
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Appendix A: S1000 data collection process 
 
Recruited from 
Fetal Med at 
CHBH 
• Discuss study with her & give her a Fetal Growth Study Information Sheet 
• Complete BAS  
• Get her contact details and nurse to give her contact details. Plan an appointment.  
Visit 1 
<14 weeks 
• Pregnancy test - if positive continue 
• Discuss study with her 
• Give her a Fetal Growth Study Information Sheet 
• Get her to sign the Fetal Growth Study Consent Sheet 
• Give her a Fetal Growth Study DNA & RNA Information Sheet 
• Get her to sign a Fetal Growth Study DNA & RNA Consent Sheet 
• Complete a Contact Sheet 
• Send her for a Dating Scan- USD 
• Complete BAS and MSE – (for 3G there is no restriction on BMI) 
• Complete BPMS 
• Complete page 2 of the Pregnancy and Delivery form (DEV)- SES questions 
• Complete HHP  
• Complete SSS 
• Complete Visit 1 Lab Sheet 
• Nurse to give participant her contact details 
• Make a follow-up appointment for 5 weeks’ time/ for when she is 14-18 weeks 
pregnant 
• Give her a refreshment & R50 transport money 
Visit 2 
14-18 weeks 
• Complete PFU  
• Complete BPMS 
• Complete UFU and UMS  
• Complete GPAQ and SBQ  
• Complete FFQ 
• Complete Visit 2 Lab Sheet  
• Complete BAS and MSE (if not completed previously) 
• Send her for a Scan- USD  (if not completed previously) 
• Complete Visit 1 Lab Sheet (if not completed previously) 
• Nurse to give participant her contact details (if not given previously) 
• Make a follow-up appointment for 5 weeks’ time/ for when she is 19-23 weeks 
pregnant 
• Give her a refreshment & R50 transport money 
Visit 3 
19-23 weeks 
• Complete PFU 
• Complete BPMS 
• Complete UFU and UMS 
• Complete Visit 3 Lab Sheet 
• Complete BAS and MSE (if not completed previously) 
• Send her for a Scan- USD  (if not completed previously)  
• Complete Visit 1 Lab Sheet (if not completed before) 
• Nurse to give participant her contact details (if not given previously) 
• Make a follow-up appointment for 5 weeks’ time/ for when she is 24-28 weeks 
pregnant 
• Remind her to fast overnight (from 10pm; can have water) for her next 
appointment 
• Give her a refreshment & R50 transport money 
Visit 4 
24- 28 weeks 
• Begin with OGTT 
• Complete GLUQ 
• Complete PFU 
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• Complete BPMS 
• Complete SSS 
• Complete UFU and UMS 
• Complete Visit 4 Lab Sheet 
• Complete BAS and MSE (if not completed previously) 
• Send her for a Scan- USD  (if not completed previously)  
• Complete Visit 1 Lab Sheet (if not completed before) 
• Nurse to give participant her contact details (if not given previously) 
• Make a follow-up appointment for 5 weeks’ time/ for when she is 29-33 weeks 
pregnant 
• Give her a refreshment & R50 transport money 
Visit 5 
29-33 weeks 
• Complete PFU 
• Complete BPMS 
• Complete UFU and UMS 
• Complete GPAQ and SBQ  
• Complete Visit 5 Lab Sheet 
• Complete BAS and MSE (if not completed previously) 
• Send her for a Scan- USD  (if not completed previously) 
• Complete Visit 1 Lab Sheet (if not completed previously) 
• Nurse to give participant her contact details (if not given previously) 
• Give instructions for delivery 
• Make a follow-up appointment for 5 weeks’ time/ for when she is 34-38 weeks 
pregnant 
• Instructions to be given around delivery 
• Give her a refreshment & R50 transport money 
Visit 6 
34-38 weeks 
• Complete PFU 
• Complete BPMS 
• Complete UFU and UMS 
• Complete PAI 
• Complete Visit 6 Lab Sheet 
• Complete BAS and MSE (if not completed previously) 
• Send her for a Scan- USD  (if not completed previously) 
• Complete Visit 1 Lab Sheet (if not completed previously) 
• Nurse to give participant her contact details (if not given previously) 
• Make a follow-up appointment for 5 weeks’ time/ for when she is 39-42 weeks 
pregnant (tell her she should come to that appointment if she is still pregnant) 
• Instructions to be given around delivery 
• Give her a refreshment & R50 transport money 
Visit 7 
39-42 weeks 
• Complete PFU 
• Complete BPMS 
• Complete UFU and UMS 
• Complete Visit 7 Lab Sheet 
• Complete BAS and MSE (if not completed previously) 
• Send her for a Scan- USD  (if not completed previously) 
• Complete Visit 1 Lab Sheet (if not completed previously) 
• Nurse to give participant her contact details (if not given previously) 
• Instructions to be given around delivery 
• Give her a refreshment & R50 transport money 
Delivery • Complete DEV  
228 
 
Appendix B: S1000 sample collection table 
 
Measurement Time Point 
 
Key: 
 Pregnancy Delivery Neonate 
 
Infant Follow-up  
Wks = Weeks  
 
Mnth = Months 
  
M = Mother 
 
F = Foetus
  
I = Infant 
 
FOB = Father 
of the Baby
  
BPD = 
Biparietal 
Diameter
  
OFD = 
Occipito-
Frontal 
Diameter
  
HC = Head 
Circumference 
  
SAT = 
Subcutaneous 
Adipose Tissue 
 
VAT = 
Visceral 
 <14 
Wks 
14-18 
Wks 
19-23 
Wks 
24-28 
Wks 
29-33 
Wks 
34-38 
Wks 
38-42 
Wks 
Del NN 6 
Wks 
2 
Mnth 
3 
Mnth 
6 
Mnth 
12 
Mnth 
18 
Mnth 
24  
Mnth 
Length/Height M         I M I I I I I I  I 
Weight M  M M M M M M  I M I M I M I M I M I M I M I 
Head Circumference F F F F F F   I I I I I I I I 
Baseline Info M                
Urine M M M M M M M          
Haemoglobin M M M M M M M          
Whole Blood M   M    M          
Serum M   M  M  M         
Plasma M   M    M         
Buffy Coat M   M    M         
HBA1C    M  M           
Ultrasound (BPD, OFD, 
HC, TAD, APAD, AC, 
FL, AFI) 
F F F F F F F          
Blood Pressure M M M M M M M   M I M I M I M I M I M I M I 
Capillary (Heel Prick) 
Dried Blood 
        I I  I I I  I 
Oral Glucose Tolerance 
Test 
   M             
Glucose Metabolism    M             
Fasting Glucose          M   M    
Lipids    M   M          
Cord Blood        M         
Placental Tissue        M         
Faeces        M         
PEAPOD         I I I I I    
DXA (Full Body Scan)         I M   M I I  M I 
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Breast Milk         M M  M     Adipose Tissue 
 
TAD = 
Transverse 
Abdominal 
Diameter
 
  
APAD = 
Anterior-
Posterior 
Abdominal 
Diameter
  
 
AC = 
Abdominal 
Circumference 
 
FL = Femur 
Length 
 
AFI = 
Amniotic Fluid 
Index 
 
PCR HIV Test          I       
Prenatal Attachment 
Inventory 
     M           
Food Frequency  M               
Sedentary Behaviour  M   M            
Global Physical Activity  M   M            
Breastfeeding Intentions         M        
Diet History & 24 Hour 
Recall & Weaning  
         M  M M M M  
Household Composition 
and Pregnancy 
M       M         
SES & Household 
Composition 
        FOB      M  M 
Morbidity & Illness Child 
Assessment 
         M M M M M M M 
Social Support Stress & 
Depression  
M   M    FOB  M   M   M 
Ages and Stages: Social 
Emotional 
            M    
Ages and Stages             M M  M 
Attachment              M   
Home Screening                M 
Reactivity/Temperament             M     
Clinic Link-Up M         I I I I I I I 
Executive Functioning                I 
Parenting Stress Index - 
Short Form 
              M  
Role of the Father 
Questionnaire 
            M    
Infant VAT and SAT by 
ultrasound 
         I I I I I I I 
Maternal beliefs 
Questionnaire 
            M M   
Maternal reported infant 
physical activity 
           I I I I  
Home environment 
Questionnaire 
           M M M M  
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Objective physical activity 
(Accelerometry) 
           M I M I M I M I M I 
Age at the attainment of 
developmental milestones 
           I I I I I 
InterBio Infant Follow-up 
Questionnaire 
             M  M 
Buccal Swabs              I  I 
Arm Circumference              I  I 
Tricep Skinfold              I  I 
Subscapular Skinfold              I  I 
Postnatal Abnormality 
Questionnaire 
             M  M 
24-Hour Food Recall              M   
InterBio FFQ              M   
Motor Development 
Assessment 
             I  I 
Food Intake Questionnaire                I 
Cognitive Functioning                I 
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Appendix C: PhD relevant data collection sheet 
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 Appendix D: Food frequency questionnaire 
 
  
 
Soweto Fetal Growth Study 
FOOD FREQUENCY QUESTIONNAIRE (FFQ) 2013 
 
 
 
 
 
  
  
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Participant’s date of birth (DD/MM/YYYY): _______________________________ 
 
BTT ID: ____________________________________________________________ 
(Her or her ♂ partner’s BTT ID) 
 
Partner ID: _________________________________________________________ 
(♀partner of a ♂ BTT participant) 
 
3G ID: _____________________________________________________________ 
Or 
 
INTERBIO ID: _______________________________________________________ 
       Or 
 
SFG ID: ____________________________________________________________ 
 
Interviewer’s name: __________________________________________________ 
 
Interview date: ______________________________________________________ 
FV: FFQ 
University of the Witwatersrand, Johannesburg 
Developmental Pathways for Health Research Unit 
Department of Paediatrics and Child Health 
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Food habits 
1. Are you on a special diet that has been prescribed for you e.g. by a doctor or one that you 
have adopted from someone e.g. a TV star/magazine? 
 
YES 1 
NO 0 
 
2. If NO, go to question 4. 
    If YES, describe what kind of diet you are on and where you got the diet from?  
 
________________________________________________________________ 
 
3. How long have you been on that diet?__________months/years. 
 
4. Do you currently take any vitamin and mineral supplements?    
 
YES 1 
NO 0 
   
    IF YES, what do you take? 
 
 
 Name of product Amount/day 
(or how many tablets) 
Vitamins/vitamins and minerals   
Tonics   
Vitamin D   
Calcium   
Body building preparations   
Dietary fibre supplement   
Other: specify 
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5. Which meals do you skip almost on a daily basis? 
 
 
 
 
 
 
6.  Is salt added to your food while it is being cooked? 
Always 1 
Sometimes 2 
Never 3 
Don’t know 4 
 
7.  Do you add salt to your food before you eat it? 
YES 1 
NO 0 
 
8.  If yes, how much salt do you add to your food each day? 
¼ teaspoon 1 
½ teaspoon 2 
¾ teaspoon 3 
1 teaspoon 4 
Other  specify: 
 
5 
 
9. Do you add Aromat to your food before you eat it? 
YES 1 
NO 0 
 
10. If yes, how much Aromat do you add to your food each day? 
¼ teaspoon 1 
½ teaspoon 2 
¾ teaspoon 3 
1 teaspoon 4 
Other  specify: 
 
5 
Breakfast 1 
Lunch 2 
Evening meal 3 
None 4 
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11. There are some factors which influence the choice of foods we eat.  Which of the 
following statements are true for you?  
 
 
 12. Do you ever eat outside the home  e.g. at  fast food shops such as Nandos, KFC and 
Steers?  
 
YES 1 
NO 0 
 
 
13.  If YES, in an average month how often do you eat at the following places?  
 
 Frequency of visits 
 Times/week Times/month Rarely/never 
Nandos    
Spur    
Macdonalds    
Steers    
KFC    
Chicken Licken    
Debonaire’s Pizza    
Romans    
Anat    
Wimpy    
Something fishy    
Fontana    
Chinese takeaway    
Other restaurants/takeaways    
(Quarters from tuck shop)    
    
 Strongly 
agree 
Agree Disagree Strongly 
Disagree 
I choose to eat certain foods because they taste 
good 
1 2 3 4 
The food I eat depends on whether it is expensive  1 2 3 4 
I choose to eat certain foods because it looks 
good 
1 2 3 4 
The food I choose to eat differs according to my 
mood (i.e. happy/sad) 
1 2 3 4 
My hunger level determines what type of food I 
eat. 
1 2 3 4 
I choose foods which are not time consuming to 
prepare 
1 2 3 4 
I consider whether a food is good for my health 
before eating the food. 
1 2 3 4 
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Generic 
Sketch 
(look 
up) 
A.  
Food items (with FPM numbers) 
B.  
Description of food 
item 
Tick 
for 
yes 
C.  
Item 
code 
D.  
Amount usually eaten(g) 
Generic/amount = g 
E.  
Eaten 
every 
day 
F.  
Eaten 
every 
week 
G.  
Eaten  
Occasi
onally  
H. 
Never 
eaten 
Grams (g) /day 
 
      Times/ 
day 
Times/ 
week 
   
 DAIRY-BLUE          
 1.Tea Ordinary  4038       
 Herbal  4053       
 Rooibos  4054       
 1. Sugar in tea   3989       
 2. Milk in tea Full cream  2718       
 Low fat 2%  2772       
 Skim fat free  2775       
 Other         
 1. Coffee   4037       
 2. Milk in coffee  Full cream  2718       
 Low fat 2%  2772       
  Skim fat free  2775       
  Other         
 2. Sugar in coffee   3989       
 2. Milk as a drink Full cream  2718       
 Low fat 2%  2772       
 Skim fat free  2775       
 3. Buttermilk/maas Buttermilk  2713       
 Maas  2787       
          
 4. Milk drinks, flavoured          
           
           
X 5. Yoghurt Fruit, LF, 
sweetened 
 2732       
  Plain LF  2734       
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Generic 
Sketch 
(look 
up) 
A.  
Food items (with FPM numbers) 
B.  
Description of food 
item 
Tick 
for 
yes 
 
C.  
Item 
code 
D.  
Amount usually eaten(g) 
Generic/amount = g 
E.  
Eaten 
every 
day 
F.  
Eaten 
every 
week 
G.  
Eaten  
Occasi
onally  
H. 
Never 
eaten 
Grams (g) /day 
 
      Times/ 
day 
Times/ 
week 
   
 3. Breakfast cereals          
 2. Milk added to cereal          
 1. Sugar added to cereal   3989       
 9. Ice cream Full cream  3519       
  Low fat  4325       
 9. Ice lollies   3982       
 ASK ABOUT TYPE OF BREAD,THICKNESS OF SLICES AND THE SPREAD  
 1. Bread/rolls  White  3210       
  Brown  3211       
  Whole wheat  3212       
  Traditional  3210       
 Toppings: Roti   ___ x 54g      
Meat           
Veg?           
           
 Spread? Y / N Brand name Do you use spread every day on your bread?    
 1. Brick margarine HM  3484       
 1. Tub margarine PUM  3496       
 1. other tub e.g. floro   3521       
 1. Butter   3479       
 Cheese spread WM  2730       
 Fish paste   3109       
 Honey/syrup   3988       
 Jam   3985       
circle Marmite/Bovril          
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Generic 
Sketch 
(look 
up) 
A.  
Food items (with FPM numbers) 
B.  
Description of food 
item 
Tick 
for 
yes 
C.  
Item 
code 
D.  
Amount usually eaten(g) 
Generic/amount = g 
E.  
Eaten 
every 
day 
F.  
Eaten 
every 
week 
G.  
Eaten  
Occasi
onally  
H. 
Never 
eaten 
Grams (g) 
/day 
 
      Times/ 
day 
Times/ 
week 
   
 Sandwich spread   3522       
 Peanut butter   3485       
 Chocolate spread          
 Cold meats Ham  2967       
  Polony  2919       
  Salami  2948       
 6. Cottage cheese Low fat  2729       
  Full fat  2759       
X 7. Cheddar    2722       
 7. Gouda   2723       
 7. Other cheese          
 8. Cheese wedges   2728       
 2. Fat cakes   3257       
 Any topping?          
(Red) QUARTER Tick toppings:         
 White bread   3210 ¼ loaf  = 225      
 Fried Chips   3740 1 portion = 90       
 Cheese   2722 ___ slices x 20 =      
 Polony / French    2919 ___ slices x 15=      
 Vienna (Russian)   2936 ___ unit x 40 =      
 Fried egg   2869 ___ medium x 45 =      
 Atchar   3117 ___ Tsp x 40 =      
 Tomato sauce   3139  ___Tsp x 25 =      
 Mashed potato   3876   ¼ cup = 62.5       
 Mince meat, regular   2987       
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Generic 
Sketch 
(look 
up) 
A.  
Food items (with FPM numbers) 
B.  
Description of food 
item 
Tick 
for 
yes 
C.  
Item 
code 
D.  
Amount usually eaten(g) 
Generic/amount = g 
E.  
Eaten 
every 
day 
F.  
Eaten 
every 
week 
G.  
Eaten  
Occasi
onally  
H. 
Never 
eaten 
Grams (g) 
/day 
 
      Times/ 
day 
Times/ 
week 
   
 4.  Maize porridge stiff     3400       
 4.  Maize porridge soft          
 2. Milk on soft porridge          
 1. Sugar on soft porridge   3989       
 1. Fat on soft porridge          
 4. Mabele/maltabella stiff   3241       
 4. Mabele soft          
 2. Milk on Mabele          
 1. Sugar on Mabele   3989       
 1. Fat on Mabele          
 4. Oats   3239       
 2. Milk on Oats          
 1. Sugar on Oats   3989       
 4. Maize & pumpkin porridge          
 5.  Pasta/Pasta dishes          
 Remember to ask about added cheese! Grated?         
           
           
 6. Spaghetti Bolognaise Regular mince  3260       
           
 6. Macaroni and cheese WH, HM  3301       
 6. Lasagne Regular  3261       
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Generic 
Sketch 
(look 
up) 
A.  
Food items (with FPM numbers) 
B.  
Description of food 
item 
Tick 
for 
yes 
C.  
Item 
code 
D.  
Amount usually eaten(g) 
Generic/amount = g 
E.  
Eaten 
every 
day 
F.  
Eaten 
every 
week 
G.  
Eaten  
Occasi
onally  
H. 
Never 
eaten 
Grams (g) /day 
 
      Times/ 
day 
Times/ 
week 
   
 7. Rice White  3247       
  Brown  3315       
circle 
 
circle 
Add anything?  
Inkomazi / 
Plain yoghurt LF/WM 
How much, 
t/T/S spoons? 
        
           
Tick Biryani: Chicken          
 Mutton          
 Vegetable          
 7. Samp/mealie rice With fat?         
 7. Samp and beans With fat?  3402       
 7. Wheat rice   3249       
 8. Pizza (toppings?)          
 8. Savoury tart          
X EGGS-YELLOW          
 Boiled/poached   2867       
 Fried  HM  2877       
  PUM  2878       
  Sun oil  2869       
Tick Scrambled LFM, PUM  2888       
  LFM, Sun oil  2889       
  WM, HM  2890       
  WM, Sun oil  2873       
  WM  2872       
 Omelette (tick scrambled & 
add topping here)  
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Generic 
Sketch 
(look 
up) 
A.  
Food items (with FPM numbers) 
B.  
Description of food 
item 
Tick 
for 
yes 
C.  
Item 
code 
D.  
Amount usually eaten(g) 
Generic/amount = g 
E.  
Eaten 
every 
day 
F.  
Eaten 
every 
week 
G.  
Eaten  
Occasi
onally  
H. 
Never 
eaten 
Grams (g) 
/day 
 
      Times/ 
day 
Times/ 
week 
   
 FRUITS-ORANGE          
X 1. Apples   4222       
X 2. Bananas Fresh  3540       
  Fried  3611       
 3. Berries Fresh         
  Candied         
X 4. Figs/prickly pears & Fresh         
 Coconuts, dates Candied         
 5. Fruit salad Fresh         
  Sugar added?         
  Canned juice  3667       
  Canned syrup  3580       
X 6. Grapes   3550       
X 7. Guavas Fresh  3551       
  Canned juice  3628       
  Canned syrup  3553       
X 8. Mango Fresh  3556       
  Canned syrup  3633       
 8. Pawpaw Fresh         
 8. Kiwi fruit   3660       
 8. Lychees   3632       
 9. Watermelons   3576       
X 9. Sweet melon          
  
248 
 
 
Generic 
Sketch 
(look 
up) 
A.  
Food items (with FPM 
numbers) 
B.  
Description of food 
item 
Tick 
for 
yes 
C.  
Item 
code 
D.  
Amount usually eaten(g) 
Generic/amount = g 
E.  
Eaten 
every 
day 
F.  
Eaten 
every 
week 
G.  
Eaten  
Occasi
onally  
H. 
Never 
eaten 
Grams (g) 
/day 
 
      Times/ 
day 
Times/ 
week 
   
X 10. Naartjies Mineola fresh  4227       
  Naartjie fresh  3558       
  Naartjie canned 
in syrup 
 3635       
X 11. Oranges Fresh  3560       
 11. Grapefruit Fresh  3546       
X 12. Peaches Fresh  3565       
  Canned juice  3640       
  Canned syrup  3567       
X 12. Nectarines Fresh  4228       
X 13. Pears Fresh  3582       
  Canned juice  3643       
  Canned syrup  3583       
 14. Pineapple Fresh  3581       
  Canned juice  3647       
  Canned syrup  3648       
X 15. Plums Fresh  3570       
 15. Apricots   3534       
 16. Dried fruit          
 16. Dry stewed fruit          
 16. Raisins   3552       
 17. Fruit juice Fresh         
  Sweetened         
  Unsweetened         
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Generic 
Sketch 
(look 
up) 
A.  
Food items (with FPM 
numbers) 
B.  
Description of food 
item 
Tick 
for 
yes 
C.  
Item 
code 
D.  
Amount usually eaten(g) 
Generic/amount = g 
E.  
Eaten 
every 
day 
F.  
Eaten 
every 
week 
G.  
Eaten  
Occasi
onally  
H. 
Never 
eaten 
 
      Times/ 
day 
Times/ 
week 
   
 SOUPS, LEGUMES, NUTS         
 1. Soups Powder, average  3158       
  Reconstituted 
(power + water) 
 3165       
  Vegetable  3162       
  Meat, lentil veg  3153       
  Dried bean, 
meat, veg 
 3145       
Type? 2. Beans (baked or other)          
Type? 2. Lentils          
Type? 3. Nuts           
 3. Peanuts           
     Peanuts & raisins          
 FISH & SEAFOOD- BEIGE      ask which type of fish was eaten?     Or if they don’t know what colour was the meat of the fish?  
 1. Fried fish ?         
 1. Fish cakes          
 1. Fish fingers          
Circ le 1. Calamari  Batter/ No batter         
Circle 
one 
2. Grilled/smoked/dried 
fish 
?         
 2. Haddock          
Circle 
one 
3. Pilchards & sardines Canned water  3055       
 Canned  Tomato sauce  3102       
  Mayonnaise  3488       
 3. Tuna Brine water  3054       
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Generic 
Sketch 
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 3. Tuna In oil  3056       
  Mayonnaise  3488       
 3. Pickled fish          
 MEAT- RED How do you eat meat?      1= with fat            2= fat trimmed  
 1. Roast beef          
 1. Beef chops          
 1. Beef steak (bone)          
 1. Beef steak (no bone)          
 1. Beef stir-fry          
 1. Beef stew / vegetable   3020       
 1. Beef stew / cabbage   3006       
 2. Beef patties   2984       
 2. Mince Regular  2987       
  With vegetables         
X 2. Meatballs  Egg / no egg         
 2. Cottage pie   3009       
 3. Burgers Bun  3210       
 please tick, quantify, brand 
names ( McDonalds bigmac) 
Patty: Beef  2984       
 Cheese slice  2722       
 Tomato sauce  3139       
  Mayonnaise  3488       
Meal? Chips (fried) Size?  3740       
 Soft drink  Size?  3981       
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 3. Hot dog Roll         
  Vienna         
  Tomato sauce  3139       
 3. Pita with…           
 3. Chicken burger Bun  3210       
 please tick, quantify, name of 
burger (e.g KFC twister) 
Crumbed, fried  3011       
 Cheese slice  2722       
 Tomato sauce  3139       
 Mayonnaise  3488       
Meal? Chips (fried) Size?  3740       
 Soft drink  Size?  3981       
 3. Chicken nuggets   3018       
 4. Chicken stew          
 4. Fried chicken pieces With skin         
  Without skin         
 4. Roast chicken With skin         
  Without skin         
 4. Chicken stir-fry          
 6. Fat cakes & mince          
 7. Meat pies which meat?          
Circle! 7. Samoosas Beef / lamb         
  Chicken          
Circle!  Veg / cheese & 
corn / potato 
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 7. Sausage rolls    2939       
 7. Spring rolls   2918       
 8. Mutton stew no veg          
 8. Mutton stew with veg          
 8. Mutton leg chop          
 8. Mutton loin chop   2927       
 8. Roast mutton   2947       
 9. Spare ribs   3010       
 9. Pork chops    2930       
 9. Bacon   2906       
 9. Roast pork          
 10. Pork sausages   2932       
 10. Viennas   2936       
Circle 10. Frankfurters Beef/pork/chicken         
 10. Boerewors   2931       
 11. Traditional / organ meats         
 Chicken livers   2970       
 Chicken giblets   2998       
 Chicken head   2999       
 Chicken feet   2997       
 Liver & fat   2920       
 Sheep intestine / lungs   4342       
 Shank pork/lamb/beef          
Circle Mopani worms Dried/ cooked         
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 12. Vegetarian products          
 13. Dry sausages   2949       
 13. Biltong   2912       
 VEGETABLES – GREEN         
 1. Asparagus Fresh boiled  3695       
  Canned boiled  4094       
 2. Avocado  Fresh  3656       
 3. Baby marrows Fresh boiled  4171       
 Brinjal (how cooked?)          
 Okra (how cooked?)          
 4. Beetroot  Boiled  3698       
Circle Grated / sliced Salad  3699       
 Chutney, onion,  Salad         
 5. Butternut Boiled  3759       
  Boiled Sugar added  3989       
  Sugar & fat added  4273       
 5.Pumpkin Boiled  4164       
  Sugar & fat added  3893       
 6. Broccoli,  
Fresh/frozen 
Boiled          
  Fat added  3808       
 6. Cauliflower Boiled  3716       
  Boiled + cheddar  3715       
 Quantify white/cheese sauce Pg 23         
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 7. Cabbage Boiled  3756       
 7.  ..with potato, onion HM  3813       
 7.  ..with potato, onion Sun oil  3815       
 7. coleslaw (mayo)   3705       
 7. Cabbage, fried HM  3810       
 7. Cabbage, fried Sun oil  3812       
 8. Carrots  Raw  3709       
 8. Carrots Boiled  3757       
  Sugar added  3818       
 9. Gem squash Boiled  3760       
  Boiled + sugar  3754       
 10. Green beans Boiled  3696       
 10.. with potato, onion No fat  3933       
 10.. with potato, onion HM  3792       
 10.. with potato, onion Sun oil  3794       
 11. Mealies Whole, boiled  4133       
  Whole, boiled canned  4134       
 11. Sweet corn          
 12. Mixed vegetables Canned, boiled  4264       
 carrot, corn, peas, green beans Frozen, boiled  3727       
 caulif’, carrot, green beans Frozen, boiled  4265       
  Fresh boiled, PUM  3836       
  Fresh boiled, HM  3835       
 13. Mushrooms Fried HM  3893       
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 13. Mushrooms Fried in Sun oil  3841       
 14. Peas Frozen boiled  4146       
  Boiled, sugar, HM  3859       
 15. Potatoes, Baked (ate flesh & skin)  3736       
  (ate skin only)  3970       
  (ate skin, sour 
cream & chives 
 3973       
 Boiled (ate skin & flesh)  4155       
  (ate no skin)  3737       
  HM  3867       
  PUM  3868       
 Croquette/cake   3915       
 Fried/sautéed HM  3871       
  Sun oil  3873       
 Frozen, boiled   4156       
 Mashed  (SM, PUM)  3875       
  (WM, HM)  3876       
 Roasted in.. .. beef fat  3878       
  .. chicken fat  3923       
  .. lamb fat  3735       
  .. pork fat  3956       
  ..Sun oil  3979       
 15. Potato Salad (mayonnaise)  3928       
 Potatoes, whole canned   4159       
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 16. Potato chips Fried in Sun oil  3740       
  Oven baked  3945       
  Mayonnaise  3488       
  Tomato sauce  3139       
 If take away where from?          
 17. Salad vegetables French  3921       
  Greek  4271       
 Dressing? See pg 19! Mixed green  3927       
 Raita (yoghurt, LF/ 
WM cucumber, tomato, 
onion)  
         
 17. Raw tomato    3750       
 17. Cucumber   3718       
 17. Peppers raw, green   3733       
 17. Onion, raw   3755       
 17. Onion, fried  HM  3844       
 17. Onion, fried  Sun oil         
 18. Spinach/morogo Boiled  3913       
  Boiled + HM         
  Boiled + PUM         
 18.. with potato, onion HM  3901       
 18.. with potato, onion Sun oil         
 19. Sweet potatoes Baked, ate skin only  3748       
  Boiled, no skin  3903       
  Sugar + HM  3749       
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 20. Tomatoes, cooked Fried,  onion  3925       
  Fried, onion, 
peppers 
        
  Fried, onion, 
peppers, carrots 
        
 Fried onions (only)          
           
 FATS-TAN ‘prompt’          
Circle 1. Tub margarine Where used         
Circle 1. Butter  / Ghee Number of spoons         
 1. Brick Margarine Number in family         
 2. White margarine 
(type of fat) 
         
 3. Cream and substitutes 
(brand, real dairy/plant fats) 
         
 4. Oils Where used         
  Number of spoons         
  Number in family         
 5. Salad dressings Homemade         
  Shop bought         
 5. Mayonnaise Where used         
  Number of spoons         
  Number in family         
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 BISCUITS, CAKE & PUDDING – PURPLE       
 1. Biscuits/cookies Commercial plain  3216       
Brand  Commercial, filling  3217       
  Homemade, plain  3341       
 2. Biscuits/savoury Provita  3235 ___ x 6 g      
  Ry-vita  3236 ___ x 5 g      
  Cream crackers  3230 ___ x 8 g      
 High fat (circle which one) Tuc/salticrax/kips  3331       
 Harvest wheat Whole wheat   3391       
 Spread?          
 Topping?          
 3. Special buns (hot 
cross, Danish, raisin) 
  3409       
 3. Muffins Bran  3407       
  Plain  3408       
 3. Scones Plain  3237       
 4. Tart          
 4. Cake (circle) Iced/Cream         
  Plain         
 5. Doughnuts Plain   3232       
 5. Doughnuts Jam  3423       
 5. Doughnuts Icing   3422       
 5. éclairs   3268       
 5. Koeksisters   3231       
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X 6. Pancakes/crumpets WM/Sun oil  3238       
 Toppings?          
           
 6. Waffles WM/Sun oil  3238       
 Toppings?          
 7. Baked pudding          
 7. Trifle          
 7. Custard          
 7. Instant pudding          
 8. Rusks Commercial  3329       
 9. Special breads Banana loaf  3333       
  Date loaf  3256       
  Raisin bread  3214       
 Spread?          
 SNACKS, SWEETS & COLD DRINKS-PINK        
 1. Carbonated cold 
drinks e.g. coke 
  3981       
           
 1. Diet cold drinks e.g. 
diet coke 
  3990       
 2. Mageu   4056       
 2. Cold drinks (powder)          
 2. Energy drinks   4007       
 2. Squashes   3982       
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Brands 3. Crisps, potato (lays)   3417       
Size &  
Circle! 
3. Crisps Savoury, (nik 
naks, fritos, ghost pops) 
  3418       
           
 3. Popcorn, plain   3332       
 3. Popcorn, sugar coated   3359       
 4. Sweets          
           
           
 Lollipops          
Brands 4. Chocolates          
Describe           
Sizes           
           
           
           
           
 SAUCES & CONDIMENTS-GREY         
 1. Cheese sauce    LFM, HM, cheese  3126       
  LFM, PUM, cheese  3127       
  SM, PUM, cheese  3128       
  WM, HM, cheese  3125       
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 1. White sauce LFM, HM  3143       
  LFM, PUM  3164       
  SM, PUM  3141       
  WM, HM  3142       
 2. Chakalaka          
 2. Atjar   3117       
 2. Tomato sauce & other          
 2. Chutney          
 ALCOHOLIC DRINKS-GREY         
 1. Beer  
(regular/low alcohol) 
         
 1. Cider          
 Coolers          
 2. Wine          
 2. Champagne          
 3. Spirits (any carbonated 
drink e.g. coke added) 
         
           
 4. Liqueurs & Fortified 
wine 
         
 OTHER:             
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Appendix E: Neonatal data collection sheet 
BABY PEAPOD & DXA STUDY  
 
 DATE:     
                                            Day                          Month                                          Year 
 
BTT ID :   ______________________________________________ 
INTERBIO ID: _______________________________________________ 
SFG ID:  _______________________________________________ 
NEONATAL ID: _______________________________________________ 
 
 DXA SCAN DONE? 
If Not done please describe : 
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
________________________________________________________________________________ 
 
PEAPOD DONE? 
IF Not done please describe: 
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________ 
Radiographer's  Name: _____________________________________________ 
 
        
YES NO 
YES NO 
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Participants Name: 
Gestational age: 
 
DATE OF 
BIRTH:   
MEASUREMENTS 
 
DATE OF MEASUREMENTS: 
 
Weight:  
   
Length:                    
                     
Head Circumference:  
Research Assistant:   
 
SECOND MEASUREMENTS: 
 
Weight:  
   
Length:                    
                     
Head Circumference:  
Research Assistant: 
 
Day    Month    Year     
      
    G 
  .  cm 
  .  cm 
 
    G 
  .  cm 
  .  cm 
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Appendix F: Soweto Fetal Growth Study (SFGS) information sheet 
 
 
 
 
 
 
 
 
FETAL GROWTH STUDY: 
INFORMATION SHEET 
Hello, my name is Professor Shane Norris, and I am a Researcher for the Department of Paediatrics at 
the University of Witwatersrand. Together with other colleagues from the University we will be 
conducting a research study to investigate the effects of nutrition on fetal growth and development. 
Before you decide to participate, we would like you to understand why the research is being done, and 
what it would involve for you and your baby. 
 
What is involved in the study? 
The study will be conducted at our offices in Chris Hani Baragwanath Hospital (MRC/Wits 
Developmental Pathways for Health Research Unit). For this study there are certain investigations 
that we will be performing at our offices, but you will still get your routine antenatal management and 
care at your local antenatal clinic.  
If you agree to take part in the study, we will collect the following research data: 
- 5 ultrasound scans at 4-6 weekly intervals.  At each scan, we will measure your baby, and the 
blood flow to the placenta and the baby.  Each ultrasound scan session will take 
approximately 30-60 minutes. 
- Blood samples for micronutrients and glucose metabolism. 
- Ask you a series of questions related to yourself and your pregnancy.  
- Weight and height for exploring weight gains and calculating BMI 
- An ultrasound scan measuring your subcutaneous fat will be conducted and will take 
approximately 10 minutes 
- Skinfold anthropometric measurements on your biceps and subscapular will be done 
and recorded and this will take approximately 10 minutes using callipers 
 
When you enroll in our study we will assign a Research Nurse to you so that you can contact her if 
you require any further advice or assistance during your pregnancy. You will also be required to 
Corner of College and Clinic Road                                       Telephone: +27-11-933-1122 
Chris Hani Baragwanath Hospital                                                                                                      Fax: +27-11-933-3242 
 MRC/WITS DEVELOPMENTAL PATHWAYS FOR HEALTH 
RESEARCH UNIT 
 
Department of Paediatrics, School of Clinical Medicine 
University of the Witwatersrand 
Johannesburg 
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contact the nurse when you go into labour so that she can arrange to be present at the delivery of your 
baby. At the delivery, the research nurse will take a cord blood sample, a faecal sample and your 
placenta for investigations. When your baby is born, we would like to weigh your baby and measure 
his/her length and head circumference. This is to help us better understand how babies grow.  
 
Procedures 
Interviewer-completed questionnaires 
At each visit at our offices, we will fill in some questionnaires with your help about your education, 
household circumstances and employment, your physical activity and dietary intake, events that have 
recently happened in your life and your health. We will also ask you questions around your pregnancy 
planning and menstrual and obstetric histories as well as some questions about your family. If you are 
uncomfortable about answering any of the questions you need not answer them.  
 
Anthropometric measurements 
Height (in mm) will be measured using a stadiometer (Holtain, UK) and converted to metres 
(m), and weight was measured to the nearest 0.1 kg using an electronic bathroom scale. All 
participants were measured wearing light clothing and without shoes. BMI will be calculated as 
weight in kilograms (kg) divided by height (m)
2
. 
Skinfold measurement will be taken on the bicep, triceps and subscapular sites using a skinfold 
caliper (Holtain, UK) to the nearest 0.2mm. Participants will be asked to remove excess clothing. All 
measurements will be carried out by a Research Assistant of the same sex as the participant. 
 
Blood taking 
A nurse will collect blood from you (from a vein in your arm) at these visits: 
1. Visit 1: (±15ml total; 3 teaspoons of blood) for biochemical analysis (e.g. Vitamin D, folate) 
and DNA analysis (see separate information and consent sheet). 
2. Visit 4: (±56ml total; 10 teaspoons) for glucose, insulin, and biochemical analysis (e.g. 
lipids and Vitamin D analysis etc). 
3. Visit 6: (±10ml total; 2 teaspoons) for DNA and RNA analysis (see separate consent sheet).
   
Sometimes when blood is taken you may feel a prick at the place where the needle enters your body. 
Afterwards there may be some slight bruising. Sterile, disposable syringes will be used once only so 
there is no chance of infection.  This procedure is safe and there is only a slight prick as the needle is 
placed through the skin.  There will be no charge for these blood tests. The results from the blood tests 
will be absolutely confidential; this means a code will be used instead of your name. We will tell you 
the results of your blood tests and explain them in detail so that you can understand what they mean. 
If the results indicate there is any health concern we will assist in referring you to the appropriate 
doctors.   
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Haemoglobin 
At each visit a nurse will perform a finger prick test on you to check your haemoglobin levels. 
Haemoglobin is a protein that carries oxygen in your blood.  
 
Ultrasound 
We would like to perform 5 ultrasounds (sonar examinations) on your baby at various stages during 
your pregnancy. Ultrasound measurements are safe and carry no risk to you or your baby. If any 
problems are detected on ultrasound we will refer you to the appropriate doctors at Chris Hani 
Baragwanath Hospital. It is important to realise that ultrasound is a screening technique, which means 
that it is not 100% effective in detecting fetal abnormalities and so sometimes problems with the baby 
can be missed. An ultrasound scan measuring your subcutaneous fat will be conducted and will 
take approximately 10 minutes and will be done at each visit for the pregnant woman. 
  
Urine dipstick test 
As part of each follow-up visit, we will collect a urine sample from you to perform a urine dipstick 
test, which can indicate if there is protein, blood, and sugar in your urine. The nurse will explain the 
test to you and provide you with the results immediately and counsel you on what the results mean. 
These tests will be done at all of your 5 visits. 
 
The Oral Glucose Tolerance Test 
When we eat certain foods our bodies break the food down into sugar (glucose) which provides us 
with energy. When our blood sugar levels rise our bodies produce a hormone called insulin to control 
the sugar levels. However, sometimes there can be too much sugar in our blood stream which can 
cause problems. One of the most common problems resulting from too much sugar is a condition 
called diabetes. Some women can develop diabetes during pregnancy without ever having had it 
before (this is called gestational diabetes). Developing diabetes during pregnancy can impact the 
mother’s and baby’s health. Therefore, we want to determine your glucose and insulin levels. 
 
When you are around 24-28 weeks (6-7 months) pregnant an oral glucose tolerance test (OGTT) will 
be performed on you. You will have to have fasted from 10pm the night before you come for this 
visit. You may drink water but must not eat any food or drink anything else. The test will involve you 
drinking approximately 1 cup of a sweet sugary drink. Before you drink the liquid a nurse will prick 
your finger to check your fasting blood sugar level and she will take two blood samples from a vein in 
your arm (one for glucose and one for insulin testing). You will then be given the sugary liquid to 
drink. This has to be drunk within 5 minutes. Thereafter, two blood samples will be taken from you at 
30 minutes, 1 hour and 2 hours after you have swallowed the drink. 
 
As soon as this test is completed we will offer you a sandwich and a drink.  
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Delivery Process 
You need to be booked into your local antenatal clinic for regular antenatal care and management. 
Usually, you will deliver your baby at the clinic at which you received your antenatal care. You will 
have a research nurse available to you throughout your pregnancy. Once you are ready to be admitted 
to hospital/clinic, you will need to contact the research nurse who will be present at your delivery. 
Once you have delivered your baby we will collect some biological samples; cord blood, a faecal 
sample and the placenta, and we would also like to measure your baby’s weight, length and head 
circumference.  
 
Possible risks 
Sample of blood: You may experience discomfort, bleeding, and/or bruising.  You may feel dizzy or 
faint.   
 
What to do if you have problems: If it is discovered that you may have a health problem when your 
blood results or other results are received, you will be notified and the right health care practitioner to 
help you with your problem and treatment will be recommended.  
 
Possible benefits: 
You will have 5 ultrasound scans which monitor the growth of your baby. If we find any problems 
during follow-up visits we will refer you to back to your antenatal clinic for further management and 
referral.   
 
Costs to you:   
Collecting a sample of blood and testing it in a research laboratory will not cost you anything. You 
will be given a sandwich and fruit juice once your measurements and assessments have been 
completed. You will also be given R50 for transport costs. 
 
Voluntary participation in research:  
You have the right to agree or refuse to participate in this research.  If you decide to participate and 
later change your mind, you are free to stop at any time. Your refusal to participate will not result in 
any penalty or loss of benefits to which you are otherwise entitled. 
 
Records of your participation in this research:  
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You have the right to privacy.  The principal investigator will keep information about your 
participation in locked files.  Your samples will be labelled with a code to ensure your privacy. 
 
 Ethical approval: This study protocol has been submitted to the University of the 
Witwatersrand’s, Human Research Ethics Committee (HREC), and written approval has been 
granted by that committee. Ethics Clearance number: M120524 
 
 Publication of the results of the research: The results of this research may appear in scientific 
publications without identifying you in any way. 
 
Your questions:  
The investigator listed on the first page of this form is available to answer your questions about this 
research. You may contact the investigator at any time on the following number (011) 933-1122. If 
you require any further information or have any questions/complaints about the study please contact 
the Human Research Ethics Committee of the University of the Witwatersrand on (011) 717-1234 or 
anisa.keshav@wits.ac.za 
 
YOU WILL HAVE A COPY OF THIS INFORMATION SHEET TO KEEP 
 
If you are happy to take part in the study please read and sign the attached consent form and contact 
us to confirm your participation. 
 
Your signature on the consent form certifies the following: 
· You have read the information provided in this consent form 
· You have received answers to all of your questions. 
· You have freely decided to participate in this research. 
· You understand that you are not giving up any of your legal rights 
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Appendix G: Soweto Fetal Growth Study (SFGS) consent sheet 
 
 
 
 
 
 
 
 
 
FETAL GROWTH STUDY: CONSENT SHEET 
 
I agree to myself being a participant in the study. The goals and methods of the study are clear to me. 
 
I understand that the study will involve interviews, measurements, collection of biological samples, 
blood taking, an oral glucose tolerance test and ultrasound examinations. All the details and purposes 
of this study have been explained to me. I understand that I have the right to refuse to participate in 
the study. 
 
I agree to participation in the study on the condition that: 
1. I can withdraw voluntarily from the study at any time and that no adverse consequences will follow 
on withdrawal from the study. 
2. I have the right not to answer any or all questions posed in the interviews and not to participate in 
any or all of the procedures / assessments. 
3. The University of the Witwatersrand’s Human Research Ethics committee has approved the study 
protocol and procedures. 
4. All results will be treated with the strictest confidentiality. 
5. Only group results, and not my individual results, will be published in scientific journals and in the 
media. 
6. The study scientific team are committed to treating participants with respect and privacy through 
interviews conducted in private and follow-up counselling available on request.   
7. I will receive a referral note to a health service if any result is out of the normal range or a problem 
is detected during the course of the study. 
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PARTICIPANT 
 
______________________________________________________________________________ 
Printed Name   Signature / Mark or Thumbprint  Date and Time 
 
RESEARCH ASSISTANT 
 
______________________________________________________________________________ 
Printed Name    Signature               Date and Time 
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Appendix H: Soweto Baby Growth Study (SBGS) information sheet 
 
 
 
 
 
 
 
 
 
 
 
 
THE SOWETO BABY GROWTH STUDY: 
INFORMATION SHEET 
Hello, my name is Professor Shane Norris, and I am a Researcher for the Department of Paediatrics at 
the University of Witwatersrand. Together with other colleagues from the University we will be 
conducting a research study to investigate the wellbeing of mothers and growth and development of 
babies over the first two years of the babies’ lives. Before you decide to participate, we would like 
you to understand why the research is being done, and what it would involve for you and your baby. 
 
What is involved in the study? 
The study will be conducted at our offices in Chris Hani Baragwanath Hospital (MRC/Wits 
Developmental Pathways for Health Research Unit). For this study there are certain investigations 
that we will be performing at our offices, but your baby will still need to go for his/her regular clinic 
and doctor checkups.   
 
We would like to collect data from you and your baby at various time points over the next two years 
(at delivery and then when your baby is 6 weeks and 2, 3, 6, 12, 18 & 24 months of age)  
 
If you agree to take part in the study, we will collect the following research data: 
- Your baby’s weight and length at each of the visits 
- Body composition measures on you and your baby (DXA and PeaPod)  
- Fasting blood glucose samples on you 
- Heel-pricks from your baby to test his/her glucose metabolism profile 
- Ask you a series of questions related to yourself and your baby 
- Adiposity for the infants (non-invasive) - Triceps, sub scapular and arm circumference: 
Skinfold measurement will be taken on the bicep, triceps and subscapular sites using a 
skinfold caliper (Holtain, UK) to the nearest 0.2mm. Participants will be asked to 
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remove excess clothing. All measurements will be carried out by a Research Assistant of 
the same sex as the participant. 
- A buccal swab from these infants at each 12 and 24 months will be collected. These 
samples would be used to compliment the samples already collected at delivery and 
allow us to investigate the effect of the intrauterine and early growth environments on 
the epigenome, which influences patterns of growth and development in infancy and 
childhood 
 
Procedures involving the mother 
 
Measurements 
- Your weight will be measured at every visit. 
- Adiposity: Biceps, Subscapular and subcutaneous fat (ultra sound). An ultrasound scan 
measuring your subcutaneous fat will be conducted and will take approximately 10 
minutes and will be done at each visit for the mother. 
- An ultrasound scan measuring your subcutaneous fat will be conducted and will take 
approximately 10 minutes 
- Skinfold anthropometric measurements on your biceps and subscapular will be done 
and recorded and this will take approximately 10 minutes using callipers 
 
Interviewer-completed questionnaires 
At each visit at our offices, we will fill in some questionnaires with your help about your education, 
household circumstances and employment, your dietary intake and events that have recently happened 
in your life. We will also ask you some questions around your feeding practices for you baby as well 
as some questions about your interaction with and feelings around your baby   If you are 
uncomfortable about answering any of the questions you need not answer them. Each questionnaire 
will take approximately one hour to complete.  
 
Blood taking for maternal fasting glucose 
When we eat certain foods our bodies break the food down into sugar (glucose) which provides us 
with energy. When our blood sugar levels rise our bodies produce a hormone called insulin to control 
the sugar levels. However, sometimes there can be too much sugar in our blood stream which can 
cause problems. One of the most common problems resulting from too much sugar is a condition 
called diabetes. Diabetes can impact seriously on your health. Therefore, we want to determine your 
fasting glucose levels. 
 
A nurse will collect blood from you (from a vein in your arm) at two visits (at the 6 week visit and at 
the six month visit). You will have to have fasted from 10pm the night before you come for these 
visits. Approximately 5ml of blood (1 teaspoon of blood) will be taken from you for glucose analysis. 
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Your samples will be analysed in the laboratory soon after they have been taken and results will be 
given to you at your next visit. 
 
Sometimes when blood is taken you may feel a prick at the place where the needle enters your body. 
Afterwards there may be some slight bruising. Sterile, disposable syringes will be used once only so 
there is no chance of infection.  This procedure is safe and there is only a slight prick as the needle is 
placed through the skin.  There will be no charge for this blood test. The results from the blood test 
will be absolutely confidential; this means a code will be used instead of your name. We will tell you 
the results of your blood test and explain them in detail so that you can understand what they mean. If 
the results indicate there is any concern regarding your glucose levels we will assist in referring you to 
the appropriate doctors. 
 
Duel-energy X-ray Absorptiometry (DXA) 
DXA is a full body scan which determines your muscle, fat and bone mass. You will lie on a bed and 
then a machine will move over you (it does not touch you) and sends an image to the computer of 
your bone, fat and muscle composition. The levels of radiation in DXA are extremely low. A DXA 
scan will be performed on you at your 6 weeks, 6 month and 24 month visits.  
 
Procedures involving the baby 
 
Measurements 
At every visit we would like to measure the baby’s weight, length/height and head circumference. 
 
Biological samples taken on your baby 
 Heel prick 
When your baby is 3, 12 and 24 months old we would like to take a heel prick from him/her. A heel 
prick involves pricking the heel of the baby with a small needles and putting the drop of blood on a 
special card. The blood dries on this card and we can then test the blood. The heel prick blood spots 
will be used to assess your baby’s diabetes risk. Our laboratory will test the heel prick blood spots for 
insulin, glucose, C-Peptide and IGF1; all factors involved in glucose metabolism (how the body 
breaks down sugar). 
 
Pricking the heel may cause the baby some discomfort and so some babies may cry when the heel 
prick is performed but, the actual procedure is not harmful to the baby.  As with all blood taking 
procedures, a new clean sterile needle will be used.  
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Buccal swabs 
A buccal swab from these infants at 12 and 24 months will be collected. These samples would be 
used to compliment the samples already collected at delivery and allow us to investigate the 
effect of the intrauterine and early growth environments on the epigenome, which influences 
patterns of growth and development in infancy and childhood 
 
PeaPod  
The PeaPod is a machine that determines infant body composition. The machine is safe and non-
invasive. The process entails the baby being placed into a warmed test chamber where body mass and 
body volume is measured. The baby will lie inside the chamber for a few minutes and you will be able 
to see him/her through a glass lid. PeaPod assessments will be done at delivery then when the baby is 
6 weeks old and again when he/she is 2, 3 and 6 months old. 
 
Duel-energy X-ray Absorptiometry (DXA) 
DXA is a full body scan which determines your muscle, fat and bone mass. Your baby will lie on a 
bed and then a machine will move over him/her (it does not touch the baby) and sends an image to the 
computer of the baby’s bone, fat and muscle composition. The levels of radiation in DXA are 
extremely low. DXA scans will be performed on your baby at delivery and when he/she is 6, 12 and 
24 months old. 
 
Possible risks 
Sample of blood: You may experience discomfort, bleeding, and/or bruising.  You may feel dizzy or 
faint.   
 
What to do if you have or your child has problems: If it is discovered that you or your child have a 
health problem when the blood results or other results are received, you will be notified and the right 
health care practitioner to help you with the problem and treatment will be recommended.  
 
There are chances that some of the questions we ask might trigger some emotional set-backs. If this 
does occur one of our midwives trained in counselling will be available to talk with you and then we 
can refer you to the Psychology Unit at Chris Hani Baragwanath Hospital where you will be given an 
appointment with a psychologist. 
 
Possible benefits: 
If we find any problems during the visits we will refer you to the appropriate medical professionals 
further management and referral.   
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Costs to you:   
Participating in the research will involve no cost to you. You will be given a sandwich and fruit juice 
once your measurements and assessments have been completed. You will also be given R75 for 
transport costs. 
 
Voluntary participation in research:  
You have the right to agree or refuse to participate in this research.  If you decide to participate and 
later change your mind, you are free to stop at any time. Your refusal to participate will not result in 
any penalty or loss of benefits to which you are otherwise entitled. 
 
Records of your participation in this research:  
You have the right to privacy.  The principal investigator will keep information about your 
participation in locked files.  Your samples will be labelled with a code to ensure your privacy. 
 
 Ethical approval: This study protocol has been submitted to the University of the 
Witwatersrand’s, Human Research Ethics Committee (HREC), and written approval has been 
granted by that committee. Ethics Clearance number:  
 
 Publication of the results of the research: The results of this research may appear in scientific 
publications without identifying you in any way. 
 
Your questions:  
The investigator listed on the first page of this form is available to answer your questions about this 
research. You may contact the investigator at any time on the following number (011) 933-1122. If 
you require any further information or have any questions/complaints about the study please contact 
the Human Research Ethics Committee of the University of the Witwatersrand on (011) 717-1234 or 
anisa.keshav@wits.ac.za 
 
YOU WILL HAVE A COPY OF THIS INFORMATION SHEET TO KEEP 
 
If you are happy to take part in the study please read and sign the attached consent form and contact 
us to confirm your participation. 
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Your signature on the consent form certifies the following: 
· You have read the information provided in this consent form 
· You have received answers to all of your questions. 
· You have freely decided to participate in this research. 
· You understand that you are not giving up any of your legal rights. 
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Appendix I: Soweto Baby Growth Study (SBGS) consent sheet  
 
 
 
 
 
 
 
 
 
THE SOWETO BABY GROWTH STUDY: CONSENT SHEET 
 
I agree to myself and my child being participants in the study. The goals and methods of the study are 
clear to me. 
 
I understand that the study will involve interviews, measurements, blood taking, and body 
composition assessments. All the details and purposes of this study have been explained to me. I 
understand that I have the right to refuse to participate in the study. 
 
I agree to participation in the study on the condition that: 
1. I can withdraw voluntarily from the study at any time and that no adverse consequences will follow 
on withdrawal from the study. 
2. I have the right not to answer any or all questions posed in the interviews and not to participate in 
any or all of the procedures / assessments. 
3. The University of the Witwatersrand’s Human Research Ethics committee has approved the study 
protocol and procedures. 
4. All results will be treated with the strictest confidentiality. 
5. Only group results, and not my individual results, will be published in scientific journals and in the 
media. 
6. The study scientific team are committed to treating participants with respect and privacy through 
interviews conducted in private and follow-up counselling available on request.   
7. I will receive a referral note to a health service if any result is out of the normal range or a problem 
is detected during the course of the study. 
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MOTHER OF CHILD 
 
________________________________________________________________________________ 
Printed Name   Signature / Mark or Thumbprint  Date and Time 
 
 
RESEARCH ASSISTANT 
________________________________________________________________________________ 
Printed Name    Signature    Date and Time 
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Appendix J: Soweto Fetal Growth Study (SFGS) ethical clearance certificate 
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Appendix K: Soweto Baby Growth Study (SBGS) ethical clearance certificate 
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Appendix L: PhD study ethical clearance certificate 
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Appendix M: Supplementary tables and figures 
 
 
 
 
Supplementary figure 1: Scree plot of eigenvalues after principal component 
analysis (PCA)  
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Supplementary table 1: Associations between maternal characteristics and dietary pattern 
scores (n=538) 
Variable  Dietary pattern 
Western Traditional Mixed  
Maternal characteristics    
Age, y    
<25 0.68 ± 2.27 -0.16 ± 1.78 0.10 ± 1.66 
25-29 0.21 ± 2.12 -0.21 ± 1.81 -0.06 ± 1.52 
30-34 -0.22 ± 1.96
b
 0.10 ± 1.68 0.06 ± 1.69 
35-39 -0.47 ± 1.64
b
 0.37 ± 1.84 -0.00 ± 1.65 
≥40 -0.97 ± 1.36bc 0.03 ± 1.36 -0.30 ± 1.41 
p-value
a
 <0.001 0.094 0.745 
Parity    
Para 0 0.15 ± 1.97 -0.39 ± 1.40 -0.11 ± 1.38 
Para 1 0.23 ± 2.12 0.22 ± 1.91
e
 0.20 ± 1.74 
Para ≥2 -0.44 ± 1.93d -0.00 ± 1.74 -0.19 ± 1.57f 
p-value
a
 0.003 0.006 0.034 
HIV status    
HIV-negative -0.06 ± 2.05 -0.03 ± 1.67 0.05 ± 1.56 
HIV-positive (pre-pregnancy ART) 0.23 ± 2.19 0.40 ± 2.20 -0.02 ± 1.81 
HIV-positive (antenatal ART) 0.05 ± 1.92 -0.13 ± 1.73 -0.14 ± 1.64 
p-value
a
 0.560 0.126 0.538 
Smokes/chews tobacco    
No -0.02 ± 2.06 0.03 ± 1.76 0.06 ± 1.63 
Yes 0.15 ± 1.91 -0.23 ± 1.71 -0.42 ± 1.40 
p-value
a
 0.512 0.239 0.019 
Socioeconomic characteristics    
Maternal education    
Primary -1.54 ± 1.29 -0.41 ± 1.29 0.15 ± 1.92 
Secondary -0.07 ± 2.05 -0.01 ± 1.74 -0.04 ± 1.64 
Tertiary 0.28 ± 2.01
g
 0.06 ± 1.84 0.08 ± 1.53 
p-value
a
 0.011 0.704 0.700 
Marital status (n=509)    
Single 0.15 ± 2.15 -0.14 ± 1.66 0.07 ± 1.61 
Married/cohabiting -0.24 ± 1.84 0.20 ± 1.88 -0.08 ± 1.61 
p-value
a
 0.035 0.032 0.315 
Household SES    
Low -0.10 ± 2.15 0.00 ± 1.75 -0.67 ± 1.59 
Medium 0.00 ± 2.01 0.03 ± 1.77 0.11 ± 1.61
h
 
High 0.22 ± 1.82 -0.44 ± 1.57 0.15 ± 1.30
i
 
p-value
a
 0.759 0.353 <0.001 
Anthropometry    
BMI at recruitment, kg/m
2
 (<14 weeks)    
Normal weight  0.06 ± 2.06 0.10 ± 1.91 0.09 ± 1.62 
Overweight -0.09 ± 1.98 -0.12 ± 1.63 -0.15 ±  1.47 
Obese 0.03 ± 2.09 0.02 ± 1.72 0.06 ± 1.75 
p-value
a
 0.736 0.460 0.289 
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Gestational weight gain, kg/w   
Normal weight   
Inadequate (<0.35) -0.29 ± 2.02 0.22 ± 2.11 0.04 ± 1.73 
Adequate (0.35-0.50) -0.09 ± 2.01 0.43 ± 2.02 0.27 ± 1.51 
Excessive (>0.50) 0.44 ± 2.09 -0.21 ± 1.63 0.01 ± 1.63 
p-value
a
 0.117 0.152 0.313 
    
Overweight    
Inadequate (<0.23) -0.31 ± 1.55 0.10 ± 1.50 -0.47 ± 1.40 
Adequate (0.23-0.33) -0.19 ± 1.93 -0.08 ± 1.66 -0.48 ± 1.20 
Excessive (>0.33) 0.01 ± 2.12 -0.20 ± 1.67 0.04 ± 1.52 
p-value
a
 0.656 0.597 0.064 
    
Obese    
Inadequate (<0.17) 0.21 ± 2.32 0.06 ± 2.05 -0.01 ± 1.96 
Adequate (0.17-0.27) 0.18 ± 2.29 -0.28 ± 1.37 0.03 ± 1.50 
Excessive (>0.27) -0.06 ± 1.97 0.09 ± 1.69 0.10 ± 1.75 
p-value
a
 0.742 0.614 0.951 
    
Dietary pattern scores presented as mean ±SD                                                                                                                                                                
Normal weight, BMI 18.5-24.9kg/m
2
; overweight, BMI 25-29.9kg/m
2; obese, BMI ≥30kg/m2                                                                                                                                                                          
a
Independent t-test (two groups) or analysis of variance (ANOVA) (more than two groups)                                                                                                           
b
Tukey post-hoc test: p<0.01 vs. <25 years                                                                                                                                   
c
Tukey post-hoc test: p<0.05 vs. 25-29 years                                                                                                              
d
Tukey post-hoc test: p<0.05 vs. para 0; P<0.01 vs. para 1                                                                                                                       
e
Tukey post-hoc test: p<0.01 vs. para 0                                                                                                                                              
f
Tukey post-hoc test: p<0.05 vs. para 1                                                                                                                                                                                                                                                       
g
Tukey post-hoc test: p<0.05 vs. primary education                                                                                                                                                                      
h
Tukey post-hoc test: p<0.001 vs. low SES                                                                                                                                                                                           
i
Tukey post-hoc test: p<0.05 vs. low SE 
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Supplementary table 2: Factor loadings of various foods or food groups in the principal 
dietary components identified in those pregnant black South African women included in 
analyses for objective 4 (n=393) 
Traditional diet pattern 
Food or food group Factor loading 
Other vegetables 0.366 
Beans and pulses 0.319 
Green vegetables 0.299 
Salad vegetables 0.292 
Boiled and baked potatoes 0.230 
Maize, sorghum and oat porridge 0.220 
Vegetable dishes 0.220 
Root vegetables 0.218 
Offal and traditional meats 0.204 
Chicken and turkey 0.196 
Other fruit 0.175 
Crackers 0.167 
Citrus fruit 0.165 
Crisps and popcorn 0.162 
Diet soft drinks 0.162 
Rice and pasta 0.141 
Eggs and egg dishes 0.114 
Tinned vegetables  0.112 
Fish and seafood 0.095 
Puddings 0.083 
Red meat 0.075 
Miscellaneous (soup powder,  
condiments, sauces, etc.) 0.073 
Brown and wholemeal bread 0.072 
Cakes and biscuits 0.063 
Yoghurt, buttermilk and maas 0.063 
Cream 0.061 
Nuts and nut spreads 0.044 
Soft drinks 0.044 
Cooking fats and salad oils 0.043 
Reduced-fat milk 0.041 
Cooked and tinned fruit 0.029 
Full-fat milk 0.012 
Processed meat 0.009 
Sweets and chocolate 0.009 
Added sugar (teaspoons) 0.007 
Decaffeinated tea and coffee 0.006 
Dried fruit -0.003 
Fruit juice -0.020 
Tea and coffee -0.024 
Fat cakes and samosas -0.045 
Reduced-fat spread -0.045 
Roast potatoes and chips -0.052 
Full-fat spread -0.056 
Quiche and pizza -0.056 
Sweet spreads -0.091 
Breakfast cereals -0.093 
Cheese and cottage cheese -0.103 
White bread -0.188 
Explained variance (%)  6.8 
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Foods or food groups with factor loadings ≥0.2 were classified as 
characteristic to the dietary pattern and therefore used to describe it 
(illustrated in bold)
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Supplementary table 3: Neonatal anthropometry and body composition according to 
maternal and neonatal characteristics in urban black South Africans 
  
Total 
sample 
(n=393) 
Weight to 
length ratio 
(kg/m) 
Sub-
sample 
(n=171) 
Fat mass index    
(kg/m
3
)
b
 
  % Median (IQR) % Median (IQR) 
Maternal variables 
    
Demographic and health characteristics 
    
Maternal age, y 
    
<25 91 6.4 (5.8-6.8) 34 3.6 (2.9-4.4) 
25-29 105 6.3 (5.9-6.7) 42 3.8 (3.0-4.2) 
30-34 97 6.5 (6.0-6.9) 46 3.9 (2.9-4.8) 
35-39 79 6.2 (5.6-6.7) 39 3.6 (2.8-4.6) 
≥40 21 6.4 (6.1-6.7) 10 3.2 (2.1-4.6) 
p-value
a
 
 
0.052 
 
0.520 
Parity 
    
Para 0 97 6.1 (5.6-6.6) 44 3.1 (2.6-3.7) 
Para 1 177 6.4 (6.0-6.8) 71 3.9 (3.2-4.7) 
Para ≥2 119 6.4 (6.0-6.8) 56 3.9 (2.9-4.8) 
p-value
a
 
 
0.010 
 
0.004 
HIV status 
    
HIV-negative 258 6.4 (6.0-6.8) 114 3.6 (2.9-4.2) 
HIV-positive (antenatal ART) 92 6.4 (5.8-6.8) 42 3.9 (2.9-4.8) 
HIV-positive (pre-pregnancy ART) 43 6.3 (5.8-6.7) 15 4.0 (3.5-5.5) 
p-value
a
 
 
0.826 
 
0.066 
Smokes/chews tobacco 
    
No 341 6.4 (5.9-6.8) 148 3.6 (3.0-4.6) 
Yes 52 6.2 (5.9-6.6) 23 3.4 (2.4-4.7) 
p-value
a
 
 
0.450 
 
0.489 
Socioeconomic characteristics 
    
Maternal education 
    
Primary 7 6.4 (5.6-6.5) 4 4.1 (3.6-4.7) 
Secondary 277 6.4 (5.9-6.8) 118 3.6 (2.9-4.6) 
Tertiary 109 6.3 (6.0-6.8) 49 3.6 (2.9-4.6) 
p-value
a
 
 
0.496 
 
0.655 
Marital status [n=387] 
    
Single 236 6.4 (5.8-6.8) 103 3.6 (2.9-4.7) 
Married/cohabiting 151 6.4 (5.9-6.8) 64 3.8 (3.0-4.6) 
p-value
a
 
 
0.613 
 
0.594 
Household socioeconomic status 
 
 
 
 Low 51 6.2 (6.0-6.5) 23 3.7 (2.7-4.0) 
Medium 315 6.4 (5.9-6.8) 135 3.6 (2.9-4.7) 
High 27 6.4 (5.7-6.8) 13 3.1 (2.8-4.6) 
p-value
a
 
 
0.518 
 
 0.464 
Anthropometry 
    
BMI at recruitment, kg/m
2
 (<14 weeks) 
 
 
 
 Normal weight (18.5-24.9) 136 6.3 (5.8-6.6) 55 3.6 (2.7-4.0) 
Overweight (25-29.9) 137 6.3 (5.8-6.8) 62 3.9 (2.9-4.7) 
Obese (≥30) 120 6.5 (6.0-6.9) 54 3.7 (3.2-4.6) 
p-value
a
 
 
0.028 
 
 0.488 
GWG, kg/week 
  
 
 Inadequate 79 6.3 (5.5-6.7) 35 3.6 (2.5-4.6) 
Adequate 86 6.2 (5.7-6.6) 39 3.6 (2.5-4.6) 
Excessive 228 6.4 (6.0-6.9) 97 3.7 (2.9-4.7) 
p-value
a
 
 
0.007 
 
0.593 
Traditional dietary pattern adherence 
    
Traditional pattern score 
    
T1 (high) 131 6.3 (5.9-6.8) 71 3.8 (3.1-4.6) 
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T2 131 6.4 (6.0-6.8) 55 3.7 (2.5-4.4) 
T3 (low) 131 6.3 (5.8-6.7) 45 3.6 (2.8-4.6) 
p-value
a
 
 
 0.368 
 
0.441 
Neonatal variables 
    
Sex 
 
   
Male 204 6.4 (5.9-6.8) 97 3.5 (2.5-4.4) 
Female 189 6.4 (5.9-6.7) 74 3.7 (3.2-4.8) 
p-value
a
 
 
0.947 
 
0.034 
Gestational age at birth, w 
 
   
37-38 144 6.2 (5.7-6.7) 71 3.6 (2.9-4.6) 
39-40 219 6.4 (6.0-6.8) 87 3.7 (2.8-4.6) 
41-42 30 6.5 (6.1-7.2) 13 3.4 (3.0-3.7) 
p-value
a
   0.003   0.744 
Abbreviations: ART, antiretroviral treatment; BMI, body mass index; FMI, fat mass index; GWG, 
gestational weight gain; WLR, weight-to-length ratio                                                                                                                     
IoM GWG ranges (kg/week): inadequate, normal weight <0.35, overweight <0.23,  obese  <0.17; adequate, 
normal weight 0.35-0.50, overweight 0.23-0.33,  obese  0.17-0.27; excessive, normal weight >0.50, 
overweight >0.33,  obese  >0.27                                                                                                                                                                                                                       
a
Kruskal-Wallis test; significant results are presented in bold (p<0.05)                                                                                              
b
Measured by air displacement plethysmography (ADP; Peapod) or dual-energy x-ray absorptiometry 
(DXA) corrected for the measurement differences between techniques                                                                                                                                                                                                                                                                                                              
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